[" denosumab amgen june u.s. food drug administration fda prolia november denosumab rankl fda denosumab rankl rankl denosumab rank rankl rank-ligand rankl denosumab rankl rankl august amgen advisory committee reproductive health drugs acrhd fda committee prolia october u.s. food drug administration fda june fda november fda june fda december committee medicinal products human use chmp denosumab european commission rankl", " propoxycaine inn", " tadalafil ed cialis adcirca october u.s. food drug administration fda cialis bph bph ed icos lilly icos llc icos corporation eli lilly company cialis tadalafil tadacip cipla november fda cialis ed viagra hydrochloride cialis november eli lilly united therapeutics tadalafil u.s. food drug administration naion naion naion fda october fda tadalafil viagra cialis sildenafil cyclic gmp tadalafil june european commission cialis u.s. fda cialis ed adcirca tadalafil october u.s. fda bph bph fda bph ed tadalafil pde sildenafil sildenafil tadalafil fda viagra sildenafil march ed subsequently fda levitra august cialis november cialis glaxo wellcome glaxosmithkline glaxo icos bothell icos corporation pfizer icos ed icos ed fda glaxo icos glaxo icos corporation eli lilly lilly icos llc ed lilly icos llc fda cialis lilly icos american urological association fda cialis viagra levitra cialis viagra eli lilly company icos corporation eli lilly cialis icos icos icos cmc biopharmaceuticals cmc eli lilly company october u.s. fda bph bph fda bph ed fda grey worldwide agency grey global group cialis cialis stuart elliot times cialis levitra viagra cialis cialis ed cialis fda cialis super bowl super bowl fda cialis super bowl cialis cialis super bowl lilly-icos pfizer glaxosmithkline cialis viagra levitra cialis america cup pga tour pga tour western open", " etaracizumab abegrin medimmune", " complex cardiac depolarization bursa diseases", " american english", " bevacizumab avastin bevacizumab vegf-a vegf-a bevacizumab bevacizumab u.s. food drug administration fda world health organization list essential medicines bevacizumab fda february bevacizumab ema january fda eastern cooperative oncology group sandler nejm sandler jto avail oncol avail european vs clin colorectal cancer avaperl october barlesi eccm maintenance vs pfs vs hr national comprehensive cancer network december fda june fda roche u.s. june fda avastin october u.s. food drug administration fda fda eu bevacizumab fda cochrane amd vegf vegf bevacizumab cnv amd fda cnv bevacizumab clinical bevacizumab december fda hoffmann-la roche bevacizumab hamster ovary bevacizumab vegf napoleone ferrara ferrara vegf judah folkman avastin avastin fda november fda fda july fda genentech june fda november fda nhs cancer drugs fund january uk u.k. national institute health clinical nhs scottish medicines consortium nhs avastin robert j. mayer new journal medicine cad amd april uk amd uk european medicines agency medicines healthcare products regulatory agency avastin amd general medical council uk avastin national health service novartis roche avastin avastin amd avastin avastin amd fda national comprehensive cancer network nccn nccn clinical practice oncology breast cancer avastin genentech fda bevacizumab fda march european commission tuesday february roche u.s. genentech avastin roche avastin roche avastin july plantform pharmapraxis fraunhofer center molecular biology september specialty fda mitigation strategy rems ims health affordable healthcare act april bevacizumab iii bevacizumab bevacizumab ret vandetanib vegfr egfr cabozantinib", " linezolid linezolid vre staphylococcus mrsa linezolid pharmacia upjohn company world health organization list essential medicines u.s. food drug administration fda enterococcus s. s. s. s. mrsa linezolid sstis gram-positive sstis clinical thoracic society diseases society america mrsa mrsa thoracic society linezolid u.s. mrsa linezolid low linezolid diseases society america vre mrsa linezolid mrsa march fda iii january linezolid fda linezolid u.s. linezolid enterococcus staphylococcus staphylococcus mrsa listeria linezolid nocardia linezolid linezolid enterobacteriaceae fusobacterium legionella elizabethkingia haemophilus capnocytophaga linezolid mrsa targocid e. cubicin linezolid qt cdad c. cdad bone chemotherapy cipn melbourne iii bell linezolid maoi maois linezolid cyp linezolid peak linezolid csf csf csf linezolid rna linezolid haloarcula yale university protein data bank deinococcus ph linezolid upjohn upjohn later dr. reddy hunan university changsha hunan june annual green chemistry engineering conference pfizer enterococcus staphylococcus s. annual appraisal spectrum study s. e. rna e. rna abc staphylococcus e.i. nemours dupont dupont early pharmacia upjohn pfizer linezolid u.s. food drug administration fda april june january april latin america asia rbx linezolid u.s. pfizer food drug administration zyvox linezolid pfizer zyvox zyvoxid zyvoxam cipla nezocin brookes lizomed aglowmed linzolid incepta", " tenofovir hiv world health organization list essential medicines gilead sciences viread tdf cochrane hiv hiv u. s. centers disease control prevention cdc ministry public health mid-june hiv tenofovir tenofovir fanconi tenofovir tenofovir dna dna tenofovir dna dna dna nrti hiv tenofovir anton\u00edn hol\u00fd institute organic chemistry biochemistry academy sciences czech republic prague hol\u00fd hiv clercq holy pmpa hiv gilead sciences pmpa hiv gilead university san francisco tenofovir u.s. fda october hiv august tenofovir reviro dr. reddy laboratories tenofovir truvada atripla fda july hiv tenofovir", " fixed-dose", " formation low elevated george gulliver joseph jackson lister william addison lionel beale max schultze queen college birmingham birmingham university dr hill norris giulio bizzozero schultz it. william osler james wright platelet coulter von willibrand thrombus von willebrand vwf vwf vwf platelet vwf gpvi el pgi endothelial-adpase adp amp gs adp adp adpase adp clopidogrel platelet gpvi fc receptor vii thrombin gq gq gi thrombin platelet gpiib mitochondria intraplatelet el ocs platelet gpiib gpiib gpiib gpiib gpiib va viia xi pdgf adp duke nsaids aspirin dna nsaid platelet platelet industry standards blood banks transfusion services prp uv uva storage a-b-o rbcs rbcs rbcs pdgf tgf platelet-rich prp", " talizumab tanox houston ige ige-expressing ige talizumab national medical research center u. s. u.s. food drug administration fda houston tanox nancy t. chang tse wen chang tanox tanox novartis genentech tanox ciba-geigy tanox tanox ciba-geigy note ciba-geigy sandoz novartis genentech geigy xolair genentech tanox novartis genentech tanox ii tanox tanox genentech novartis tanox ii tanox ii ige ige-expressing ige ige tanox cgp ciba-geigy product ciba-geigy ind new drug u.s. fda tanox ciba-geigy gmp tanox houston southampton uk ii xolair omalizumab tanox novartis genentech fda", " fosamprenavir viiv healthcare lexiva u.s. telzir fda october emea july fosamprenavir", " otlertuzumab emergent biosolutions", " u.s. american college chest physicians", " basiliximab simulect food drug administration fda basiliximab lichen planus basiliximab basiliximab food drug administration fda", " ralpancizumab pfizer", " imiquimod inn fda aldara imiquimod cells ifn-\u03b1 langerhans b-lymphocytes fda fda americas graceway pharmaceuticals meda ab graceway americas medicis pharmaceutical imiquimod imiquimod", " entamoeba naegleria pentavalent", " amatuximab amatuximab morphotek inc. amatuximab amatuximab", " mdma certain", " maraviroc celsentri u.s. hiv maraviroc hiv hiv hiv t-cells hiv hiv maraviroc pfizer uk sandwich april u.s. food drug administration new drug application fda august september pfizer european commission motivate motivate", " bone mesozoic cortical volkmann trabecular bone bone ca collagen collagen paget latin greek mpa mpa mpa blood bone wolff calcitonin osteoprotegerin rank bone ii research mri paget mris salter\u2013harris cancer cancers world health organization osteoporosis dexa bird dunkleosteus aids bone oracle ancient kurdaitcha", " modafinil adrafinil", " labetuzumab cea-cide inc.", " vicriviroc sch sch-d schering-plough merck clinical hiv hiv membrane n-terminus m-tropic t-tropic causes aids caucasian hiv hiv schering-plough sch-c sch qt sch-c vicriviroc sar sch-c sch-c vicriviroc vicriviroc binding currently hiv rna hiv rna ii ii ii rna ii february vicriviroc obt obt iii victor merck january", " salmeterol formoterol spiriva copd copd dry blood gerd coffee", " farletuzumab morphotek inc. fr-alpha", " polatuzumab roche", " oxelumab oxelumab roche", " alfadolone inn", " glatiramer copolymer teva pharmaceuticals glatiramer food drug administration fda cochrane ms fda ms rebif betaseron mri primary-progressive multiple sclerosis fda precise mediguard fda glatiramer administration glatiramer multiple sclerosis ms ms eae ms glatiramer prof michael sela prof ruth arnon dr. dvora teitelbaum weizmann institute rehovot professor murray bornstein professor kenneth johnson chairman department neurology university maryland medical center baltimore mri ms centers professor g. comi department neuroscience san raffaele hospital university milan glatiramer european union countries u.s. glatiramer u.k. august december teva european union glatiramer glatiramer dry age-related macular degeneration amd glatiramer rett syndrome glatiramer", " raloxifene eli lilly serm raloxifene raloxifene raloxifene black september health human services agency healthcare research quality raloxifene serms raloxifene hcl s\u2022hcl raloxifene hcl lancet oncology", " sunovion lunesta ambien european union ema usfda eszopiclone kirsch care iv act sepracor valium u.s. prescribing information u.s. prescribing information gaba cytochrome cyp cyp new journal medicine transmission fda drug information clinicians lunesta lunesta fda september sepracor eszopiclone lunivia lunesta sepracor sepracor ema european union u.s. fda eu sepracor ema november sepracor lunesta gsk gsk actelion", " females fish list essential medicines early marriage single fatherhood p.j. james men women vs vs sexual currently fda alzheimer zurich royal holloway annual ny academy sciences estradiol rats challenge evolutionary ena trt food drug administration fda fda low alzheimer males farquharson ben johnson summer olympics congress anabolic steroid control act chris benoit food drug administration fda fda mobility national institute aging data safety committee january fda food drug administration fda later september fda therapy trt fda journal american medical association psa psa sertoli shbg fsh lh gnrh fsh lh gnrh fsh gbg dht dht dht dht free dht dht t. dna hres androgen estradiol dht bph gnrh gnrh fsh lh forms roll-on arnold adolph berthold research harvard charles-\u00e9douard brown-s\u00e9quard lancet brown-s\u00e9quard university professor physiologic chemistry fred c. koch koch lemuel mcgee ernst laqueur university schering berlin organon ciba basel switzerland)\u2014began crystalline male hormone testicles schering adolf butenandt august butenandt hanisch ciba zurich leopold ruzicka wettstein butenandt ruzicka nobel prize chemistry murlin allan kenyon golden age steroid chemistry research", " fischer benzocaine eduard ritsert eberbach vdscs oral over-application fda symptoms benzocaine britain whilst benzocaine", "", " bonta pender johnstone lsd", " properties properties emollient properties mineral mineral properties ph solutions golytely glycolax colyte miralax movicol nulytely suprep fortrans solutions softlax saline properties tegaserod zelnorm u.s. prucalopride resolor eu october resotran december food drug administration shire plc sbm peg miralax glycolax peg peg peg metabolic physicians", " nesvacumab regeneron pharmaceuticals", " robatumumab inn schering-plough", " imgatuzumab inn roche", " oral has-bled atria depletion foods st. john grapefruit iia idarucizumab fda coumadin dvt pe af heparin iii heparin vacutainer low aptt portola pharmaceuticals astellas pfizer september ii exanta food drug administration fda september february november fda atryn antithrombin fda warfarin coumadin uk acenocoumarol uk", " tuvirumab", " alirocumab praluent fda july fda fda alirocumab ldl july alirocumab alirocumab dna alirocumab regeneron pharmaceuticals velocimmune regeneron ind alirocumab sanofi new journal medicine odyssey european society cardiology april july regeneron sanofi biomarin amgen july fda ldl fda amgen express scripts cvs caremark july pharmacy fda", " amprenavir agenerase glaxosmithkline hiv food drug administration april production december telzir lexiva research hiv hiv roger d. tung mark murcko govinda r. bhisetti u.s. patent", " benilyn sudafed robitussin vicks cochrane otc american college chest physicians copd honey cochrane honey complementary echinacea cochrane clinical fda fda cough heroin times panama", " uk study european union shown humans american association control centers fat egyptians renaissance james lind lind scurvy british royal navy limey lind royal navy arctic arctic robert falcon scott antarctic nikolai university tartu estonia gustav von bunge cornelius pekelharing asia takaki kanehiro imperial japanese navy takaki japanese navy christiaan eijkman frederick hopkins hopkins eijkman nobel prize physiology umetaro suzuki casimir funk funk max nierenstein biochemistry bristol university hopkins jack cecil drummond paul karrer karrer norman haworth albert szent-gy\u00f6rgyi nobel prize chemistry albert szent-gy\u00f6rgyi joseph svirbely charles glen king szent-gy\u00f6rgyi nobel prize physiology medicine edward adelbert doisy henrik dam nobel prize physiology medicine george wald nobel prize ragnar granit haldan keffer hartline kazimierz funk lister institute english mccall good world war ii robert w. yoder supplement health education act fda food drug administration event reporting code federal cfr iii gmp european union food supplements directive pharmacopeia usp ph.eur f\u2013j koagulation b-complex provitamin", " aids", " prilocaine claes tegner nils l\u00f6fgren citanest emla ivra citanest forte", " emtricitabine ftc emtriva coviracil nrti hiv truvada bristol-myers squibb u.s. food drug administration fda july atripla quad stribild world health organization list essential medicines hiv fda hiv hbv hbv hiv hbv hbv hiv fda hbv hiv hbv hbv clinical hiv rna dna hiv hiv dr. dennis c. liotta dr. raymond f. schinazi dr. woo-baeg choi emory university triangle pharmaceuticals emory triangle pharmaceuticals gilead sciences emtriva fda july", " tabalumab baff tabalumab eli lilly company iii feb september iii lilly", " stamulumab wyeth pharmaceuticals md stamulumab wyeth collegeville pennsylvania myostatin stamulumab research stamulumab duchenne wyeth becker wyeth january wyeth neurology march wyeth md", " besilesomab scintimun scintimun czech republic emea scintimun", " eisai gerd gerd gerd zollinger-ellison helicobacter nitration treatment polonovski saponification", " cinacalcet inn van wagenen u.s. pat amgen sensipar mimpara cinacalcet cinacalcet cinacalcet fda march cinacalcet cinacalcet hypocalcemia hypocalcemia cinacalcet clinical amgen fda february cinacalcet cinacalcet cinacalcet cinacalcet hyperparathyroidism chronic kidney disease parathyroid carcinoma hyperparathyroidism cinacalcet cinacalcet pth cinacalcet pth cinacalcet ca", " emibetuzumab eli lilly company", " hydrocodone vicodin october drug enforcement administration iii ii hydrocodone u.s. dea national forensic laboratory information nflis retrieve information stride low use hydrocodone respiratory june u.s. food drug administration fda fda vicodin percocet tylenol january fda fda august drug enforcement administration dea hcps schedule iii schedule ii act csa october hcps hcps", " pagibaximab march", " tarextumab jan fda", " perakizumab inn roche", " dacetuzumab seattle genetics inc.", " onartuzumab onartuzumab genentech inc.", " simtuzumab gs", " ii iii iv vi vii dmitri ivanovsky martinus beijerinck dna rna dna norovirus hiv immune aids avestan english john trevisa bartholomeus anglicus proprietatibus rerum virulent latin dmitri ivanovsky english neo-latin charles chamberland chamberland dmitri ivanovsky ivanovsky martinus beijerinck wendell stanley friedrich loeffler paul frosch frederick twort french-canadian f\u00e9lix ross granville harrison e. steinhardt c. israeli r. a. lambert h. b. maitland m. c. maitland ernest william goodpasture john franklin enders thomas weller frederick robbins jonas salk ernst ruska max knoll wendell meredith stanley rna bernal fankuchen rosalind franklin heinz fraenkel-conrat robley williams rna bovine baruch blumberg howard dna rna howard martin temin david baltimore luc montagnier pasteur institute hiv dna rna currently rna dna dna rna kuru creutzfeldt\u2013jakob gerstmann\u2013str\u00e4ussler\u2013scheinker complex proteins mimivirus las cruces chile megavirus pandoravirus chile megavirus mimivirus archaea september ncbi dna rna dna rna rna rna dna rna dna rna hepadnaviridae rna dna rna rna rna rna rna-dependent rna dna rna genome circoviridae rna dna rna dna single-strand dna dna rna rna genetic dna dna rna dna attachment hiv uncoating rna rna hiv release hiv classification andr\u00e9 lwoff robert horne paul tournier international committee taxonomy baltimore classification international committee taxonomy ictv report ictv caudovirales herpesvirales mononegavirales nidovirales picornavirales tymovirales nobel prize david baltimore baltimore ictv baltimore baltimore rna dna rt vzv herpesviridae alphaherpesvirinae varicellovirus vzv group baltimore classification aids sars mechanisms epstein\u2013barr viral transmission hiv horizontal transmission hiv epstein\u2013barr control britain native american native americans columbus americas hiv joint united nations programme hiv unaids world health organization aids june hiv filoviridae marburg april angola ebola disease west cancer rna dna epstein\u2013barr kaposi t-lymphotropic merkel merkel hepatitis t-lymphotropic human herpesviridae kaposi kaposi epstein\u2013barr burkitt hodgkin merkel rna rna rna rna risc igm igg igm igg igg hiv smallpox biotechnology hepatitis dna dna dna dna herpes hiv hepatitis aciclovir hiv hepatitis rna diseases dna rna vlps dna dna crispr rna dna sulfolobales thermoproteales rna dna crispr\u2013cas dna rna dna rna dna industrial virotherapy gm-csf gm-csf naval research laboratory d.c. cowpea cpmv dna cpmv dna dna rna dna rna march national institutes health vector institute centers disease control prevention", " tc verluma tc nofetumomab epcam fab mab phenthioate o,o-dimethyl-s-(carbethoxy-phenylmethyl)dithiophosphate", " isatuximab sanofi-aventis", " raxibacumab december letter cambridge technology human genome sciences cambridge technology human genome sciences hgs glaxosmithkline pa gsk human genome sciences hgs biomedical advanced research development authority barda office assistant secretary response aspr u.s. department health human services hhs gsk gsk hgs july november drugs advisory committee food drug administration fda fda levaquin dec fda raxibacumab", " desflurane desflurane baralyme dry desflurane gaba desflurane", " romosozumab romosozumab celltech ucb celltech amgen romosozumab romosozumab ii january", " bezlotoxumab actoxumab ii medarex massbiologics university massachusetts medical school merck sharp dohme corp", " inn usp hybri-ceaker", "", " ii acth hres dna ii licorice hyperaldosteronism addison florinef", " metomidate janssen pharmaceutica hypnodil nokemyl pet", " raltegravir ral isentress merck hiv u.s. food drug administration fda october hiv december fda raltegravir raltegravir hiv hiv raltegravir retroviruses iii hiv raltegravir haart july fda haart hiv rna raltegravir hiv hiv hiv research hiv research new journal medicine july research hcmv january ii ms human endogenous retroviruses hervs epstein-barr ms raltegravir", " metelimumab genzyme metelimumab cambridge technology cat cat genzyme cat genzyme genzyme", " carlumab carlumab johnson johnson", " hydroxydione inn usan ban viadril predion presuren", " anifrolumab medimmune", " solitomab inn mhc", " tocilizumab inn hoffmann\u2013la roche chugai actemra roactemra ra interleukin october tocilizumab dmards tnf ra general fda sjia castleman early nmo devic elevated ra tocilizumab ra tocilizumab interleukin osaka university tadamitsu kishimoto chugai pharmaceuticals clinical castleman hoffmann\u2013la roche ra dmards june castleman january european medicines agency ema roactemra january u.s. food drug administration fda actemra tocilizumab therapeutic goods administration pharmaceutical august july pharmac july july fda april ema august tocilizumab chugai chugai roche hoffmann\u2013la roche great britain tocilizumab pah", " pertuzumab perjeta genentech pertuzumab fda june pertuzumab genentech roche genentech pertuzumab trastuzumab iv trastuzumab trastuzumab pertuzumab pertuzumab trastuzumab pertuzumab early iii cleopatra clinical pertuzumab trastuzumab iv iv feb gillian keating iii cleopatra marianne neosphere tryphaena ii aphinity", " hmg-coa hmg-coa high cvd cvd cvd pfizer clinical cochrane national institute health clinical nice american college cardiology american heart association steven e. nissen aha european society cardiology atherosclerosis society ldl cvd ldl hdl-cholesterol cochrane canadian working group consensus conference fda ben goldacre canadian working group consensus conference fda coenzyme graham cerivastatin lovastatin furanocoumarins fda hmg-coa hmg-coa hmg-coa hmg-coa hmg-coa ldl ldl vldl hmg coa asteroid researchers click cerivastatin august akira endo sankyo research hmg-coa endo hmg-coa mevastatin p. roy vagelos ceo merck merck mevacor treatment daniel steinberg coronary prevention trial merck sankyo bristol-myers squibb april simvastatin survival study researchers merck zocor zocor mevacor merck endo prize lasker-debakey clinical medical research award endo national hall fame alexandria virginia michael c. brown joseph goldstein nobel prize endo akira endo research", " mental high effects usd single convention drugs topical moffett solution coca physiological coca andes journal american medical association u.s. health inca tea dea georgia east coast cd john belushi chris farley mitch hedberg river phoenix layne staley philip seymour hoffman inhalation brookhaven national laboratory smoking anxiety dat physiological ph ph stevens\u2013johnson dat dat research sigma nmda kappa-opioid eme cas street hcl smoking pure nahco pure smoking coca peru bolivia cuzco peru la paz bolivia lima peru willst\u00e4tter willst\u00e4tter robert robinson edward leete mannich claisen claisen s)-enantiomer mannich sam-dependent nadph benzoyl-coa edward leete ornithine plp schiff hemscheidt robinson nadph ii tri trii tri trii tri john jay college criminal justice united nations wales bolivia chile republic europeans republic u.s. studio south american spanish devil nicol\u00e1s monardes padre blas valera coca friedrich gaedcke archiv pharmazie friedrich w\u00f6hler dr. carl scherzer novara emperor franz joseph w\u00f6hler albert niemann ph.d university g\u00f6ttingen niemann \u00fcber base new organic base coca ph.d british library quechua willst\u00e4tter vassili von anrep university w\u00fcrzburg karl koller heidelberg ophthalmological society jellinek william halsted james leonard corning heinrich quincke paolo mantegazza peru milan angelo mariani mantegazza mariani vin mariani vin mariani john styth pemberton coca-cola pure food drug act \u00fcber coca exhilaration u.s. parke-davis arthur doyle memphis beale street mississippi river ernest shackleton march\"-brand antarctica captain scott south pole wwii d-ix harrison act congress popularization african american medical news colorado northeast mainstream dallas alabama georgia hyperbolic african americans atlanta constitution negroes times negroes negroes negroes mississippi negro african americans police south african americans georgia new orleans food drug act harrison narcotics tax act harrison act journal american medicine harrison act jones-miller act u.s. uk u.s. u.s. world health organization united nations interregional crime justice research institute unicri world health assembly world health organization october novocain centre drugs drug addiction single convention united nations convention illicit traffic psychotropic act peru bolivia united nations peru bolivia peru huallaga valley bolivia bolivia peru coca u.s. u.s. department formation pcp organized bolivia peru central america u.s.\u2013mexico arizona caribbean bahama island south dominican republic u.s. bahama islands chile bolivia chile iquique antofagasta chile peru bolivia south american bulk caribbean\u2013 gulf march summer u.s. office national drug control policy san diego bridgeport boston west quality centre drugs drug addiction cyprus turkey world world drug report north american parkinson", " lulizumab bristol-myers squibb", " integrated authority normdatei universal authority gnd gnd national library gnd creative commons gnd rdf integrated authority april april gnd", " list essential medicines epinephrine ph lidocaine cpr ehlers-danlos adrs cns cns treatment na megx megx bengt inn ban aan ban world anti-doping agency", "", " drozitumab drozitumab genentech", " abrilumab crohn medimmune", " rilotumumab rilotumumab amgen inc. november amgen iii", " chloroethane cl chloroethane tel tel chloroethane chloroethane carnaval chloroethane chloroethane immediate cpr chloroethane group confirmed carcinogen humans state", " vapaliximab", " caplacizumab inn ablynx nv iii von willebrand ii titan", " demcizumab oncomed pharmaceuticals celgene notch demcizumab", " renin raas angiotensin ii angiotensin converting enzyme january robert tigerstedt bergman pepstatin aliskiren iii food drug administration european medicines agency cochrane hypertension raas raas blood renin renin raas ang ace ii ang ii raas ang ii ang ii ang ii ang ii ang ii ang ii raas renin african american renin raas ang ang ii renin ii ang ii raas ang ii prc pra ace ii pra raas pra prc pepstatin pepstatin statine compounds development remikiren aliskiren asp s\u2032 s\u2032 interaction occupation asp gly tyr ser arg aliskiren april food drug administration fda ace arbs arbs gfr aliskiren fda tekturna hct actelion actelion ii speedel iia ii speedel", " anrukinzumab anrukinzumab wyeth", " methylphenidate ritalin cns adhd methylphenidate adhd ciba novartis corporation u.s. food drug administration fda medical adhd britain adhd methylphenidate methylphenidate methylphenidate methylphenidate methylphenidate methylphenidate adhd adhd adhd methylphenidate u.s. food drug administration fda cbt adhd adhd adhd children adhd adhd narcolepsy methylphenidate methylphenidate multiple sleep latency test methylphenidate methylphenidate adhd methylphenidate john harris barbara sahakian ritalin methylphenidate u.s. fda methylphenidate cardiac hyperhidrosis hypersensitivity methylphenidate logorrhea adhd treatment methylphenidate methylphenidate methylphenidate adhd methylphenidate coingestion methylphenidate ndri methylphenidate methylphenidate methylphenidate methylphenidate methylphenidate parkinson methylphenidate methylphenidate ritalin ritalin sr concerta methylphenidate methylphenidate ciba novartis leandro panizzon marguerite rita methylphenidate adhd add mbd charles bradley alza corporation u.s. food drug administration fda concerta methylphenidate ritalin concerta methylin daytrana methylin metadate phenida attenta rilatine portugal ritalina hynidate addwize inspiral sr focalin attenade concerta methylin medikinet ritalin equasym xl xr metadate methylphenidate methylphenidate ritalin generic ritalina rilatine attenta medikinet metadate methylin penid tranquilyn rubifen concerta ritalin\u00a0la ritalin\u00a0la pfizer methylphenidate adhd adhd adhd ritalin treatment adhd u.s. u.s. food drug administration adhd adhd nice methylphenidate", " golimumab cnto simponi golimumab tnf golimumab centocor golimumab johnson johnson centocor european medicines agency emea golimumab merck inc. j&j merck", " necitumumab inn egfr fda portrazza nsclc", " dimethocaine uk june", " method\u2014the hormonal currently birth iud oral iud mirena birth modern jadelle implanon contraceptive technology serm ius technology cocps nuvaring cocps dvt smoking cocps cocps cocps pop pop cocps ius mirena ius mirena iud ius noristerat jadelle ormeloxifene serm centchroman centron saheli ormeloxifene ormeloxifene progestogen gnrh fsh fsh progestogen fsh low jadelle mirena intermediate cerazette implanon high noristerat ormeloxifene ormeloxifene worldwide cocps ludwig haberlandt cocp enovid cocp u.s. food drug administration enovid progestasert norplant deladroxate latin america cyclo-provera cyclofem lunelle cyclofem mesigyna world health organization nuvaring ortho evra cocs cycle cocs", " darunavir prezista hiv darunavir oarac food drug administration fda june darunavir pis early pis darunavir hiv world health organization list essential medicines darunavir hiv darunavir pis darunavir oarac dhhs fda october hiv aids hiv norvir hiv st. john darunavir high clinical darunavir pr pr kd pr pr darunavir pr pis fda pr-pi darunavir asp asp asp gly uk hiv fda hiv fda pis darunavir fda june hiv", " valaciclovir inn usan glaxosmithkline valtrex zelitrex valaciclovir u.s. november valaciclovir p.cornaglia ferraris valaciclovir aciclovir subsequently aciclo-gtp dna dna dna aciclo-gtp aciclovir hsv vzv ebv cmv epstein\u2013barr mechanisms hsv dna valtrex fd&c blue lake valaciclovir hsv vzv stevens\u2013johnson", " cedelizumab", " tenofovir truvada hiv gilead sciences hiv food drug administration july hiv msm fem-prep african truvada hiv ole prep cochrane hiv rr ci truvada hiv hiv truvada truvada rna actg df df truvada gilead sciences food drug administration truvada sustiva atripla truvada hiv truvada currently fda prep truvada truvada hiv hiv prep prep medication truvada truvada truvada truvada atazanavir truvada adefovir dabigatran etexilate vincristine", " hiv grimaux ivy pinner pinner gabriel colman brown albert electron n-alkylation reduction uv principal synthesis n-c-n biginelli n-vinyl n-aryl electrophilic c-substitution nitration nucleophilic c-substitution amination grignard free dna rna dna rna rna dna,but watson-crick dna rna rna rna march nasa ames dna rna pahs universe", " ace later ace ace ace raas ii ii ai ii aii ai aii aii ace ii ace aii ace ace ace ace ace inhibitors ace cachexia ace ace ace ace ace ace gfr gfr ace hyperkalemia ace ii ace ace hyperkalemia ace ace raas elevated ace ii rash hematologic ace warnings ace ace symptoms treatment ace treatment captopril ace u.s. ace ace ace ace raas nsaids ace ace ace ace captopril ace ace ace ace arb hr ci hr ci ace ace ace ace ii ace ii ii ii ii ace ii ace ii ace arbs iga ace ace leonard t. skeggs s\u00e9rgio henrique ferreira bpf bothrops south american ferreira john vane bpf ii kevin k. f. ng john r. vane ace ii bradykinin ii ii ii ng vane bpf ferreira bpfs ace molecular bpf bpf ace ace david cushman miguel ondetti ace ace captopril food drug administration ace ace ace ipp vpp ipp ipp vpp ace-inhibiting ipp vpp", " matuzumab egfr wistar institute pennsylvania merck serono takeda pharmaceutical ii august merck serono february matuzumab egfr iii egfr egfr egf egf egfr development egfr ii american society clinical oncology asco ii egfr nsclc egfr pfl ecx rates ecx august merck ii february takeda merck", " blosozumab sost sost blosozumab eli lilly company", " bapineuzumab alzheimer tau csf bapineuzumab n-terminal a\u03b2 bapineuzumab a\u03b2 alzheimer alzheimer bapineuzumab wyeth iii december johnson johnson alzheimer elan wyeth pfizer wyeth mri alzheimer august pfizer johnson johnson alzheimer johnson johnson july mathew martoma s.a.c. capital advisors february sid gilman", " use ldl crohn sehcat cholestyramine cholestyramine b. gi gi", " valsartan diovan ii arb valsartan valsartan valheft ontarget ii valsartan fda discontinuation rates rates vs vs vs vs clinical vs vs vs minor ii ace ii ii ii ace ace diovan september u.s. department veterans alzheimer", " fontolizumab huzaf crohn ii", " oncoscint dtpa", " mri mri", "", " sevoflurane sevoflurane sevoflurane ross terrell bernard regan wallin bernard regan martha napoli ivan stern abbott laboratories sevoflurane sevoflurane sevoflurane panda gas sevoflurane gaba nmda sevoflurane sevoflurane", "", " vegf fgf cell vegf vegf vegfr vegfr vegf bevacizumab bevacizumab vegf vegf bifidobacteria research vegf vegfr vegf vegf bevacizumab avastin vegf vegf avastin fda fda avastin november august cancer research vegf bevacizumab vegf ml maitland hg hg", " nerelimomab tnf", " dexlansoprazole inn kapidex dexilant takeda pharmaceuticals gerd dexlansoprazole takeda ph dexlansoprazole auc november u.s. food drug administration fda kapidex fda takeda dexilant", "", " reslizumab cinquil", " dalotuzumab dalotuzumab merck inc.", " dinutuximab unituxin fda march u.s. national cancer institute children oncology group united therapeutics nci august united therapeutics fda unituxin abbvie forbes tim worstall fda fda", " iii ifn-\u03bb iii acceptance ii medical headings", " panobacumab inn", " pemtumomab theragyn iii", " teneliximab", " teprotumumab teprotumumab roche", " solifenacin inn vesicare astellas glaxosmithkline teva pharmaceutical industries solifenacin qt solifenacin qt solifenacin peak yamanouchi pharmaceutical ltd. tokyo", " dupilumab regeneron pharmaceuticals thoracic society nejm", " morolimumab rhesus", " afp-cide", " clenoliximab macaca", " immunogen inc. nasdaq adc immunogen waltham massachusetts immunogen adc adcs immunogen immunogen amgen bayer healthcare biotest genentech roche eli lilly novartis sanofi takeda roche kadcyla immunogen adc genentech roche group october kadcyla gatsby immunogen adc", " novo nordisk levemir levemir hba nph ns hba nph nph nph hba nph nph nph levemir nph insert june u.s. food drug administration fda levemir u.s. fda http: biphasic prandial basal insulin oral therapy diabetes rury r. holman m.b. ch.b f.r.c.p. kerensa i. thorne m.sc andrew j. farmer d.m. f.r.c.g.p. melanie j. davies m.d. f.r.c.p. joanne f. keenan b.a. sanjoy paul ph.d jonathan c. levy m.d. f.r.c.p. study group http: insulin journal diabetologia april", " hpv vaccination world health organization variolae edward jenner inquiry cow pox jenner hiv mmr calmette gu\u00e9rin toxoid crotalus hepatitis vlp hpv jenner bcg mycobacterium advisory committee immunization practices centers disease control prevention hib mmrv u.s. uk chinese royal society dr. martin lister east clopton havers ottoman empire lady mary wortley montagu hans sloane king edward jenner jenner jenner maurice hilleman hiv andrew wakefield hiv pharmaceutical world health organization haemophilus combination u.s. european union iscom notable dna lyme diva j.t. central veterinary institute lelystad aujeszky elisa diva diva bovine diva diva transgenic complex hepatitis bovine viral diarrhea bvdv", " ige histamine epi-pen american college chest physicians updates first-generation benadryl clistin chlor-trimeton dimetane u.s. army medical corps otc ernest fourneau daniel bovet pasteur institute bovet nobel prize physiology medicine second-generation ph fexofenadine", " tenofovir truvada hiv gilead sciences hiv food drug administration july hiv msm fem-prep african truvada hiv ole prep cochrane hiv rr ci truvada hiv hiv truvada truvada rna actg df df truvada gilead sciences food drug administration truvada sustiva atripla truvada hiv truvada currently fda prep truvada truvada hiv hiv prep prep medication truvada truvada truvada truvada atazanavir truvada adefovir dabigatran etexilate vincristine", " natalizumab natalizumab crohn biogen idec tysabri natalizumab natalizumab crohn natalizumab u.s. food drug administration fda pml june pml pml october european medicines agency january pml fda european union pml biogen idec september natalizumab crohn natalizumab ms kurtzke edss ms ms natalizumab ms ms ms natalizumab european union ms natalizumab ms crohn natalizumab crohn treatment january fda crohn european union progressive fda august december january fda pml february pml pml ms pml pml ci ms pml fda emea crohn crohn crohn natalizumab pml natalizumab natalizumab ms natalizumab ms ms crohn addressin peyer cd cd natalizumab cd natalizumab pml pml crohn pml pml pml natalizumab pml pml june pml january food drug administration pml pml corticosteroids tysabri crohn pml natalizumab fda fast track february ms june fda ms natalizumab april committee medicinal products human use ms european medicines agency european union ms health schedule food april", " methisoprinol", " olaratumab", " foravirumab sanofi crucell", " inn fibriscint centocor fab", " pentothal abbott laboratories world health organization drugs list u.s. hospira norcuron u.s. lancet december state ohio kenneth biros u.s. september cal coburn brown jeffrey landrigan u.s. uk december u.s. european union torture regulation december european union union thiopental hollywood dutch professor jan bastiaans holocaust gaba glyr gaba gaba gaba hospira hospira hospira january thiopental premedication thiopental addison co-administration ernest h. volwiler donalee l. tabern abbott laboratories march dr. ralph m. waters dr. john s. lundy mayo clinic abbott abbott hospira pearl harbor british journal anaesthesia tripler army hospital", " key medical george winter epicel laserskin transcyte dermagraft alloderm biobrane integra apligraf orcel graftjacket permaderm vyas modern", " actoxumab ii medarex massbiologics university massachusetts medical school merck inc.", " regavirumab", " seroquel astrazeneca fda cochrane review cochrane review mdd uk pharmaceutical scheme mdd alzheimer tourette parkinson quetiapine clozapine seroquel british national formulary quetiapine off-label british national formulary european union astrazeneca seroquel xr seroquel prolong seroquel depot seroquel xl astrazeneca u.s. fda seroquel xr astrazeneca seroquel xr u.s. august seroquel xr u.s. fda seroquel xr november seroquel xr health seroquel xr september fda seroquel xr october astrazeneca seroquel xr fda july handa pharmaceuticals fremont astrazeneca fda december biovail fda anda biovail astrazeneca seroquel xr december fda food drug administration fda quetiapine u.s. fda april astrazeneca u. s. department justice seroquel department justice astrazeneca seroquel multiple astrazeneca dan markingson seroquel university minnesota university minnesota august uk medicines healthcare regulatory agency mhra nurofen seroquel xl drug alert reckitt benckiser uk nurofen plus seroquel xl pfizer neurontin mhra defective medicines report centre dmrc reckitt benckiser uk nurofen plus drug alert", " behenyl cachalot docosyl emery docosanol food drug administration fda otc abreva docosanol fda july avanir pharmaceuticals abreva healthcare brands erazaban uk blistex cold cream march avanir glaxosmithkline skin allergic nursing cosmetic docosanol", " oportuzumab inn epcam viventia bio http: winnipeg pennsylvania usa oportuzumab ii vol june supplement", " serms er er er different ia serm serm ia serm ia serms raloxifene serm serms serms clomifene clomifene february toxicological december serms toremifene raloxifene ospemifene february serm october bazedoxifene serm serms serm serms tamoxifen toremifene dna raloxifene preclinical ospemifene clinical bazedoxifene serms tsec serm serm er er er\u03b1 er\u03b2 er\u03b1 er er\u03b2 er\u03b1 er\u03b2 er\u03b1 er\u03b2 dna-binding leu met er\u03b1 er\u03b2 n-terminus er\u03b1 er\u03b2 dna-binding dna dna-dependent dna-binding er\u03b1 er\u03b2 er lxxll lxxxixxx(i smrt dna-binding serms er\u03b2 serms serms serm serms multiple pkc er\u03b1 er\u03b2 high er\u03b1 ers serms er\u03b1 er\u03b2 function er er\u03b1 er\u03b2 er\u03b1 er\u03b2 er\u03b1 er\u03b2 serms er\u03b1 er\u03b2 er\u03b1 er\u03b2 er serm er er er c-terminal er er er er serms serms er er serms serms triphenylethylene h-bonding er clomifene cis cis tamoxifen er tamoxifen tamoxifen cyp n-desmethyltamoxifen er glu er er er er er er dna tamoxifen er serm er toremifene dna dna toremifene toremifene n-desmethyltoremifene n-demethylation n-desmethyltoremifene er raloxifene serm er raloxifene er\u03b1 serm serm serms serms er serm-er serms bazedoxifene ospemifene it\u00b4s ospemifene serms serms er er\u03b1 er a-ring b-ring b-ring er er\u03b1 er\u03b2 er\u03b1 er\u03b2 er\u03b1-preferential-binding er\u03b2 er\u03b1 er\u03b2 er\u03b2 er\u03b1 er\u03b2 er\u03b1 er\u03b1 er\u03b2 tamoxifen er\u03b1 er\u03b2 er dna clomifene er\u03b1 er\u03b2 raloxifene lasofoxifene er\u03b1 serm-er\u03b1 c-ring lasofoxifene er\u03b1 er\u03b2 ospemifene er\u03b1 er\u03b2 ospemifene ospemifene", " alfentanil alfenta rapifen alfentanil ph alfentanil alfentanil schedule ii usa u.s. dea alfentanil janssen pharmaceutica fentanyl estonia", " taribavirin icn iii dna rna taribavirin taribavirin taribavirin j.t.witkowski icn pharmaceuticals taribavirin valeant pharmaceuticals international c. note chemid pubchem ph", " lirilumab inn blood http: innate pharma bristol-myers squibb", " methoxypropane metopryl neothyl", " etomidate usan inn ban amidate janssen pharmaceutica etomidate neurological institute etomidate jabre rapid sequence induction hohl hohl acth gaba gaba gaba etomidate etomidate etomidate", " radretumab", " novocain alfred einhorn novocaine latin heinrich braun einhorn einhorn vasoconstriction ana aslan asa mdma mdma application north americans vysya raney", " mepivacaine carbocaine polocaine", " reverse-transcriptase rtis hiv aids rtis dna hiv hiv rna dna dna dna dna hiv dna rna-dependent dna hbv nrtis ntrtis dna dna nrtis ntrtis nrti ntrti dna nrti ntrti dna nrtis ntrtis nrtis dna nrtis' nnrtis dna nrtis dna nrtis dna nrtis nrti dna ntrtis nrtis nnrtis rega institute medical research researchers rt nrtis nnrtis dna hiv hiv rt nrtis nnrtis aspartate dna ftc hiv nrtis azt abc ftc dna azt nnrtis dna treatment efv nvp nrti nnrti nnrti nnrti nnrti", " enfuvirtide inn hiv hiv fuzeon roche hiv leu lys lys ala nh enfuvirtide duke university trimeris trimeris trimeris hoffmann-la roche u.s. food drug administration fda march hiv toro hiv hiv hiv formyl low", "", " metabutoxycaine primacaine", " gevokizumab xoma corporation gevokizumab beh\u00e7et gevokizumab eyeguard\u2122 servier xoma niu eyeguard-a beh\u00e7et eyeguard-b niu eyeguard-c proof-of-concept poc company january national eye institute poc separately schnitzler july iii beh\u00e7et eyeguard-b gevokizumab ii", " ezetimibe zetia ezetrol vytorin ezetimibe american heart association american college cardiology american heart association college cardiology european society atherosclerosis society atherosclerosis society national institute health clinical international atherosclerosis society improve-it ezetimibe ezetimibe alt ast ezetimibe niemann-pick caveolin ezetimibe ezetimibe ezetimibe", " tralokinumab tralokinumab cambridge technology april medimmune astrazeneca tralokinumab cambridge technology march medimmune llc july medimmune llc november astrazeneca medimmune", " entecavir inn etv hbv entecavir dna entecavir hbv hiv hbv entecavir hiv hiv-hbv hiv entecavir alt oral bristol-myers squibb baraclude\u00ae baraclude\u00ae august teva pharmaceuticals usa fda baraclude\u00ae hetero labs august aurobindo pharma august", " figitumumab nsclc pfizer january iii nsclc december", " saquinavir invirase fortovase hiv hiv saquinavir world health organization list essential medicines usd saquinavir hiv fortovase saquinavir invirase fortovase invirase pi hiv saquinavir hiv saquinavir saquinavir saquinavir roche saquinavir food drug administration fda aids roche invirase fda aids nov fortovase roche fortovase invirase usd", " sofituzumab roche", " urelumab bristol-myers squibb urelumab jan", " abagovomab abagovomab abagovomab ii abagovomab menarini mimosa abagovomab usa czech republic iii", " rovelizumab rovelizumab icos food drug administration fda fda development icos rovelizumab multiple genentech protein design labs pdl centocor", " certolizumab cimzia crohn ucb certolizumab pegylated fab tnf", " ctx ctx al crohn dosage bsa bsa bsa bsa bsa bsa bsa bsa bsa bsa bsa folfox folfox pfs carboplatin world war rna dna dna dna dna dna dna n-nitroso-n-methylurea mnu bcnu ccnu meccnu azq cisplatin non-classical dna rna dna rna dna dna rna dna dna dna dna s-phase dna methotrexate dhfr dna pemetrexed dna dhfr fluorouracil fump fump rna capecitabine vidaza vinca vinca s-phase m-phase pacific yew taxus taxus paclitaxel s-phase american mayapple mayapple topoisomerase ii dna dna dna dna dna dna ii camptotheca drugs ii ii dna dna dna ii dna dna doxorubicin dna dna actinomycin dna rna bleomycin streptomyces dna dna mitomycin dna picc hickman port-a-cath picc chemotherapeutic neutropenia g-csf bmts bmts herpesviridea trametes malnutrition self-care coates cinv alopecia chemotherapy scalp development gnrh chemotherapy cipn chemotherapy cipn cipn cipn cipn high cardiotoxicity dna hepatotoxicity nephrotoxicity ototoxicity mopp hodgkin blood cancer research cancer dna dna upregulation dna cancer dna hodgkin heterogeneic methotrexate ra ra cyclophosphamide al al al chemotherapy cyclophosphamide chemotherapy healthcare routes world war world war ii yale school medicine december world war ii bari allied wwii paul ehrlich ehrlich list adcs reduced mylotarg wyeth pfizer hodgkin passive blood dna clinical standard operating procedures electrochemotherapy standard operating procedures sop hyperthermia hyperthermia bcnu cddp chemotherapy ret vandetanib vegfr egfr cabozantinib", " medicated anatomical therapeutic chemical classification codes atc national atc", " apap nsaids world health organization greek aspirin nsaids paracetamol nsaids reye nsaids nsaids research nsaids nsaids nsaids etoricoxib morphine snri tramadol tapentadol snri opioids pruritus flupirtine nefopam nsaids topical february fda tetrahydrocannabinol thc cannabis nmda nsaids cns nmda nmda high-alcohol cns american civil war", " narnatumab narnatumab imclone systems", " vorsetuzumab adc mmaf seattle genetics inc.", " edobacomab", " giardia nitazoxanide chemically tizoxanide nitazoxanide giardia entamoeba hymenolepis ascaris cyclospora september nitazoxanide nitazoxanide nitazoxanide hbv dna hbv dna hbeag hbsag hbv dna hbsag hbv dna hbeag hbsag b. hbsag romark ii romark laboratories ii ii lancet pediatric center albina patin\u00f6 cochabamba bolivia august february taenia taenia michael dan jack d. sobel case nitazoxanide nitazoxanide oral peak tizoxanide nitazoxanide nitazoxanide nitazoxanide jean-fran\u00e7ois rossignol pasteur institute dr. rossignol romark laboratories usa unimed pharmaceuticals inc. marietta ga aids fda romark zambia zambia nitazoxanide nitazoxanide nitazoxanide adonid alinia allpar annita colufase daxon kidonax mitafar netazox niazid nitamax nitax nitaxide nizonide nt-tox pacovanton paramix toza zox pentavalent", " neurotology otolaryngology", " zidovudine zdv azt hiv nrti azt hiv dna dna azt u.s. hiv retrovir azt aids hiv azt hiv hiv azt haart azt combivir trizivir world health organization list essential medicines treatment azt haart azt hiv azt pep hiv hiv pep azt hiv azt azt hiv hiv azt aids azt azt azt azt early azt azt dna azt drugs azt iarc group azt hiv azt hiv azt azt haart anti retroviral therapy azt azt hiv dna rna hiv dna cellular azt hiv dna azt dna azt hiv dna azt hiv azt hiv azt dna azt nobel howard temin david baltimore nobel george hitchings gertrude elion jerome horwitz barbara ann karmanos cancer institute wayne state university school medicine azt national institutes health nih development wolfram ostertag max planck institute medicine g\u00f6ttingen azt friend azidothymidine cancer wofram ostertag max planck institute azt friend friend instiut pasteur hiv aids samuel broder hiroaki mitsuya robert yarchoan national cancer institute nci hiv hiv nci june burroughs-wellcome marty st. clair hiv burroughs-wellcome gertrude elion david barry paul mcguirt jr. philip furman martha st. clair janet rideout sandra lehrman hiv friend harvey wellcome hiv azt friend harvey azt janet rideout nci hiv february nci azt azt nci nci duke university azt hiv aids azt azt burroughs-wellcome cdc nih azt hiv burroughs-wellcome azt anti-infective advisory committee food drug administration fda azt fda fda hiv aids aids related complex arc march azt hiv azt azt hiv hiv azt public citizen subsequently barr laboratories novopharm ltd. nci samuel broder hiroaki mitsuya robert yarchoan fda azt burroughs wellcome court appeals federal circuit burroughs wellcome hiv nci supreme court aids healthcare foundation azt azt glaxosmithkline u.s. fda azt u.s.", " imalumab mif currently baxalta", " lebrikizumab inn tanox hodgkin tanox ii periostin ii", " monomethyl mmae mab international nonproprietary names mmae-mab-conjugates mmae hodgkin mmae monomethyl mmae", " celecoxib nsaid nsaids july fda nsaids pfizer celebrex celebra onsenal celecoxib american heart association celebrex pfizer americans celebrex celecoxib nsaids nsaids gi gi nsaids celecoxib nsaids nsaids nsaids stevens-johnson naproxen vioxx nsaids february american heart association internal medicine april fda cv nsaids celecoxib fda nsaids celecoxib nsaids celecoxib searle nhch celecoxib nsaids daniel l. simmons brigham young university byu monsanto monsanto pfizer byu pfizer pfizer byu april pfizer university rochester searle pfizer university rochester g.d. searle fed cir searle national academy sciences philip needleman monsanto searle celebrex food drug administration fda pharmacia celecoxib g. d. searle company fda december monsanto company searle pfizer celebrex monsanto pharmacia medical research division pfizer pfizer celebrex searle pfizer university rochester g.d. searle fed cir university rochester pat searle university september celebrex apc december celebrex pfizer celebrex celebrex pfizer celebrex april celebrex public citizen pfizer public citizen celebrex fda pfizer celebrex pfizer randomized celecoxib integrated safety ibuprofen naproxen cleveland clinic dr. steven nissen cleveland clinic dr. nissen jama merck bextra pfizer pharmacia monsanta celebrex celebrex pfizer pharmacia journal american medical association food drug administration pfizer pharmacia pfizer march scott s. reuben baystate medical center springfield massachusetts vioxx reuben pfizer pfizer dr. reuben celebrex lyrica pfizer pfizer food drug administration european union pfizer dr. scott reuben dr. reuben february pharmacia pfizer celebrex december march fda small-scale fap aspirin", " peregrine pharmaceuticals inc. peregrine peregrine avid bioservices peregrine avid halozyme therapeutics bavituximab bavituximab university southwestern medical center dallas peregrine alan j. schroit patents philip e. thorpe june fda peregrine january iii ii ii f(ab pet cotara dna peregrine glioblastoma", " copd glaxosmithkline advair seretide eu m\u00e9xico turkey uk estonia viani adoair foxair quikhale sf advair food drug administration fluticasone dpi hfa mdi hfa advair hfa advair hfa uk uk laba labas mometasone advair november teva pharmaceutical industries teva seroflo cipla advair glaxosmithkline gsk gsk gsk advair usa january", " igg", " anti-obesity fda acomplia european medicines agency october sibutramine meridia october current soranus ephesus dnp dnp fda amphetamines benzedrine obetrol senate fda fen-phen dexfenfluramine redux fen-phen september ephedra orlistat orlistat fda february u.s. food drug administration fda lorcaserin belviq june sibutramine meridia meridia district court northern district ohio uk eu rimonabant acomplia european union october european medicines agency emea acomplia uk sanofi-aventis diabetes metformin exenatide byetta byetta diabetes byetta byetta byetta diabetes symlin pramlintide amylin amylin amylin currently symlin symlin symlin qsymia u.s. fda july european medicines agency redux fen-phen food drug administration products pyruvate fen-phen fda sir arthur macnalty chief medical officer acarbose ssris ssris empatic contrave gt peptimmune genzyme peptimmune liquidation rnai smrt dr. russell nofsinger dr. ronald evans salk institute smrt october cetilistat boss olivier karl g. hofbauer boca raton crc press isbn", " aas aids american college sports medicine aas aas health ergogenic aas ioc aas blue cross blue shield aas aas aas journal health psychology u.s. oral injection aas cns aas high aas aas mood aas aas aas aas dsm-iv general cooper noakes dunne lambert rochford aas pope katz aas aas aas aas malone dimeff lombardo acne conversion dht international agency research cancer iarc androgenic group aas ldl hdl development reduced female-specific kidney high different bmr bmr effects aas vp la vp la aas aas la aas oecd aas aas aas aas medical adolf butenandt marburg leopold ruzicka zurich karoly gyula david e. dingemanse j. freud ernst laqueur crystalline male hormone testicles august butenandt g. hanisch ruzicka wettstein testicular hormone testosterone ruzicka butenandt nobel prize chemistry butenandt world war ii clinical health u.s. second world war aas nazis president soviet union eastern bloc east olympic u.s. olympic team john ziegler ziegler ciba pharmaceuticals u.s. food drug administration fda ziegler aas ioc aas aas u.s. schedule iii act schedule iv ii iii canadian centre drug-free sport canadians portugal class\u00a0c drugs u.s. u.s. congress act ben johnson summer olympics seoul american medical association ama drug enforcement administration dea food drug administration fda national institute drug abuse nida act. schedule iii act control act u.s. u.s. ciba searle syntex act anabolic steroid control act january schedule home office association tennis professionals major league baseball f\u00e9d\u00e9ration internationale football association olympics national basketball association national hockey league world wrestling entertainment national football league world anti-doping agency wada russian president international convention doping sport wada lawrence payne drug enforcement administration fbi law enforcement bulletin chris benoit oversight government reform committee committee wwe nonstop action wrestling wwe ceo chairman linda vince mcmahon aas dea aas u.s aas u.s. u.s.", " dexmethylphenidate focalin attenade d-tmp cns adhd dexmethylphenidate adhd adhd improvements adhd oros methylphenidate u.s. fda products methylphenidate cardiac hyperhidrosis hypersensitivity methylphenidate logorrhea adhd treatment methylphenidate methylphenidate methylphenidate adhd methylphenidate coingestion methylphenidate dat mph ss rr mph dexmethylphenidate rr dexmethylphenidate focalin xr dl concerta ritalin la adhd mph", " cinchocaine inn ban usan cincain nupercainal nupercaine sovcaine proctosedyl somulose", " seribantumab sanofi pharmaceuticals inc.", " tft viroptic glaxo wellcome glaxosmithkline monarch pharmaceuticals king pharmaceuticals dna cf dna cochrane systematic review", " capecitabine inn roche capecitabine world health organization list essential medicines genentech notes dpd dpyd click capecitabine dna", " enokizumab enokizumab medimmune", " halothane fluothane list essential medicines usd mac halothane national institute occupational safety health niosh rel halothane gaba nmda ampa chemically isoflurane halothane c. w. suckling imperial chemical industries widnes m. johnstone halothane halothane", " orticumab inn", " zanolimumab ii", " adhd ritalin metadate concerta focalin dexedrine zenzedi desoxyn controlled-release ampa darpa ssri iii snri add adhd l-dopa l-tyrosine\u2014it l-dopa cns adhd amphetamine amphetamine benzedrine benzedrine dexedrine vyvanse amphetamine caffeine ephedra mdma dea mdma schedule mdma mdma mdma methylenedioxypyrovalerone mdpv ndri boehringer ingelheim mdpv products mdpv spice mdpv mephedrone mcat mdma internet december eu usa federal analog act september usa october methamphetamine adhd methamphetamine cns food drug administration usfda desoxyn recreationally methamphetamine ii ii united nations convention psychotropic methamphetamine cns nicotine aids phenylpropanolamine accutrim propalin proin ppa ppa february propylhexedrine obesin benzedrex benzedrex injection aids jack nsaid horn arabian peninsula world health organization djibouti ethiopia yemen sndri south american bolivia peru asia abuse cns adhd-prescribed adderall-type desoxyn desoxyn adhd", " desflurane general clinical general general overton meyer overton meyer cns cns multiple gaba trek task hcn stage isoflurane propofol", " adhd ssris snris maois nassas st john hamilton depression rating scale ham-d ham-d uk national institute health care nice ssris american psychiatric association ect ect researchers irving kirsch thomas moore fda freedom information act kirsch paxil u.s. fda national institute health care cochrane collaboration cochrane collaboration st john st. john reversible ssris st john journal american medical association cam national institute mental health sequenced treatment alternatives relieve depression star*d study hamilton depression scale ham-d ssris centers disease control prevention americans american psychiatric association practice guideline american psychiatric association nris ssri-associated ssris ssris tcas tcas maois superior amh australian medicines gi gastrointestinal ir ortho qtc qtc sd sexual extended drug tricyclic preferentially uk antidopaminergic causes clomipramine tcas dosulepin uk danger doxepin tca uk qtc nortriptyline uk maois rima czech republic uk amh parkinson mao-b mao-a metabolized ssris citalopram ssris qt ssri qtc s-enantiomer ssris r,s)-citalopram fluoxetine ssri fda fluvoxamine fda fda ocd ssri ssri persistent pulmonary hypertension newborn fda d. ssris ssris ssris ssri ssris gi snris milnacipran danger gi ir noradrenergic nassas mianserin uk bnf amh mirtazapine uk mianserin saris serotonin smss danger september uk bupropion uk uk st john national institute health care nice gad gad key gad gad ssris ssris ssris ocd ssris bupropion ssris clinical ssris treatment national institute health care ssris american psychiatric association ssris snris european league rheumatism eular cochrane collaboration maois maoi rima ssris ssri ssri fda maoi ssris ssris food drug administration fda fda national institute health care nice sexual ssris ssris moclobemide mao-a biochemical mirtazapine ssris bupropion ndri ssri tca teca-class maois ssris snris common ssris prozac ssris ssris ssris ssris ssris snris snris ssris sert snris adhd fms smss smss brintellix sri viibryd spari saris neris adhd nri nris dri ndris snris sert tcas dat dris ssris snris nris tcas ssris tetracyclic maois parkinson maois maois maoi maois parkinson mao-b mao-a mao-b stephen m. stahl st john irving selikoff edward robitzek sea view hospital staten island hoffman-laroche selikoff robitzek sea view hospital cincinnati max lurie harry salzer jean delay sainte-anne hospital cochin hospital lurie salzer delay buisson selikoff robitzek later jackson smith gordon kamman george crane frank ayd ernst zeller nathan kline rockland state hospital roche roland kuhn kuhn\u00a0\u2013 geigy pharmaceutical company kuhn h\u00e4fliger schindera maoi carlsson oxenkrug researchers fluoxetine food drug administration fda ssri fluoxetine eli lilly company bryan molloy klaus schmiegel david wong ssris snris nris st john otc research uk national health service nhs gp west coral", " galiximab september iii macaca", " tc inn", " bimagrumab august food drug administration bimagrumab ii novartis fda bimagrumab", " risocaine", " elotuzumab empliciti breakthrough therapy fda november fda elotuzumab", " cymbalta snri eli lilly duloxetine uk american society clinical oncology interdisciplinary association grade american association neurology european federation neurological cochrane prescrire cochrane review ssris generic gad maudsley canadian psychiatric association internal medicine dpn dpn prescrire international bmc neurology cochrane food drug administration june november u.s. food drug administration sui fda mdd mdd sexual frequency ssris stevens\u2013johnson ssris snris ssri subsequently mdd fda fda fda fda fda sui u.s. cymbalta sui cymbalta duloxetine ne ne ne gaba ne absorption food distribution metabolism lilly david robertson david wong joseph krushinski lilly new drug application nda food drug administration fda fda good manufacturing practice eli lilly indianapolis qtc fda nda fda fda health sui eu lilly sui u.s. fda lilly u.s. fda february cymbalta u.s. january lilly june dr. reddy brand ariclaim dimorex xeristar yentreve duzela dulane cymbalta coperin abretia m\u00e9xico cymgen", " futuximab inn", " foralumab", " ligelizumab inn ighe", " valproate vpa valproate world health organization list essential medicines usd usd depakote valproate valproate off-label parkinson valproate aids pcos pcos valproate children iqs maternal iq valproate valproate cns supplemental gaba gabaergic gaba gaba gaba gaba intermediate vegf bdnf gdnf beverly s. burton pierre eymard valproate pharmac depakine depakine chrono epilim epilim chrono chrono epilim epilim chrono sanofi-aventis", " imd imp ms peroxynitrite university pennsylvania ms center ms nih ii parkinson iii parkinson alseres pharmaceuticals boston life sciences ms anatomical therapeutic chemical classification rna adars rna au iu", " pateclizumab", " lemalesomab", " fc-part fc fc epcam lymphomun ektomab cross-linking catumaxomab bites single", " exbivirumab", " inn inhalation mometasone mometasone mometasone monooxygenase elocom hhsone nasonex asmanex twisthaler dpi mometamax", " modafinil inn usan ban jan modavigil provigil iv modafinil european medicines agency modafinil cephalon ms modafinil parkinson modafinil foreign legion ministry qinetiq indian air force air force november air force dexedrine canadian medical association journal international space station modafinil teva pharmaceuticals december january fda em sjs dress fda fda fda dress stevens\u2013johnson sjs modafinil fda iv large-scale oral clinical fda coadministration research modafinil dat dri ic subsequently dat dri dat dat pet dat pet dat modafinil dat dat dat dat dri dra dat dat dri dri dat dat dat dra modafinil high ec modafinil modafinil comt research val met modafinil p-glycoprotein pgp pgp food auc auc cyp modafinil instrumental modafinil michel jouvet lafon laboratories modafinil modafinil modiodal provigil u.s. food drug administration stanford sleepiness test uk december modafinil cephalon inc. lafon cephalon r-enantiomer u.s. u.s. u.s. patent laboratoire l. lafon october october u.s. patent april april december mylan teva barr fda cephalon october u.s. reissue patent district court eastern district pennsylvania u.s.c. laboratoire l. lafon u.s.c. u.s.c. cephalon teva barr pharmaceuticals ranbaxy laboratories watson pharmaceuticals april litigation ftc april apotex cephalon shire pharmaceuticals apotex nuvigil cephalon teva ftc par pharmaceutical mylan inc. orchid january cephalon november modafinil schedule iv dea u.s. food drug act fda fda u.s. currently world anti-doping agency wada agency august summer olympics modafinil modafinil kelli white david clinger taurasi timothy grant taurasi monique coker balco major league baseball barry bonds modafinil vo modafinil world anti-doping agency prohibited list modafinil legal modafinil adhd stevens\u2013johnson u.s. food drug administration adhd modafinil dr. evan torch parkinson modafinil modafinil dan umanoff national association advancement advocacy clinical psychiatry bmi bmi modafinil modafinil modafinil", " enoticumab inn", " myoscint", " durvalumab medimmune nsclc", " fomivirsen vitravene cmv aids fda cmv aug cmv cmv fda", " milatuzumab milatuzumab food drug administration milatuzumab morris plains nj usa milatuzumab milatuzumab adc", " fezakinumab wyeth pfizer fezakinumab ii development august", " pexelizumab alexion", " panitumumab inn abx-egf egfr panitumumab amgen vectibix abgenix inc. amgen illumina u.s. food drug administration fda september egfr-expressing panitumumab european medicines agency emea health egfr-expressing kras panitumumab kras panitumumab september crc july fda kras panitumumab egfr egfr panitumumab egfr cho pk pk panitumumab oral panitumumab kras egfr adcc ret vandetanib vegfr egfr cabozantinib", " minretumomab ca lu ii", " obinutuzumab glycart biotechnology ag biogen idec chugai pharmaceutical hoffmann-la roche inc. glycart golgi obinutuzumab gazyva fda ema gazyva november food drug administration gazyva october nice nhs roche obinutuzumab gazyva january pan-canadian oncology drug review agency drugs technologies health hoffmann-la roche cdn national cancer institute iii cll rituximab cll cll cll nhl nhl", " inns combivir hiv epivir azt zdv retrovir transcriptase inhibitors nrtis food drug administration september viiv healthcare", " peregrine pharmaceuticals inc.", " interleukin iii second international lymphokine workshop interlaken dr vern paetkau university victoria interleukin ii molecular interleukin dna interleukin beta interleukin research solution nmr a-d gmcsf interleukin interleukin ige interleukin edf gcsf interleukin gcsf mgf gcsf mgf interleukin interleukin interleukin interleukin ifn-gamma tnf gm-csf human interleukin family interleukin leishmania toxoplasma measles human hiv nk interleukin interleukin interleukin pfam interpro", " ocaratuzumab b-lymphocytes adcc fc\u03b3riiia iii fc\u03b3riiia adcc mentrik biotech llc b-lymphocytes applied molecular evolution fab cdrs mentrik biotec mentrik biotech mentrik biotech eli lilly u.s. u.s. mentrik biotech council december mentrik biotech llc dallas tx mentrik biotech http:", " solar radioactive william ramsay morris travers september ramsay ramsay harold edgerton edgerton albert r. behnke jr. nikolay v. lazarev john h. lawrence stuart c. cullen university british columbia neil bartlett ptf ptf bartlett march bartlett ptf harf november liquid worldwide solar sun jupiter sun pu spin american manhattan chernobyl john h. reynolds solar solar mars mars sun mars new neil bartlett xef nif xef xef naf xef xef xecl xe cl xef hxeo xeo xeo xef xef na xeo csf xeof kf rbf csf f\u2013xe\u2013n(so f\u2013xe\u2013bf bf auxe sb m. r\u00e4s\u00e4nen university helsinki hxeh hxeoh hxecch khriachtchev hxeoxeh hxeod dxeoh lake vostok antarctic clathrate nmr sun imax hid bell laboratories nmda nmda ca atpase ca atpase mac xenon katp\\hif nmda nmda pkc-epsilon xenon katp st. michael hospital bristol august world anti doping agency wada gamma mri hyperpolarization krypton nmr nmr nmr wimps wimp jpl deep space nasa dawn spacecraft chemically mems applied mpa", " conatumumab trail tr amgen inc.", " phencyclidine pcp pcp parke-davis pcp pcp pcp nmda nmda pcp pcp pcp people mike wallace pcp pcp pcp pcp pcp schedule ii acscn schedule drugs list opium law low high pcp drug abuse warning network big lurch pcp pcp pcp nmda management benzodiazepines pcp pcp pcp pcp pcp nmda pcp nmda nmdar pcp david lodge nmda pcp research pcp pcp nmda nmda pcp pcp pcp nmda pcp pcp pcp pchp ppc pcaa pcp usa pcp pcp usa pcp nmda olney nmda olney frank sharp pcp pcp pcc pcp victor maddox parke-davis pcp pcp sernyl", " blinatumomab blincyto bites blinatumomab december food drug administration blinatumomab bcell blinatumomab micromet inc. lonza micromet amgen july fda october amgen biologics application fda fda december fda amgen merck peter bach center health outcomes memorial sloan-kettering cancer center amgen blincyto", " ramucirumab cyramza vegf vegf imclone systems inc. dyax april fda december fda egfr september eli lilly iii june iii", " pritumumab", " nacolomab staphylococcus", " pankomab ta pankomab glycotope gmbh ii", " alfaxalone inn jan ban alfaxan", " rituximab rituxan mabthera zytux rituximab world health organization list essential medicines usd rituximab rituximab hodgkin lymphoma rituximab mtx ra mtx ra pml itp evans wegener sjogren devic graves opsoclonus october plos october july rituximab pml pml pml rituximab hepatitis hepatitis ca rituximab nk rituximab rituximab nabil hanna idec pharmaceuticals u.s. u.s. food drug administration rituximab chop european commission rituximab biogen idec genentech u.s. hoffmann\u2013la roche european union chugai pharmaceuticals zenyaku kogyo aryogen world health organization list essential medicines avastin herceptin rituxan specialty fda mitigation strategy rems androgel rituximab belimumab ret vandetanib vegfr egfr cabozantinib", " human ifns ifn-\u03b1 ifnar ifn-\u03b1 ifn-\u03b2 ifn-\u03ba ifn-\u03b4 ifn-\u03b5 ifn-\u03c4 ifn-\u03c9 ifn-\u03b6 ifn-\u03b1 ifn-\u03b1 international nonproprietary inn ifn-\u03b2 ifn-\u03b5 ifnk ifn-\u03c4 ifn-\u03c9 ifn-\u03b6 ifn-\u03b4 ifn-\u03b5 ifn-\u03ba ifn-\u03c9 ifn-\u03c9 interferon ifn-\u03bd ifn-\u03b1 ifn-\u03b2 t-cells nk plasmacytoid ifn ifn-\u03b1 ifn-\u03c9 ifn-\u03b1 ifn-\u03b1 ifn-\u03b2 ifn ii ifn iii turtle piscine ifns ifn", " translation dna chimeric pcr dna gst di etanercept tnfr vdj", " pufas c=c ala epa dha marine sacha inchi echium epa ala epa epa dha ala february dpa epa dha fish epa dha ala epa dhas tnf ra pufas american college rheumatology acr acr national center complementary integrative health ra adhd adhd cochrane pufa pufa adhd pufas adhd fish epa epa alzheimer lcpufa ala epa dha dha researchers humans epa dha higher ala dha ala epa dha ala ala ala ala human metabolites september u.s. food drug administration epa dha epa dha dha epa canadian food inspection agency dha dha dha institute medicine reference intakes allowances rdas macronutrient distribution ranges rda ai ai amdr ala epa dha epa dha ala amdr amdr epa dha heavy pbdes fda dha epa council nutrition world health organization international fish standard fish american heart association epa epa dha epa dha epa dha harvard school public health journal american medical association marine epa dha krill epa dha squid ala ala epa dha purslane ala rothamsted research uk camelina epa dha epa dha epa eggs dha dha epa fda omega usda clemson university south carolina b-vitamins cla cla vs kangaroo dha dha seal epa dpa dha health european union dha epa c. epa epa nannochloropsis epa journal dairy science cla", " vatelizumab", " inn pontocaine ametop dicaine tac world health organization list essential medicines iv", " tocilizumab inn hoffmann\u2013la roche chugai actemra roactemra ra interleukin october tocilizumab dmards tnf ra general fda sjia castleman early nmo devic elevated ra tocilizumab ra tocilizumab interleukin osaka university tadamitsu kishimoto chugai pharmaceuticals clinical castleman hoffmann\u2013la roche ra dmards june castleman january european medicines agency ema roactemra january u.s. food drug administration fda actemra tocilizumab therapeutic goods administration pharmaceutical august july pharmac july july fda april ema august tocilizumab chugai chugai roche hoffmann\u2013la roche great britain tocilizumab pah", " hoechst ag ultracain north american ultracaine hoechst-marion-roussel hansamed limited ultracaine septanest septodont astracaine astrazeneca dentsply zorcaine carestream health kodak orabloc pierrel fda april america septocaine septodont articadent dentsply october novocol pharmaceuticals inc. ubistesin ubistesin forte espe orabloc pierrel fda north american ultracain d. supracain methylparaben methemoglobinemia paresthesia haas lennon royal college dental surgeons ontario rcdso ontario ontario miller haas pubmed", " fluorobenzoyloxy)tropane emcdda", " fentanyl sublimaze actiq durogesic duragesic fentora matrifen onsolis instanyl abstral lazanda fentanyl fentanyl paul janssen demerol janssen sublimaze fentora mylan fentanyl deaths fentanyl fentanyl durogesic dosage rate fentanyl actiq fentanyl pcts fentanyl recuvyra fda fentanyl fentanyl u.s. food drug administration fda september fda april fentanyl fentanyl fda july medicines healthcare products regulatory agency mhra structural fentanyl meyer-overton cns fentanyl paul janssen janssen pharmaceutica sublimaze janssen pharmaceutica duragesic actiq food drug administration fda onsolis bema fentanyl dea acscn u.s. fentanyl fentanyl fentanyl estonia fentanyl actiq dayton ohio detroit baltimore pittsburgh st. louis milwaukee camden new jersey little rock vancouver dallas u.s. june border patrol u.s. april azusa oxycontin white amf department justice white schedule amf june centers disease control prevention cdc rhode island asia west coast mdma health naloxone army armadillo air force pararescue moscow", " humanization human international nonproprietary names dna dna dna dna humanization fc cdr reopro erbitux fab fc fab cdr fab cdr fab dna otelixizumab cdr dna dna dna dna dna cdr alemtuzumab cdrs alemtuzumab rna fab adalimumab humira", "", " olokizumab ra ii ra", " atazanavir reyataz pi hiv atazanavir pis hiv u.s. food drug administration fda june atazanavir pi pis world health organization list essential medicines atazanavir hiv art-naive bilirubin atazanavir april fda prilosec aciphex fda auc cmin reyataz bold guido f\u00e4ssler alexander capraro hans-georg cozens robert klimkait thomas janis mestan j\u00fcrgen poncioni bernard new aza-dipeptide analogues orally protease inhibitors clinical development journal medicinal chemistry pmid october fda", " guselkumab interleukin janssen global services llc march ii ii american academy global assessment pga", " g-csf cpg immune nk cell ctl cancer rosenberg national institutes health asi interleukin bcg injection hpv lung til til clinical tils national cancer institute bethesda,md,usa moffitt cancer center tampa,fl,usa md anderson cancer center houston,tx,usa sheba medical center tel hashomer herlev university hospital herlev,denmark nki antonie leeuwenhoek aiet nk cytotoxic hepatitis chronic syndrome tcr tcr tcr morgan iv surgery branch national cancer institute bethesda maryland clinical research division dr. cassian yee fred hutchinson cancer research center seattle dr. cassian cancer research institute international symposia series hiv hiv immune immune immune immune injection immunotherapy grazax trichuris hookworm crohn interferon-gamma ifn-\u03b3 factor-alpha interleukin crohn celiac disease", " ii arbs ii ace ace ace irbesartan ii candesartan lisinopril ii cozaar ii arbs micardis valsartan diovan kanarb ii arbs alzheimer department veterans arbs losartan losartan ii blockage arb pd ii bp fda pis arbs pi vs bp fda pi arb fda pis adrs ace ace ii mi mi arbs mi arbs arbs ii ii arbs fda arbs arbs department veterans affairs journal hypertension journal clinical pharmacology veterans arbs food drug administration medical team leader thomas marciniak fda fda arb fda marciniak ellis unger dr. marciniak wall street journal knockout arbs losartan arbs", " clinical clinical clinical clinical people clinical open evar book daniel king avicenna canon medicine lady mary wortley montagu edward jenner james lind john woodall british east company lind john haygarth perkin sir william gull baronet frederick akbar mahomed guy collective investigation record british medical association sir ronald a. fisher rothamsted british medical research council council therapeutic trials committee mrc tuberculosis research unit sir geoffrey marshall sir austin bradford hill hill karl pearson doll royal society international u.s. national institutes health nih clinical currently multiple amgen astrazeneca pfizer details european union good clinical practice international conference harmonization human use regulatory journals clinical researchers declaration helsinki clinical drugs pharmaceutical research america phrma southern northern hemisphere clinical health study clinical clinical cro cro cro specialist cro irb cro irb irb cro janet yang interactional justice clinical clinical cros advanced edc iwrs statistical fda clinical institutional review board irb irb irb irb hipaa international conference harmonisation good clinical practice pharmaceutical research america congress ii iii national institutes health fda food drug administration researchers responsibility irbs dmc dmc fda ich irb irb institutional review board irb irb irbs irbs irb irb fda u.s. fda fda u.s. fda fda u.s. asia eastern central jacob sijtsma wemos european union international conference harmonisation human use currently clinical national national institutes health clinical new cro vis research institute volunteers fox trial finder parkinson volunteers clinicaltrials.gov u.s. national institutes health national library medicine z. janet yang katherine mccomas geri k. gay john p. leonard andrew j. dannenberg hildy dillon risp", " glembatumumab adc nmb gpnmb u.s fda fast track gpnmb-expressing mmae adc mmae gpnmb september june patients gpnmb ii gpnmb-expressing", " atorolimumab rhesus", " david f. duncan robert s. gold atropa brugmansia angel datura hyoscyamus mandragora benadryl native americans user erowid jimson", " tc emily", " janssen hiv nnrti iii caesar avanti nnrtis", " urtoxazumab escherichia", " tanezumab inn pfizer iii iii oa june tanezumab ii anti-ngf fda committee iii", " zalutumumab humax-egfr egfr genmab utrecht scchn scchn zalutumumab egfr egfr egfr sos ras gdp gtp gdp gtp ras pak mapk mek erk erk scchn egfr egfr domain iii egf adcc fab egfr nk fc fc nk fc fast track u.s. food drug administration scchn ii ii scchn scchn ii scchn iii scchn scchn iii progression-free scchn", " peramivir rapivab biocryst pharmaceuticals peramivir october u.s. food drug administration fda eua june december fda peramivir rapiacta peramiflu october october u.s. food drug administration fda use authorization peramivir u.s. health human services biocryst pharmaceuticals iii health human services health human services use authorization june biocryst biomedical advanced research development authority barda new drug application june asia na biocryst pharmaceuticals nda u.s. food drug administration fda december peramivir rapivab dec", " dabigatran pradaxa usa prazaxa inr fda boehringer ingelheim dabigatran dvt pe dvt pe dabigatran dabigatran gi gi ph ph reduced dabigatran fatty dabigatran bibr bibr march european medicines agency pradaxa national health service britain bbc dabigatran nhs pradax notice compliance noc health june october u.s. food drug administration fda pradaxa october september february american college cardiology foundation american heart association fda medicare agency agency july british medical journal bmj boehringer review boehringer fda ema boehringer bmj boehringer august idarucizumab october", " ertumaxomab rexomun ii fresenius", " lucatumumab hodgkin novartis pharmaceuticals corp", " tremelimumab pfizer tremelimumab ctls tremelimumab ctls tremelimumab april pfizer iii october october medimmune llc tremelimumab pfizer iii pfizer response criteria recist april pfizer response criteria october medarex bristol-myers squibb", " interferon ms ms ms interferon interferon skin mild ms uhthoff interferon-beta cis cis treatment ms mri ms interferon rrms ms ms betaferon bayer healthcare schering ag berlex bayer healthcare extavia", " interferon ms e. ms interferon ms interferon avonex biogen rebif merck serono pfizer cinnovex cinnagen cis cis treatment ms mri ms interferon rrms ms ms interferon skin mild ms uhthoff interferon-beta interferon ms avonex ms biogen orphan drug act avonex rebif dmd merck serono pfizer orphan drug act rebif cinnovex interferon cinnovex fraunhofer institute cinnagen cinnovex avonex projekt management vpm gmbh braunschweig interferon plegridy avonex usd avonex rebif interferon multiple sclerosis interferon bayer betaseron betaferon", " c=ch ethylene h-c-h c-c linear ethylene pd(ii products ethylene ethylene lummus ifp lummus ifp mideast ethylene ethylene care ethylene egyptians chinese dimitry neljubow sarah gane crocker ethylene yang shang fa yang sam adomet met adenosyltransferase sam acc acc acs acs acc-oxidase aco efe iaa arabidopsis arabidopsis arabidopsis loss-of-function dna cyanobacteria environmental acc acc ethylene aminoethoxyvinylglycine avg aoa zeise pt(pph rh cl greek oracle delphi pythia ethylene johann joachim becher physica subterranea joseph priestley jan ingenhousz mr. en\u00e9e ingenhousz johann rudolph deimann adrien paets troostwyck anthoni lauwerenburgh nicolas bondt ancient greek august wilhelm von hofmann hofmann geneva international congress luckhardt crocker carter university", " thiotetrabarbital thionarcex", " detumomab", " ixekizumab ii iii november ixekizumab eli lilly ixekizumab", " apolizumab", " international nonproprietary inn pharmacopeia usp usp inn ama usp pharmacopeial convention usan council usan usp", " hypothalamic-pituitary hp hpa hpg hpt", " ofatumumab arzerra fda diffuse ofatumumab genmab cll cll fda april cll mhra april ema june health august ofatumumab hepatitis ofatumumab cdc adcc genmab gsk ret vandetanib vegfr egfr cabozantinib", " opicinumab biogen idec inc.", " hexobarbital citopan evipan tobinal hexobarbital", " ascaris treatment", " nos list essential medicines robert goddard nofb nofb nofb world war ii luftwaffe luftwaffe luftwaffe mw multiple carbon december horace wells hartford gardner quincy colton colton dental association new haven city oxide entonox nitronox inhalation britain entonox nitronox research inhalation consumers union maryland vancouver dr. edward j. lynn contact august borough lambeth council nmda ampa gaba gaba gaba administration nmda cpp cpp nmda olney olney nmda biological national institute occupational safety health national institute occupational safety health niosh rel gwp america united nations framework convention climate change unfccc protocol u.s. u.s. environmental protection agency human nobel laureate paul crutzen environmental protection agency atmospheric george poe trenton new jersey downstream hydroxylammonium hno sncl hcl ph \u2013n ph mosier bouwman beauchamp dobbie smith smith dalal nanh nan agriculture industrial human control joseph priestley different kinds air thomas beddoes james watt medical use production airs james watt thomas beddoes thomas beddoes pneumatic institution relieving diseases medical airs hotwells bristol humphry davy davy researches chemical philosophical davy davy horace wells gardner quincy colton john mankey riggs december wells hartford wells boston december wells january boston gardner quincy colton colton dental association new haven city colton october joseph thomas clover clover colton c. l. blood jerome harris boston charles e. barney dea food drug administration food drug cosmetics act ministry health medicines act. oxide ip oxide ip boyle food drug authority fda-india", " adecatumumab adecatumumab", " adhd adhd adhd adhd mri adhd adhd adhd iq adhd adhd adhd children adhd cochrane collaboration adhd cochrane collaboration adhd tourette amphetamine adhd adhd amphetamine national football league nfl major league baseball mlb national basketball association nba national collegiate athletics association ncaa nfl injection international programme chemical safety ipcs food drug administration usfda maois raynaud amphetamine ipcs usfda usfda usfda adderall cardiovascular raynaud sexual amphetamine amphetamine adhd usfda amphetamine symptoms pathological addiction \u03b4fosb creb nf-\u03bab february nmda cochrane collaboration manufacturer cochrane collaboration amphetamine adderall cart adderall levoamphetamine ph ph ph ph ph ph ph ph n-acyltransferase amphetamine n-oxidation n-dealkylation amphetamine aadc l-dopa n-methyltransferase richwood pharmaceuticals shire duramed pharmaceuticals duramed pharmaceuticals teva pharmaceuticals barr pharmaceuticals barr duramed ir later barr barr april chemically adderall cns ir december teva pharmaceutical industries actavis barr pharmaceuticals shire adderall xr ir obetrol richwood rexar fda nda adderall fda february", " anatumomab fab staphylococcus", " ppis world health organization list essential medicines specialty ppi food drug administration ppis barrett ppis ppis ppi low ppi high ppis fda ppi ppis fda ppi ppis ppis ppis ppis ppis ppi ppis ppi ppi ppi associations ppi ppis ppis adma associations ppi proton atpase low hcl ppis ppis", " quilizumab inn ighe genentech", " broad-spectrum antiparastics early ppps melinda gates foundation pentavalent", " dikarya deuteromycota subphyla fungi fungi eumycota fungi fungi fungi fungi kingdom fungi carl linnaeus christian hendrik persoon elias magnus fries dna kingdom fungi horace schwamm schimmel miles joseph berkeley flora sir james edward smith vol shared armillaria fungi fungi uv species dna mycology iceman austrian alps fomes ancient mycology giambattista porta pier antonio micheli nova micheli carl linnaeus dutch christian hendrik persoon later elias magnus fries miles joseph berkeley august carl joseph corda anton bary louis ren\u00e9 charles tulasne arthur h. r. buller curtis g. lloyd pier andrea saccardo dna hyphae hyphae septate septa basidiomycota coenocytic fungi fungal armillaria hyphae magnaporthe fungi fungi deuteromycota sexual glomeromycota karyogamy sexual morphology specialized buller aspergillus researchers proterozoic ma paleozoic era ascomycota cambrian fossilized wisconsin glomerales prototaxites zygomycota chytridiomycota ascomycota basidiomycota doushantuo formation paleopyrenomycites chert palaeoancistrus homobasidiomycetes agaricomycetes archaeomarasmius cretaceous amoebozoa animalia choanozoa nucleariids rozellida microsporidia chytridiomycota neocallimastigomycota blastocladiomycota zoopagomycotina kickxellomycotina entomophthoromycotina mucoromycotina glomeromycota ascomycota basidiomycota fungi fungi dna web fungorum kingdom fungi ascomycota basidiomycota\u2014are dikarya currently microsporidia chytridiomycota blastocladiomycota neocallimastigomycota glomeromycota ascomycota basidiomycota microsporidia hibbett fungi chytridiomycota molecular blastocladiomycota chytridiomycota blastocladiomycota zygomycota glomeromycota dikarya ascomycota basidiomycota neocallimastigomycota chytridomycota glomeromycota glomeromycota glomeromycota zygomycota glomeromycota zygomycota fungi zygomycota glomeromycota mucoromycotina kickxellomycotina zoopagomycotina entomophthoromycotina zygomycota mucor rhizomucor rhizopus ascomycota eumycota kluyveromyces candida aspergillus penicillium fusarium claviceps ascomycota neurospora basidiomycota ustilago malassezia cryptococcus fonticula amoebozoa rhizaria excavata opisthokonta stramenopiles stramenopiles fungi mastigomycotina gymnomycota phycomycetes fungi opisthokonta corallochytrium stramenopiles alveolata schizomycetes rozellida rozella dna choanozoa kingdoms mycorrhizal sirex monascus candida lachancea mycetophilidae keroplatidae magnaporthe ophiostoma ophiostoma cryphonectria ustilago alternaria cochliobolus candida cryptoccocus histoplasma pneumocystis fungal amanita st anthony claviceps ustilago u. u. u. u. dna dna cryptococcus neoformans c. c. c. c. dna c. dna modern staphylococcus hmg-coa penicillium certain notable agaricus ganoderma ophiocordyceps research krestin trametes baker shoyu shoyu rhizopus aspergilli quorn fusarium portobello west flammulina certain stilton roquefort molds conocybe galerina lepiota amanita a.\u00a0virosa tricholoma asia koryak siberia beauveria metarhizium hirsutella paecilomyces isaria n. certain fungi neurospora schizosaccharomyces candida magnaporthe fungi psilocybin", " po(oh bone paget paget paget risedronate mpq crps oral fda po bis bisphosphonates bisphosphonate fpps hmg-coa bisphosphonates disruption hmg coa-reductase fpps ras rho rac hmg-coa bisphosphonates fosamax merck", " budesonide bud pulmicort copd crohn budesonide budesonide world health organization list essential medicines usd usd budesonide formulations crohn cochrane crohn budesonide budesonide budesonide aquacort cort bronex ph budair budecort dp budenofalk gb hk kp ph sg budeson ar budeson aqua ar budespray budiair kp budicort respules il bunase clebudan cn cycortide hk denecort ph duasma tw eltair entocort ar br cz dk fi fr gb hk il kp nl pl pt se tr giona easyhaler sg th inflammide pe miflonid cz miflonide il nz pt neumocort py novopulmon fr pulmicon susp nebulizer kp pulmicort bg br cl cn cr cz dk ee fi fr gb gr gt hn id ni nl pa pk pl pt ru se sv tr tw uy ve za turbohaler cl ke mu ng turbuhaler ke mu ng rafton fr rhinocort au rhinocort aqua hk rhinoside gr symbicort fr uceris", " efavirenz atripla hiv atripla u.s. gilead sciences medicines patent pool merck u.s. fda july uk nhs march atripla atripla gilead sciences bristol-myers squibb merck atripla hiv atripla atripla gilead sciences medicines patent pool merck atripla atripla crcl tdf ftc crcl efavirenz nnrti nrti ntrti hiv vascor orap halcion wigraine cafergot discuss hiv st. john atripla atripla atripla atripla st. john hypericum atripla", " obiltoxaximab elusys therapeutics inc.", " foscarnet ho cpo clinigen foscavir cmv cmv foscarnet hiv foscarnet dna dna dna hsv hsv cmv dna", " otelixizumab tolerx inc. abbott laboratories otelixizumab c-peptide defend early diabetes defend otelixizumab u.s. food drug administration", " pcv pcv prevenar synflorix prevnar s. crm crm c. pfizer prevnar synflorix prevnar children pneumococcal conjugated vaccine pcv prevnar whilst uk children centers disease control cdc advisory committee immunization practices ipd ipd prevnar ipd hiv aids u.s. ci ci world health organization pneumococcal development pneumoadip gavi alliance gavi gavi march gavi-eligible gavi gavi prevnar wyeth", " lebrikizumab inn tanox hodgkin tanox ii periostin ii", " alacizumab f(ab", " brevital methohexital cl gaba cl side-chain methohexital methohexital ect borowitz methohexital n-methylurea", " samalizumab samalizumab alexion pharmaceuticals", "", "", " ethinylestradiol", " treatment helicobacter", " sevirumab aids", " ketamine ketalar heart effects elevated spasms ketamine nmda ketamine world health organization list essential medicines usd ketamine ketamine low ketamine ketamine ketamine low high ketamine low-dose crps crps ketamine benefit nmda wales u.k. pcp dxm john c. lilly marcia moore d. m. turner moore turner ketamine john olney gabaergic iv nmda management nsaids snri maois ketamine ketamine nmda nmdar nmdar ketamine ketamine ketamine n-demethylation intermediate bioavailability peak ketamine plasma ketamine bioavailability ketamine ketanest ketamine calvin l. stevens chemistry wayne state university parke davis pcp fda war west coast early furry freak brothers john lilly marcia moore howard alltounian bright world mdma ketamine ketamine world health organization drugs list schedule iii act august january december uk advisory council misuse drugs acmd february home office uk minister state crime prevention norman baker acmd ketamine poisons standard october poisons act schedule schedule chapter drugs ordinance iii east asia ii december schedule cosmetics act brand krupitsky krupitsky kolp ketamine", " permethrin", " indinavir crixivan merck hiv world health organization list essential medicines hiv indinavir treatment indinavir food drug administration march indinavir hiv aids", " novo nordisk novolog novorapid novolog dna jdrf food drug administration june ph csii flexpen novopen i-port novolog\u00ae novolog\u00ae novolog\u00ae novolog\u00ae novo nordisk medtronic paradigm\u00ae minimed disetronic\u00ae d-tron\u00ae h-tron\u00ae novolog mix novo nordisk novolog mix ph novolog mix novo nordisk flexpen novolog\u00ae novolog\u00ae flexpens\u00ae novolog\u00ae flexpen\u00ae novolog\u00ae novolog\u00ae flexpen\u00ae novolog\u00ae novopen\u00ae novolog novolog novolog\u00ae novolog\u00ae novolog\u00ae", " phenoperidine paul janssen janssen pharmaceutica otto eisleb ig farben janssen janssen janssen neuroleptic convention regulating distribution world health organization single convention drugs drug enforcement administration dea", " sifalimumab sle sifalimumab medimmune", " efungumab mycograb neutec pharma novartis candida european medicines agency mycograb chemically", " varlilumab celldex therapeutics", " dmards rids saards dmard crohn sle sjogren syndrome itp c-reactive dmards dmards dmards dmards tnf nice combinations dmards dmard dmard dmard", " pidilizumab medivation pidilizumab ii ii", " oseltamivir tamiflu disease society america centers disease control prevention cdc national institute health care cdc cochrane gilead sciences roche world health organization list essential medicines oseltamivir world health organization list essential medicines oseltamivir centers disease control prevention cdc european centre disease prevention control ecdc public health american academy aap americas disease society america cdc plos cochrane cochrane nis cdc ecdc public health disease society america aap roche cochrane ema cochrane new journal medicine pcr cdc cochrane cochrane collaboration european centers disease control cdc public health disease society america american academy roche cochrane cdc adrs oseltamivir stevens\u2013johnson u.s. eu cochrane meta-analysis december world health organization cdc november cdc cdc influenza b. january cdcs october cdc october oseltamivir na oseltamivir gilead e. roche philippines fda june ema oseltamivir tamiflu southeast asia november u.s. president congress congress defense secretary cochrane december cipla tamiflu antiflu cipla antiflu tamiflu antiflu june nice cdc european centre disease prevention cochrane roche european medicines agency cochrane roche cochrane cochrane ema roche gsk cochrane", " corneliu e. giurgea alzheimer parkinson huntington adhd adhd racetams june ampa", " sitagliptin januvia merck sitagliptin u.s. food drug administration fda october merck april fda janumet october fda juvisync sitagliptin gip gip sitagliptin u.s.", " rontalizumab genentech november", " roledumab rhd rhesus", " high nacl loop loop henle glucosuria na loop na(+)-cl classification diuretics", " ffp temogram aptem tem", " enavatuzumab enavatuzumab facet biotech corp", " itolizumab inn alzumab biocon itolizumab iii psoriasis area severity index biocon drugs controller general dcgi january august", " greek hypnos early z-drugs research treatment barbiturates benadryl\u00a0\u2013 gaba athinazone ethinazone nubarene casfen agency healthcare research quality uk national institute health clinical nice z-drugs nice nice gaba imovane zimovane ambien stilnox stilnoct research melatonin circadin\u00ae eu ramelteon rozerem\u00ae valdoxan\u00ae melitor\u00ae thymanax\u00ae hetlioz\u00ae benadryl second-generation high drowziness", " edrf ca class ii class iii sa", " siplizumab nk", " first-generation national institute health clinical nice american psychiatric association british society psychopharmacology pace assessment crisis clinic cops criteria syndromes nice cbt cbt response maintenance cochrane american psychiatric association uk national institute health care aripiprazole food drug administration fda tourette low tourette ocd ptsd personality disorders tourette uk fda aggressive amisulpride clozapine national institute mental health catie compliance uk nice antipsychotics antipsychotic meta withdrawal withdrawal british national formulary trade different higher ci ors cis notable legend lobotomy henri jean delay pierre deniker frederik f. yonkman cibapharmaceutical howard fabing alister cameron marta joanna moncrieff use uk johnson johnson omnicare eli lilly company zyprexa bextra bextra pfizer geodon astrazeneca seroquel astrazeneca seroquel eli lilly zyprexa harvard joseph biederman senate biederman johnson johnson biederman biederman pharmaceutical physicians", " merck", " nelfinavir viracept hiv nelfinavir pis pis nelfinavir hiv hiv nelfinavir agouron pharmaceuticals eli lilly company agouron pharmaceuticals warner lambert pfizer hoffman-la roche viiv healthcare u.s. food drug administration fda march agouron june medicines healthcare regulatory agency european medicines agency nelfinavir nelfinavir nelfinavir hiv nelfinavir nelfinavir pis pis nelfinavir nelfinavir nelfinavir ii nelfinavir nelfinavir nelfinavir nelfinavir cytochrome", " abacavir inns trizivir hiv pfizer viiv healthcare aids hiv azt abc december lupin trizivir", "", " darbepoetin darbepoetin amgen aranesp september food drug administration june european medicines agency dr. reddy cresp august cresp darbepoetin dna chinese epo darbepoetin rbc darbepoetin category amgen darbepoetin rbc amgen january amgen u.s. food drug administration fda dahanca dahanca aranesp aranesp fda public health advisory march february esas american society clinical oncology asco american society hematology ash epo winter olympic games larisa lazutina olga danilova johann m\u00fchlegg epogen aranesp", " ficlatuzumab ficlatuzumab aveo pharmaceuticals aveo ii", " fluroxene inn usan fluoromar", " vepalimomab", " eculizumab inn usan soliris pnh eculizumab eculizumab alexion pharmaceuticals food drug administration fda march pnh september european medicines agency pnh june november eculizumab eculizumab soliris uk soliris pnh alexion americans alexion alexion soliris pnh eculizumab september u.s. food drug administration fda soliris thrombotic study week tma quality week study tma pe eculizumab qol tma tma week pe tma seventeen pnh aes aes sae saes eculizumab tma eculizumab eculizumab eculizumab pnh eculizumab g-kappa igg\u03ba eculizumab fda soloris orphan drug act sidhu university toronto soliris u.s. soliris public alexion eculizumab qalys qaly qalys alexion soliris forbes uk soliris soliris pnh alexion americans alexion alexion soliris december ontario soliris health soliris ontario pnh february soliris alexion international price comparison hipc june patented medicine review board pmprb canadian patent act ottawa ontario john haslam president general manager vaughan alexion alexion soliris pharmac december alexion pharmac pharmac pnh pharmac patient pharmaceutical assessment nppa fda eculizumab march trans-pacific partnership chile shiga-toxin-producing escherichia stec-hus e. stec-hus eculizumab stec-hus shiga-toxin mayo clinic ahr amr ahr eculizumab researchers johns hopkins university amr eculizumab ii transverse membranoproliferative mpgn mpgn esrd mpgn dense-deposit ddd mpgn mpgn ii ddd esrd march new journal medicine ddd new journal medicine ddd ddd ddd catastrophic caps caps caps caps", " ritonavir norvir hiv haart ritonavir ritonavir world health organization list essential medicines usd usd ritonavir hiv ritonavir cyp hiv haart aids university liverpool ritonavir norvir abbvie inc. food drug administration fda march u.s. hiv-associated abbott abbvie inc. usd congress nih nih august norvir fda viekira pak ritonavir ii ii ii ii ii form ii abbott abbvie norvir abbott abbvie fda", " ancient\u00a0greek ludwig brieger nato warsaw pact nato warsaw pact international committee red cross biological weapons convention convention code toxicology environmental health information program national library medicine nlm tehip tehip toxicology data network toxmap geographic information gis toxnet toxmap environmental protection agency epa toxics release superfund basic research programs gajendra pal singh raghava http:", " enoblituzumab inc.", " dca dca", " rinucumab regeneron pharmaceuticals inc.", " j\u0101bir hayy\u0101n ramon llull cordus august sigmund frobenius diethyl grignard ii united nations convention illicit traffic psychotropic william t.g. morton october ether dome boston massachusetts crawford williamson long m.d. georgia march boston diethyl boston dodge diethyl c.e. halothane diethyl modern hoffman drops pharmacopeia june lemkos diethyl vapor-phase diethyl ethanol le chatelier williamson vapour ether ether commercial bht storage water", " sacituzumab sclc ii ii tnbc", " placulumab teva pharmaceutical industries inc.", " fludrocortisone florinef hydrocortisone crohn addison cushing clinical csr csc nasonex flonase csr use allergen dermatitis society s. coopman hydrocortisone betamethasone iv tadeusz reichstein edward calvin kendall philip showalter hench nobel prize physiology medicine nsaid lewis sarett merck russell marker syntex mexican d.h. peterson h.c. murray upjohn rhizopus percy julian", " caribbean tethya d-arabinose d-ribose bernard randall baker stanford research institute sri international m. privat garilhe j. rudder university alabama birmingham dr. whitley d-ribose d-arabinose bbb mechanism dna dna dna dna dna dna rna s-adenosylhomocysteine dna zoster ehna chemical b. r. baker vidarabine streptomyces vidarabine arasena-a idu rna aids", " oilatum balneum medi oil diprobase sebexol exederm eucerin johnson johnson", " brodalumab january fda brodalumab amgen inc. iii november amgen astrazeneca iii amgen astrazeneca kyowa hakko kirin september astrazeneca brodalumab january biologics application bla fda november brodalumab", " sibrotuzumab fap ii", " zatuximab inn", " cidofovir vistide cmv aids cidofovir hsv cidofovir cidofovir brincidofovir cidofovir bk cidofovir hpv fda june tga april ema april cidofovir cidofovir fanconi probenecid hypersensitivity iv iv dna dna dna dna cidofovir institute organic chemistry biochemistry prague anton\u00edn hol\u00fd gilead sciences vistide gilead usa pfizer cidofovir", " crenezumab beta alzheimer crenezumab ac immune inc. ac immune crenezumab alzheimer genentech banner alzheimer institute national institutes health medell\u00edn alzheimer november ctad ii crenezumab abby blaze mri csf fdg pet", " pembrolizumab keytruda pembrolizumab gregory carven hans john dulos organon biosciences schering plough research institute merck mrc technology organon september food drug administration fda fda fast track development program braf braf merck october fda pembrolizumab pembrolizumab ii nsclc", " ophthalmology greek sushruta sushruta samhita sanskrit bc alcamaeon rufus ephesus rufus galen vesalius galen medieval islamic arabic ibn alhazen optics ibn arabic damascus book ophthalmology theory compounded ophthalmic drugs malpighi leeuwenhoek ruysch petit leeuwenhoek gottfried reinhold treviranus georg joseph school medicine great britain john freke governors st bartholomew baron michael johann baptist wenzel king george iii moorfields eye hospital clinical moorfields institute ophthalmology university college sir stewart duke elder ernst abbe zeiss jena hermann von helmholtz nazis joseph igersheimer turkey medicine university istanbul tufts university polish ophthalmological society adam zamenhof nazis zofia falkowska clinic ophthalmology warsaw md d.o. boptom fraco ranzco uk ccst mbbs diploma ophthalmology diploma community ophthalmology fellow college physicians surgeons master md royal college surgeons frcsc frcsc quebec royal college mbbs doctor medicine master surgery diploma ophthalmic medicine surgery diplomate national board ophthalmological society mbbs md ophthalmology tilganga institute ophthalmology tilganga kathmandu bpklco institute medicine tu kathmandu bp koirala institute health sciences dharan kathmandu university dhulikhel national academy medical science kathmandu nepalese medical council licensing exam ophthalmology ophthalmic society royal college surgeons mrcsi fellowship frcsi irish college clinical health service executive dublin sligo limerick galway waterford cork msc md uk mbbs fcps college physicians surgeons pakistani mcps doms armed forces post graduate medical institute rawalpindi m.s. college allied vision sciences lahore institute community ophthalmology peshawar king edward medical university al shifa trust eye hospital rawalpindi al ibrahim eye hospital karachi doctor mbbs philippine academy attainment pbo philippine academy ophthalmology board ophthalmology royal college rcophth royal college surgeons edinburgh mrcophth mrcsed royal college glasgow frcs nhs uk european union accreditation council graduate medical education osteopathic association american board osteopathic board otolaryngology doctor osteopathic medicine md american academy american society cataract refractive surgery", " tc humaspect", " hdl national education program ncep treatment panel iii atpiii", " duligotumab inn", " gemtuzumab wyeth mylotarg june gemtuzumab fda aml fda vod gemtuzumab iii wyeth fda vs vs june pfizer mylotarg fda fda pharmaceuticals medical devices agency ret vandetanib vegfr egfr cabozantinib", " tefibazumab aurexis s. s. inhibitex", " la clinical low nsaids topical emla causes general csf cardiac ph fiber injection clinical amide las la peru brachial august bier august bier fidel pag\u00e9s metam\u00e9rica achile mario dogliotti", " ezetimibe zetia ezetrol zocor u.s. merck vytorin inegy ezetimibe hmg-coa ldl improved reduction vytorin efficacy international trial improve-it acs cv cv nnt nnt cv mi enhance study clinical vytorin american college enhance merck schering plough american college cardiology march house committee energy commerce", " teplizumab fc fc fnb teplizumab columbia university inc. eli lilly one-year iii", " ascrinvacumab pfizer inc.", " bayer cremophor el propanidid althesin cremophor el cremophor", " midazolam midazolam effects gaba midazolam list essential medicines midazolam usd midazolam midazolam midazolam icu icu midazolam midazolam oral midazolam midazolam benzodiazepines kidney children midazolam cns cns cns midazolam gaba gabaergic cns treatment symptoms protease st john midazolam atorvastatin st john grapefruit midazolam midazolam midazolam midazolam cyp gaba gaba gaba gaba cl\u2212 gaba midazolam walser fryer hoffmann-laroche midazolam midazolam usd midazolam roche roche dormicum novell pharmaceutical laboratories miloz midazolam roxanne laboratories midazolam hcl syrup ph midazolam list ii opium law midazolam schedule iv convention psychotropic dea schedule iv act european medicines agency buccolam buccolam midazolam oklahoma midazolam ohio arizona ohio dennis mcguire january midazolam william happ october clayton lockett oklahoma prison lockett glossip v. gross oklahoma eighth amendment constitution june u.s. supreme court", " cl ptfe chloroform biodegradation chloroform dumas chloroform cdcl nmr teflon chlorodifluoromethane teflon protocol worldwide cdcl nmr ccl ccl reimer-tiemann kharasch chcl november james young simpson edinburgh dr. francis brodie imlach chloroform c.e. hannah john snow britain levy uk america gurlt killian chloroform joseph harris dr. h. h. holmes william marsh rice rice university use lancet chloroform chloroform cns chloroform hcl amylene phosgene hcl hcl", " motavizumab inn numax medimmune astrazeneca september ii iii june fda antiviral drugs advisory committee medimmune motavizumab palivizumab december astrazeneca motavizumab motavizumab rsv food drug administration motavizumab rsv", " cns adhd adhd ii schedule ii dea ii adhd adhd adhd mri adhd adhd adhd iq adhd adhd adhd children adhd cochrane collaboration adhd cochrane collaboration adhd tourette adhd fd&c red fd&c yellow fd&c blue amphetamine adhd adhd amphetamine pharmaceutical maoi food drug administration usfda usfda raynaud amphetamine usfda usfda therapeutic goods administration products cardiovascular raynaud sexual amphetamine amphetamine adhd usfda amphetamine symptoms pathological addiction \u03b4fosb creb nf-\u03bab february nmda cochrane collaboration manufacturer cochrane collaboration ph adderall adhd new river pharmaceuticals shire pharmaceuticals april vyvanse fda iii adhd adhd-rating scale february health adhd february vyvanse fda adhd february shire adhd shire adhd january u.s. food drug administration elvanse uk venvanse br vyvanse ca ssri snri sndris ssris snris", " tenatumomab", " infliximab remicade remsima inflectra infliximab u.s. food drug administration fda crohn fda beh\u00e7et tnf-\u03b1 tnf-\u03b1 infliximab infliximab centocor simponi humira cimzia etanercept tnf-\u03b1 tnf-receptor infliximab crohn infliximab crohn ii infliximab iii accent fda infliximab crohn accent crohn infliximab tnf paul rutgeerts william sandborn acute colitis treatment psa tnf psa nsaid psa infliximab beh\u00e7et infliximab fda september infliximab copd infliximab tnf enbrel humira fda fda maintenance crohn infliximab fda infliximab tnf-\u03b1 tnf-\u03b1 tnf-\u03b1 infliximab tnf tnf-\u03b1 etanercept tnf tnf-\u03b1 crohn infliximab tnf-\u03b1 tnf tnf\u03b2 tnf-\u03b1 infliximab tnf-\u03b1 tnf-\u03b1 janssen biotech inc. centocor biotech inc. usa mitsubishi tanabe pharma xian janssen schering-plough merck hospira celltrion healthcare european medicines agency ema committee medicinal products human use chmp remsima european union eu maa eea economic area remsima ministry health labour welfare mhlw july epirus biopharmaceuticals tnf infliximab infliximab nhs uk crohn crohn cdai february infliximab pbs crohn infliximab republic hse medical card scheme johnson johnson remicade\u00ae company tnf george kollias infliximab junming le jan vilcek university school medicine centocor janssen biotech inc.", " bectumomab", " atezolizumab roche atezolizumab", " adc mmaf denintuzumab denintuzumab mmaf dlbcl b-lineage b-all ash dec dlbcl dlbcl", " ctx ctx al crohn dosage bsa bsa bsa bsa bsa bsa bsa bsa bsa bsa bsa folfox folfox pfs carboplatin world war rna dna dna dna dna dna dna n-nitroso-n-methylurea mnu bcnu ccnu meccnu azq cisplatin non-classical dna rna dna rna dna dna rna dna dna dna dna s-phase dna methotrexate dhfr dna pemetrexed dna dhfr fluorouracil fump fump rna capecitabine vidaza vinca vinca s-phase m-phase pacific yew taxus taxus paclitaxel s-phase american mayapple mayapple topoisomerase ii dna dna dna dna dna dna ii camptotheca drugs ii ii dna dna dna ii dna dna doxorubicin dna dna actinomycin dna rna bleomycin streptomyces dna dna mitomycin dna picc hickman port-a-cath picc chemotherapeutic neutropenia g-csf bmts bmts herpesviridea trametes malnutrition self-care coates cinv alopecia chemotherapy scalp development gnrh chemotherapy cipn chemotherapy cipn cipn cipn cipn high cardiotoxicity dna hepatotoxicity nephrotoxicity ototoxicity mopp hodgkin blood cancer research cancer dna dna upregulation dna cancer dna hodgkin heterogeneic methotrexate ra ra cyclophosphamide al al al chemotherapy cyclophosphamide chemotherapy healthcare routes world war world war ii yale school medicine december world war ii bari allied wwii paul ehrlich ehrlich list adcs reduced mylotarg wyeth pfizer hodgkin passive blood dna clinical standard operating procedures electrochemotherapy standard operating procedures sop hyperthermia hyperthermia bcnu cddp chemotherapy ret vandetanib vegfr egfr cabozantinib", " isoflurane isoflurane isoflurane list essential medicines fda pocd pocd alzheimer pocd nmr alzheimer isoflurane isoflurane gaba isoflurane isoflurane atpase nadh", " inolimomab", " imatinib inn gleevec usa glivec latin america cml ph-positive cml bcr-abl bcr-abl gleevec gleevec fda gist usa january supreme court world health organization list essential medicines lasker award prize gleevec imatinib cml gists u.s. food drug administration fda cml cml fda gist february kit kit-positive gists fda january gleevec ph imatinib pdgf pdgf-r\u03b2 mouse gsap gsap gsap alzheimer alzheimer alzheimer alzheimer captisol imatinib imatinib cautions medical treatment imatinib imatinib tk imatinib tk abelson pdgf-r bcr-abl imatinib pdgf-r imatinib bcr-abl imatinib abelson abl pdgfr pdgfr imatinib st. john imatinib imatinib ciba-geigy sandoz novartis nicholas lydon elisabeth buchdunger j\u00fcrg zimmermann cml brian druker oregon health science university carlo gambacorti-passerini university milano bicocca john goldman hammersmith hospital uk charles sawyers memorial sloan-kettering cancer center druker cml imatinib april eu march april j\u00fcrg zimmermann july gleevec novartis fda orange book gleevec gleevec fda druker lydon sawyers lasker-debakey clinical medical research award fda fda blood u.s. brian druker carlo gambacorti-asserini john goldman novartis novartis bristol-myers squibb gleevec novartis gleevec supreme court novartis world trade organization novartis gleevec novartis gleevec gleevec marketing rights emr gleevec patent office emr november emr gleevec novartis gleevec novartis novartis novartis supreme court supreme court supreme court novartis gleevec ret vandetanib vegfr egfr cabozantinib", " obinutuzumab glycart biotechnology ag biogen idec chugai pharmaceutical hoffmann-la roche inc. glycart golgi obinutuzumab gazyva fda ema gazyva november food drug administration gazyva october nice nhs roche obinutuzumab gazyva january pan-canadian oncology drug review agency drugs technologies health hoffmann-la roche cdn national cancer institute iii cll rituximab cll cll cll nhl nhl", " dna dna dna rna dna rna dna rna main", " anileridine merck anileridine", " pascolizumab ii", " gantenerumab alzheimer gantenerumab alzheimer scarlet road ii december iii", " coagulation coagulation coagulation factor vii factor vii von willebrand vi vi adp paf pla iib roman fviii fv factor xiii fviia hmwk fxii prekallikrein fxii fxiia fxiia fxi fxia factor xia fix fviiia fx fxa fxii hmwk thrombin viii factor xiii fviii fix streptokinase pt measurement clauss viii fx pt platelet glanzmann bernard-soulier von willebrand von willebrand viii christmas hemophilia ashkenazi jews von willebrand von willebrand ib gpib gpib gpib thrombasthenia glanzmann naegeli glanzmann gpiib gpiib deficiency k. thrombosis iii thrombin vii anti-platelet warfarin k-dependent ii vii ix,x theories physiologist johannes m\u00fcller rudolf virchow prosper sylvain denis alexander schmidt giulio bizzozero paul morawitz iii ii iv factor paul owren factor vi va vi factor vii factor viii factor stephen christmas dr. rosemary biggs professor r.g. macfarlane oxford uk christmas factor christmas aids hageman john hageman factor ms. audrey prower mr. rufus stuart xiii macfarlane uk davie ratnoff usa roman i-xii international committee hemostasis icth factor xiii fletcher factor fitzgerald factor iii vi factor v.", " telimomab", " efavirenz atripla hiv atripla u.s. gilead sciences medicines patent pool merck u.s. fda july uk nhs march atripla atripla gilead sciences bristol-myers squibb merck atripla hiv atripla atripla gilead sciences medicines patent pool merck atripla atripla crcl tdf ftc crcl efavirenz nnrti nrti ntrti hiv vascor orap halcion wigraine cafergot discuss hiv st. john atripla atripla atripla atripla st. john hypericum atripla", " tsh tbg mit dit dit mit dit deficiency tsh fetal atp-dependent tsh oh-group ph crym dna tr tr rna effects inn charles robert harington george barger different f.d.a. congenital atpase", " sir james black smith kline french glaxosmithkline tagamet zantac\u2014which cimetidine smith kline french glaxosmithkline james w. black c. robin ganellin sk&f sk&f burimamide metiamide ranitidine zantac glaxo glaxosmithkline smith kline french glaxo ecl vs adrs cyp mdma cyp cyp famotidine cyp", " lifastuzumab roche", " emd pharmaceuticals", " gonadotropin gnrh lupron gnrh fsh clomiphene aromatase clomiphene clomid serm gnrh lh fsh lh fsh fsh fsh dna dna recombinant dna fsh follistim gonal luveris lh human lh fsh research clomiphene effects", " ancient egyptians greeks jules francois joubert alexander fleming penicillin antibacterials hiv herpes a-e organic e. copper-alloy e. mrsa staphylococcus environmental protection agency hg pb u.s. environmental protection agency epa federal insecticide fungicide rodenticide act epa products epa public epa cdc environmental protection agency", " fletikumab novo nordisk novo", " diabetes diabetes ii ii ii research insulin ii metformin gi ppar\u03b3 ppre multiple dream new journal medicine food drug administration proactive ii alpha-glucosidase gip gip glp glp glp glp dipeptidyl rct sitagliptin rcts saxagliptin rcts vildagliptin rcts alogliptin amylin januvia onglyza", " clinical clinical clinical clinical people clinical open evar book daniel king avicenna canon medicine lady mary wortley montagu edward jenner james lind john woodall british east company lind john haygarth perkin sir william gull baronet frederick akbar mahomed guy collective investigation record british medical association sir ronald a. fisher rothamsted british medical research council council therapeutic trials committee mrc tuberculosis research unit sir geoffrey marshall sir austin bradford hill hill karl pearson doll royal society international u.s. national institutes health nih clinical currently multiple amgen astrazeneca pfizer details european union good clinical practice international conference harmonization human use regulatory journals clinical researchers declaration helsinki clinical drugs pharmaceutical research america phrma southern northern hemisphere clinical health study clinical clinical cro cro cro specialist cro irb cro irb irb cro janet yang interactional justice clinical clinical cros advanced edc iwrs statistical fda clinical institutional review board irb irb irb irb hipaa international conference harmonisation good clinical practice pharmaceutical research america congress ii iii national institutes health fda food drug administration researchers responsibility irbs dmc dmc fda ich irb irb institutional review board irb irb irbs irbs irb irb fda u.s. fda fda u.s. fda fda u.s. asia eastern central jacob sijtsma wemos european union international conference harmonisation human use currently clinical national national institutes health clinical new cro vis research institute volunteers fox trial finder parkinson volunteers clinicaltrials.gov u.s. national institutes health national library medicine z. janet yang katherine mccomas geri k. gay john p. leonard andrew j. dannenberg hildy dillon risp", " didanosine ddi videx ec hiv haart world health organization list essential medicines february food drug administration didanosine azt didanosine oral food morris j. robins organic chemistry brigham young university r.k. robins subsequently samuel broder hiroaki mitsuya robert yarchoan national cancer institute nci hiv hiv nci nci national institutes health nih bristol-myers squibb bms hiv food drug administration fda october fda azt fda fda bms videx ec fda fda nih barr august", " hiv hiv hiv hiv aids hiv hiv hiv", " citatuzumab fab", " glucocorticoids gcs gr gcs gr cortisol glucocorticoid elevated glucocorticoids anp glucocorticoids gr gre gr dna new gr dna gr nf-\u03bab dna nf-\u03bab gr gr src gr gr egf na cortisol hydrocortisone oral fludrocortisone doca bsa bsa nf-\u03bab nf-\u03bab glucocorticoids ifn-\u03b3 glucocorticoids glucocorticoids fc ifn-gamma fc ri fc fc fc nsaids glucocorticoids glucocorticoid", " ranibizumab fab amd armd ranibizumab novartis lucentis ranibizumab bevacizumab cochrane ranibizumab marina anchor vision early treatment diabetic retinopathy early treatment diabetic retinopathy november times genentech catt national eye institute amd medicare medicare comparison macular degeneration treatments trials catt new journal medicine catt ivan catt", "", " nebacumab", " satere-mawe salvia ipomoea amanita dmt neo-american church dpt temple inner light sangoma cannabis cannabis timothy leary marsh chapel roland griffiths johns hopkins carl a. p. ruck jeremy bigwood danny staples evans schultes jonathan r. gordon wasson greeks genesthai entheogen hallucinogen huxley psychedelic humphry osmond huxley ruck ruck high la trobe university school psychological sciences dmt thc pausinystalia rauwolfia alchornea niando ptsd l. e. hollister pcp dxm nmda nan kpt arabic qur'an greek latin greek sucellus sucellos gauls ninkasi dionysos bacchus dionysus bc mycenean greeks mysteries plato symposium homeric demeter demeter kykeon mysteries bc osiris egyptians mysteries norse communion communion judaism shabbat kiddush passover talmud oceania ego ayahuasca cia lsd mkultra aids dmt rastafari sadhus hinduism scythians islam bwitists egyptians egyptian white crown triple crown atef crown ivory coast african mitchell hudson sobiecki american evans schultes harvard university kiowa oklahoma calia aztec aztecs turbina salvia banisteriopsis psychotria urarina amazonia san pedro trichocereus trichocereus dmt-snuffs nicotiana entheogens rastafari church universe native americans chumash tongva chumash momoy siberia amanita hinduism datura soma vedas wasson soma amanita soma soma atropa northern aegean dionysus aegean herodotus dacian roman christianity eleusinian mysteries demeter soma hindus delphi classical mushroom europeans slavic rus dmt philologist john marco allegro sacred mushroom cross christian amanita allegro plaincourault chapel christian aboriginal australian aboriginals pitcheri pitcheri m\u0101ori kava papua new guinea boletus kava piper methysticum pacific melanesian islam jainism bah\u00e1'\u00ed faith church christ saints lds church seventh-day adventist church church christ scientist united pentecostal church international theravada mahayana buddhism protestant christianity taoism hinduism pali canon theravada buddhism church judaism sula benet sara benetowa hebrew bible book exodus zion coptic church hebrew bible michael zohary hans arne jensen james a. duke acorus cymbopogon kaneh-bosm old testament ancient hebrew bible judaism hebrew bible john allegro qumran living torah hebrew hebrew old testament chris bennett sula benet professor dan merkur terence mckenna r. gordon wasson john marco allegro torah tenach allegro non-catholic dead sea allegro catholic church allegro sacred mushroom cross allegro christianity god amanita entheos christianity christianity r. gordon wasson erwin panofsky christian christianity christianity daniel merkur university toronto christian r.c. parker vajrayana ronald davidson william george stablein bulcsu siklos david b. gray benoytosh bhattacharyya shashibhusan das gupta francesca fremantle shinichi tsuda david gordon white rene nebesky-wojkowitz james francis hartzell edward todd fenner ian baker dr. pasang yonten arya vajrayana tantric saivite vajrayana anuttarayoga tantra cannabis datura vajrayana laghusamvara-tantra cakrasa\u1e43vara tantra samputa-tantra samvarodaya-tantra mahakala-tantra guhyasamaja-tantra vajramahabhairava-tantra krsnayamari-tantra cakrasa\u1e43vara tantra heruka west jack kornfield kornfield r. gordon wasson giorgio samorini tassili algeria bp hemp pazyryk scythians bc herodotus christian americas soma book rig veda rig veda law enouncing king soma soma pav\u0101mana eleusinian mysteries carl ker\u00e9nyi mother ancient east aegean odyssey narcissus ruck eyan staples indo-europeans amanita aegean indo-europeans dionysus nysa zeus amanita soma hyperboreans robert graves hellenic amanita amanita ruck staples tantalus gilgamesh gilgamesh hellenic apollodorus gaia mother ge eos dawn selene moon helios sun ge assassins nizari marco polo ismaili paradise nizari mountain marco polo joseph von hammer-purgstall von hammer assassin nizaris notable marsh chapel walter pahnke timothy leary harvard psilocybin project boston johns hopkins university australian federal government australian criminal code dmt dmt mescaline ephedrine floral emblem acacia golden wattle therapeutic goods administration dmt sherbert verner supreme court sherbert test employment division v. smith u.s. congress freedom restoration act rfra city boerne flores u.s. gonzales v. centro esp\u00edrita beneficente uni\u00e3o vegetal u.s. rfra rfra arizona idaho new oklahoma south carolina", " ghb gaba gaba ghb ghb na.ghb k.ghb ghb succinic ghb ghb u.s. food drug administration fda eds ghb ghb ghb georgia home mils fantasy mdma ghb ghb gaba ghb ghb ghb ghb ghb ghb gbl gbl ghb gbl ghb ghb u.s. fda july ghb ghb ghb ghb ghb ghb mdma ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb ghb carisoprodol ghb ghb samantha reid rockwood ghb reid hillory j. farias samantha reid date-rape drug prohibition act ghb don bolles orange county dr. bronner soap ghb april ghb act. ghb january opium act medicines healthcare inspectorate medicines ghb ghb gbl ghb xyrem ghb uk ghb ghb ghb ghb ghb felicia tang ghb ghb ghb uk ghb overdose ghb ghb ghb ghb ghb gaba ghb gaba cns gbl ghb gbl ghb ghb gaba ghb ghb ghb blood ghb gbl january ghb ghb nmda ghb ghb ghb ghb ghb-treated ghb ghb addiction rats ghb ghb ghb ghb baclofen ghb baclofen gaba ghb gaba ghb ghb ghb ghb ssr ghb ghb ghb ghb ghb gaba ghb ghb ghb ghb ghb gaba ghb ghb gaba gabaergic gaba ghb ghb ghb ghb ghb gaba ghb gaba ghb ghb ghb ghb ghb ghb drugs ghb ghb gaba(b activation ghb gaba(b ghb ghb low ghb higher gaba(b gaba(b ghb dynorphin ghb ghb ghb gaba ghb ghb ghb ghb ghv gvl ghb ghb bdda mab eab ghb ghbal ghb ghb ghb gaba ghb ghb ghb ghb ghb alexander zaytsev dr. henri laborit gaba ghb ghb ghb ghb gbl bindeez aqua dots melbourne november ghb schedule act march schedule iii schedule march commission ghb schedule iv convention psychotropic uk ghb june october acmd iv ii uk ghb schedule drugs ordinance hk department health ghb gbl gaba ghb ghv gvl gbl chile ghb ghb xyrem union chimique belge s.a. alcover", " gomiliximab fc\u03b5rii macaca idec pharmaceuticals corporation", " duranest", " integrase instis dna integrase hiv u.s. food drug administration fda october isentress research new journal medicine july hiv", " lerdelimumab trabio development", " ustekinumab inn cnto stelara centocor ustekinumab ii simponi september fda iii iii accept january cnto ii iii december application bla u.s. food drug administration fda centocor janssen-cilag international marketing authorization application maa european medicines agency emea september centocor dr. alan menter baylor research institute november european medicines agency emea committee medicinal products human use chmp december canadian health authority fda september november mount sinai medical center city drs. kornbluth sandborn ustekinumab crohn cnto cnto cnto iii psoriasis area severity index dermatology life quality index health assessment questionnaire ii rrms ustekinumab centocor clinical", " enflurane ross terrell enflurane enflurane enflurane enflurane gaba ampa nmda national institute occupational safety health niosh rel", " humphry osmond schultes timothy leary aldous huxley osmond native american san pedro ayahuasca dmt peru classical lsd dmt lsd lsa dmt nmda mdma mdea mda mda thc certain nmda s. thc nmda convention psychotropic", " ipilimumab yervoy ctls ipilimumab ctls ipilimumab u.s. food drug administration fda nsclc sclc james p. allison director cancer research laboratory university berkeley clinical medarex bristol-myers squibb dr. allison lasker award ipilimumab march february health ipilimumab european union eu november tumor mouse pd tme ipilimumab ipilimumab cancer ctls ctl ipilimumab ctls ipilimumab igg pfizer december bristol-myers squibb medarex iii ipilimumab fda medarex hrpc june mayo clinic ii medarex ii february december march march ps tumor allison krummel leach allison bluestone linsley krummel allison mark jenkins linsley krummel walunas bms medarex", " fenofibrate inn tricor vldl hdl fenofibrate fenofibrate fenofibrate fenofibrate hdl fenofibrate musculoskeletal hepatotoxicity nephrotoxicity biliary coagulation general hdl hdl fenofibrate ppar\u03b1 ppar\u03b1 ciii ppar\u03b1 ai aii vldl hdl-containing ai aii fenofibrate tricor abbvie lipofen kowa pharmaceuticals america lofibra teva lipanthyl lipidil supralip abbott laboratories ordain health care fibractiv cogentrix pharma fenogal smb laboratories antara oscient pharmaceuticals tricheck zydus cnd atorva tg zydus medica golip golgiusa stanlip ranbaxy trilipix tricor teva lofibra generic fenofibrate world health organization international nonproprietary fenofibrate groupe fournier sa solvay pharmaceuticals solvay s.a. solvay abbott laboratories abbvie fenofibrate ppar-a", " sitagliptin janumet", " aripiprazole abilify cochrane otsuka otsuka america bristol-myers squibb april march abilify aripiprazole food drug administration marketing european medicines agency health cochrane lancet qtc cochrane world federation biological psychiatry grade national institute health care british association national institute health clinical british association world federation biological psychiatry aripiprazole aripiprazole aripiprazole ssris ssris british national formulary joanne moncrieff children aripiprazole coadministration aripiprazole aripiprazole aripiprazole aripiprazole \u03b1-adrenergic aripiprazole bioavailability n-dealkylation u.s. food drug administration fda november european medicines agency june october november november tga aripiprazole fda fda otsuka october april barr laboratories teva pharmaceuticals hatch-waxman act march november new jersey otsuka october supplementary protection spc october uk intellectual property office march spc regulation ec april april u.s. food drug administration fda abilify aripiprazole", " benralizumab inn medimmune", " eli lilly engineered dna b-chain insulin insulin fda insulin", " vesencumab", " parsatuzumab inn roche", " salbutamol copd salbutamol salbutamol britain world health organization list essential medicines usd salbutamol emergency salbutamol salbutamol smn high salbutamol compliance protocol salbutamol inn usan allen hanburys uk ventolin ventolin ventoline ventilan aerolin ventorlin cipla asthalin asthavent schering-plough proventil remedica teva novo-salbutamol hfa salamol asmalin beximco azmasol ad-din pharma ventosol asmol salbutamol abuse clinical use international standard therapeutic use exemptions", " sildenafil viagra sildenafil pfizer andrew bell david brown nicholas terrett cialis sildenafil july fda october fda care hiv sildenafil sildenafil viagra sildenafil mdma ig nobel prize aviation patricia v. agostino santiago a. plano diego golombek universidad nacional quilmes acetildenafil fda eurycoma sellers sildenafil n-desmethylsildenafil sildenafil robert f. furchgott ferid murad louis ignarro nobel prize physiology sildenafil cialis sildenafil pde sildenafil sildenafil pfizer sandwich kent morriston hospital swansea ian osterloh pfizer fda march viagra peter dunn albert wood andrew bell david brown nicholas terrett senator bob dole pel\u00e9 internet viagra pfizer viagra viagra viagra cialis levitra february boots uk viagra pfizer viagra associated press pfizer eu june uk pfizer pfizer pfizer teva pfizer august revatio generic u.s. greenstone mylan watson ed pfizer revatio federal court june ratiopharm inc. november supreme court pfizer viagra teva ltd. pfizer inc. patent act teva novo-sildenafil viagra supreme court pfizer viagra november pfizer supreme court april supreme court pfizer pfizer trade kamagra ajanta pharma silagra cipla edegra sun pharmaceutical penegra zydus cadila zenegra alkem laboratories pfizer viagra pfizer pfizer", " treatment treatment antiplatelet treatment", " chloroprocaine nesacaine nesacaine-mpf chloroprocaine chloroprocaine fda ph chloroprocaine", " tetulomab radium hospital lu betalutin", " ozanezumab als neurite outgrowth inhibitor nogo-a nogo-a nogo-a mnd glaxosmithkline gsk ii gsk nogo-a nogo-a als als axon als nogo-a ozanezumab nogo-a ozanezumab glaxosmithklyne ii september", " taplitumomab pap phytolacca", " dna william prusoff therapy", " lantus toujeo abasaglar basaglar hagedorn nph insulin ph ph ph ph ph ph ph sanofi-aventis frankfurt-h\u00f6chst lantus lantus lantus frankfurt-h\u00f6chst sanofi-aventis berlin frankfurt-h\u00f6chst june european commission sanofi-aventis ltd. european union june toujeo fda patent lantus eli lilly basaglar abasaglar", " veltuzumab december inc. august fda itp ii", "", " victoza novo nordisk novo nordisk u.s. saxenda european medicines agency ema july u.s. food drug administration fda january liraglutide fda december bmi scale\u2122 prediabetes fda johns hopkins fda european medicines agency new journal medicine fda ema nep victoza u.s. u.k. uae saxenda u.s. novo nordisk saxenda citi research novo nordisk abpi victoza victoza public citizen u.s. food drug administration fda victoza april imperial college alzheimer liraglutide", " singh vaughan williams oxford university vaughan williams dr. bramah singh iii iii class ii iv singh vaughan williams amiodarone ii iii iv na membrane ii ia ib ic ia class ib class ic class ii av class ii class iii class iii qt ekg class iv av class iv iv gambit vaughan williams", " delavirdine dlv rescriptor nnrti viiv healthcare haart hiv u.s. food drug administration nnrtis u.s. dhhs st john", " aciclovir acv greater aciclovir dna world health organization list essential medicines usd usd aciclovir oral herpes aciclovir aciclovir hiv hiv art hiv category drug cdc hsv hsv iv aciclovir cdc aciclovir iv iv iv stevens\u2013johnson aciclovir ketoconazole probenecid interferon iv zidovudine hiv iv aciclovir aciclovir acv-tp acv-tp hsv-specified dna dna hiv mechanisms hsv dna aciclovir acyclovir aciclovir aciclovir herpes herpes zoster varicella caribbean cryptotethya howard schaffer robert vince s. bittner s. gurwara later schaffer burroughs wellcome gertrude b. elion u.s. schaffer vince hiv nobel prize medicine whitley university alabama birmingham usd usd aciclovir inn ban usan ban zovirax", " rosuvastatin crestor shionogi crestor stop rosuvastatin rosuvastatin rosuvastatin crestor rosuvastatin hmg-coa auc rosuvastatin rosuvastatin february fda fda august jupiter fda aurora rosuvastatin hdl hdl cochrane hdl fda asians astrazeneca zocor uk nhs october horton lancet crestor astrazeneca lancet crestor lancet astrazeneca ceo sir tom mckillop public citizen citizen fda march fda sidney m. wolfe m.d. public citizen fda crestor fda jupiter", " cardiac aids bufalin cardiac ncx sr serca sr av atpase iv atpase sr sr electrophysiological effects cardiac glycosides human cardiomyocytes guinea pig hearts cell physiol biochem", " cln mesdicain mesocain mesokain bier", " zolimomab", " sarilumab regeneron sanofi ra iii development ii ascertain june ra nov saril-ra-target", " remifentanil abbott ultiva remifentanil remifentanil children remifentanil tiva anesthesia tci remifentanil remifentanil remifentanil remifentanil benadryl remifentanil remifentanil remifentanil remifentanil remifentanil glaxo welcome fda july remifentanil schedule drugs ordinance hkd hkd department health hkd remifentanil schedule ii narcotic dea acscn", " ras raas angiotensin ii ii angiotensin ii nacl ii ii anp ii ras ii ii ace", " metoprolol lopressor metoprolol greater metoprolol world health organization list essential medicines metoprolol metoprolol blood metoprolol metoprolol lopressor novartis toprol-xl usa selokeen minax metrol arrow pharmaceuticals betaloc astrazeneca krka slovenia unipharm presolol hemofarm corvitol berlin-chemie ag met-xl metolar starpress restopress", " faralimomab", " ulocuplumab bristol-myers squibb", " proxymetacaine inn usan alcaine ak-taine", " nmda telazol rompun telazol asa iii cns abuse telazol schedule iii", " oregovomab ovarex altarex corp", " aselizumab", " idarucizumab praxbind boehringer ingelheim pharmaceuticals fda october usd", " inc.", " mdma mdma mda mdea mdoh mbdb mdma mdxx mdpv ralph metzner david e. nichols mdma david e. nichols nichols mdma lsd chemically mdma mdma lsd mdma", " otc na cl amphotericin azole allylamines amorolfin butenafine naftifine terbinafine p-glycoprotein azole ssris", " sac certain paclitaxel early sac sac dna sac high apc apc sac b. sac apc sac", " pinatuzumab roche", " diprivan maximum propofol gaba propofol list essential medicines usd propofol propofol tci propofol propofol propofol mri missouri supreme court october jay nixon european union mac august county july harris county jackson conrad murray jackson u.s drug enforcement administration propofol propofol mild propofol propofol rem propofol gaba eeg researchers gaba propofol iv propofol propofol uk imperial chemical industries ici clinical el ici astrazeneca diprivan ph diprivan edta fospropofol lusedra food drug administration schedule iv dea acscn june teva pharmaceutical industries ltd. teva hospira teva fresenius-kabi gaba gaba", " mitumomab bcg september iii", " tregalizumab", " abacavir abc hiv nrti azt world health organization list essential medicines ziagen abacavir abacavir uri alt ast hiv hiv-specific hiv abacavir abacavir americans hispanic americans chinese americans african americans kenya masai kenya common symptoms ahs hiv fda july clinical pharmacogenetics consortium cpic pharmacogenetics working group dpwg ahs march fda fda abacavir abc abc dna abc dna abacavir abacavir food drug administration fda december robert vince mei hua", " actinobacteria firmicutes tenericutes bacteroidetes chlorobi fcb\u00a0group fusobacteria gemmatimonadetes nitrospirae planctomycetes verrucomicrobia chlamydiae proteobacteria spirochaetes synergistetes acidobacteria chloroflexi chrysiogenetes cyanobacteria deferribacteres dictyoglomi thermodesulfobacteria thermotogae eubacteria woese fox march mariana trench schizomycetes archaea new latin archaea eukarya thiomargarita epulopiscium mycoplasma greek latin neisseria staphylococcus actinobacteria certain nocardia myxobacteria dna rna poribacteria archaea svedberg certain cyanobacteria intracellular volutin gas cyanobacteria archaea firmicutes actinobacteria g+c gram-positive mycobacteria mycobacteria ziehl-neelsen mycoplasma mycobacteria campylobacter flagella fimbriae fimbriae pili iv sporohalobacter anaerobacter heliobacterium anaerobacter dna uv dr. steinn sigurdsson earth\u00a0\u2014 carbon energy respiratory non-respiratory myxobacteria streptomyces dna candidatus carsonella sorangium spirochaetes borrelia lyme dna dnas dna dna dna dna dna e. dna dna dna dna dna b. dna dna gene escherichia dna crispr rna iv myxococcus reynolds e. e. listeria classification dna classification international journal systematic bacteriology bergey systematic bacteriology international committee systematic bacteriology icsb international code eubacteria archaebacteria archaea eukarya archaea hans gram-staining gram-positive nocardia ziehl\u2013neelsen culture diagnostics daptobacter certain archaea archaea lactobacillus helicobacter johne rocky mountain chlamydia burkholderia mycobacterium surgical lactococcus fertilizer prince william sound exxon valdez bt dipel thuricide dna escherichia biological resource centers antonie leeuwenhoek royal society leeuwenhoek christian gottfried ehrenberg ehrenberg robert koch pasteur robert koch koch nobel prize koch paul ehrlich treponema ehrlich nobel prize ziehl\u2013neelsen carl rna", " daratumumab darzalex daratumumab genmab genmab johnson johnson janssen biotech genmab june december november u.s. food drug administration daratumumab treatment dtt rbc dtt rbc kell k-negative rbcs", " tadocizumab yaman\u014dchi pharma america inc.", " iii fda rimonabant tolrestat ximelagatran zimelidine lsd", " secukinumab cosentyx novartis pharma ag january food drug administration july iii october fda dermatologic ophthalmic drugs advisory committee fda fda october novartis iii october fda november novartis ii ii novartis novartis january novartis fda secukinumab ii eae ms april", " etrolizumab etrolizumab genentech", " nivolumab opdivo ono pharmaceutical medarex bristol-myers squibb nivolumab nivolumab food drug administration nivolumab nivolumab fda december april committee medicinal products human use european medicines agency nivolumab march fda grade grade response ii nsclc hodgkin reed-sternberg", " lumiliximab october ii macaca", " methisazone usan inn methisazone nah mei", " ph blood blood gas circle willis diseases deep cardiovascular angiography mri mri doppler doppler cardiovascular birds muscular hemolymph hemolymph platyhelminthes ebers papyrus bce egyptians bce sushruta dwivedi dwivedi bce ancient herophilus galen blood galen canon avicenna avicenna pulse galen avicenna ibn ibn commentary anatomy avicenna canon galen ibn arabic ibn michael servetus manuscript christianismi restitutio servetus better vesalius padua realdo colombo william harvey hieronymus fabricius anatomica motu cordis sanguinis animalibus ibn harvey marcello malpighi andr\u00e9 fr\u00e9d\u00e9ric cournand werner forssmann dickinson w. richards nobel prize", " omalizumab xolair omalizumab march european union u.s.a. csu ciu csu omalizumab dna ige ige fc\u03b5ri ige u.s. allergy ige omalizumab u.s. food drug administration fda omalizumab european union iv global initiative asthma gina national heart lung blood institute national institutes health usa world health organization gete august national institute clinical nice national health service nhs nice march nice pas novartis ige march european union u.s.a. csu csu ige csu ige csu ige ige iii iv rdbpc ci ci ci rdbpc churg-strauss churg-strauss novartis argus churg-strauss ige fc\u03b5ri fc\u03b5ri tse wen chang omalizumab ige fc\u03b5ri ige fc\u03b5ri fc\u03b5ri-bound ige fc\u03b5ri ige ige fc\u03b5rii fc\u03b5ri ige fc\u03b5rii ige fc\u03b5ri fc\u03b5rii fc\u03b5ri corticosteroids clinicians ige ige ige ige ige tanox houston tanox nancy t. chang tse wen chang u.s. ciba-geigy sandoz novartis tanox ciba-geigy fda fda ind fda tanox ciba-geigy tanox stephen holgate southampton tanox ii tanox genentech genentech tanox genentech genentech tanox european union u.s. genentech tanox tanox novartis omalizumab omalizumab vs ige ige fda ige iu ige iu omalizumab omalizumab igg chinese cho igg protein uf currently omalizumab novartis genentech july ii iii clinical omalizumab august university medical center", " ibritumomab zevalin tiuxetan dtpa adcc cdc zevalin idec pharmaceuticals corp ibritumomab mbq gbq itlc-sg hama u.s. rituxan zevalin ci bq zevalin ibritumomab treatment nhl orr cr zevalin indolent fit american society hematology ash pfs ii cr malt idec pharmaceuticals biogen idec food drug administration fda nhl nhl september fda lymphoma nhl ibritumomab rituxan zevalin rituxan ret vandetanib vegfr egfr cabozantinib", " esketamine ketanest nmda july ii pcp nmda johnson johnson july ii johnson johnson janssen pharmaceutica naurex cerecor vistagen", "", " mogamulizumab poteligeo cc mogamulizumab kyowa hakko kirin ltd. amgen asthma", " ifns mhc certain ifns ifn ii ifn iii ifn ii iii ifns ii nk administration pkr rnase rna ifn mhc mhc ii higher mhc mhc higher mhc ii rna cpg rig-i ifns receptor rna rna nf-\u03bab rna release ifn-\u03b3 ifns stat stats stats ii ifns stats stat ifns janus jaks ifn isres isgs ifn isgs interferome isgs stat ifn gas isre gas ii ifn gas ifns ii ifns crk crkl map antiviral map ii ifns kinase ifn ifn ifn hcmv kaposi kshv ifn ebv ebv epstein-barr polyomavirus human hpv ifn-\u03b1 jev ifn ifn rna isgs jev non-structural protein interferon interferon ifn-\u03b1 telaprevir incivek boceprevir victrelis sofosbuvir sovaldi december biopsies control ifn interferon interferon ifns ifns january food drug administration fda usa pegintron pegasys october u.s. alick isaacs jean lindenmann national institute medical research isaacs lindenmann isaacs lindenmann isaacs lindenmann yasu-ichi nagano institute diseases university tokyo independently monto ho john enders vif chris y.h. tan tan sidney pestka alan waldman ifn-\u03b1 ifn-\u03b2 gene ifn-\u03b1 ii ifn ifn-\u03b3 interferon dna interferon kari cantell blood bank cantell tan rna rna tan cetus ms", " patritumab inn", " ab ig fc bcr bcr fc fc fc fc receptor igd bcr fcr fc fcrs ige ige fab fc fc v(d)j j. fc fc bcr bcr ig-\u03b1 ig-\u03b2 fab-epitope van iga igd ige igg igm iga igg igd ige igm igm igm igd igm ige iga igg da fcr(s ig ig iga igm igm ig igv igc ig iga igd ige igg igm ig chondrichthyes fab cdrs chothia nikoloudis cdrs fc fc fc fc\u03b3r fc\u03b5r fab fc fc iga fc fab fc fc fc fc fc fc iga igg ige fc adcc fc humans antibody\u2014the igh igl igk cdrs v(d)j ig ig multiple v(d)j shm shm v(d)j iga ige igg igm igd igg iga ige csr dna dna nhej igg single epstein-barr lyme iga igm igg coombs coombs elisa passive rhesus rhd rhesus-positive rh rhesus-negative rh\u2013 rh rh rh rho(d rhesus rhd anti-rhd treatment rh rh anti-rh rho(d immune globulin rh blood single polyclonal protein research proteins elisa elispot researchers online web modeling wam prediction immunoglobulin structure pigs rosetta cdr paul ehrlich antik\u00f6rper immunity october immunk\u00f6rper amboceptor zwischenk\u00f6rper desmon immunisin immunk\u00f6rper english kitasato kitasato paul ehrlich wright michael heidelberger oswald avery john marrack linus pauling ehrlich astrid fagreaus gerald edelman joseph gally bence-jones henry bence jones edelman fab fc igg rodney porter igg nobel prize physiology medicine fv david givol igm igg thomas tomasi iga david s. rowe john l. fahey igd ige kimishige ishizaka teruko ishizaka susumu tonegawa affimer darpin", " inn usan world health organization list essential medicines tsh tsh dosing tsh tsh tsh overdose allergic grapefruit certain jama poor tsh u.s. food drug administration category tsh tsh tsh tsh oral myxedema iv food drug administration fda american association clinical endocrinologists aace endocrine society association fda tsh l-triiodothyronine dna absorption greater half-life mayo clinic edward calvin kendall charles robert harington george barger eltroxin euthyrox letrox levaxin l-thyroxine thyrax thyrax duotab thyrox thyronorm south asia unithroid eutirox levoxyl synthroid tirosint north thyrin thyrolar", " tildrakizumab tildrakizumab schering-plough merck schering-plough sun pharmaceutical merck u.s. sun pharmaceutical march iii june", " ponezumab alzheimer ponezumab pfizer inc. november pfizer", " solanezumab inn eli lilly alzheimer solanezumab alzheimer sola klvffad id a\u03b2 a\u03b2 iii expedition expedition lilly expedition expedition financial times fda iii", " mapatumumab cambridge technology cat human genome sciences inc. hgs cat cat hgs nsclc nsclc hgs hgs august nsclc july nexavar", " streptokinase anaphylaxis", " oral", " indatuximab mab dexamethasone dec december mm", " edrecolomab panorex epcam iii iii ii edrecolomab ret vandetanib vegfr egfr cabozantinib", "", " adhd world health organization dsm-iv adhd adhd treatment adhd adhd add adhd academic adhd adhd adhd adhd adhd dcd dcd adhd adhd adhd certain twin siblings adhd dat maoa comt dbh adhd sert bdnf adhd adhd hyperactivity adhd adhd adhd adhd adhd adhd children adhd adhd european union fda adhd adhd adhd dsm-iv adhd thomas szasz adhd adhd adhd adhd adhd adhd adhd adhd adhd executive people adhd adhd adhd adhd adhd children adhd adhd adhd adhd dsm-iv dsm-iv adhd associated diagnosis adhd qeeg adhd food drug administration qeeg adhd american psychiatric association dsm dsm adhd adhd children adhd symptoms adhd adhd medical adhd sleepiness adhd adhd cbt parent adhd adhd adhd training regular adhd methylphenidate adhd atomoxetine national institute health care adhd administration regular adhd adhd adhd iron adhd adhd adhd adhd adhd adhd dsm-iv children adhd middle east rates adhd hyperactivity sir alexander crichton adhd george dsm-i dsm-ii dsm-iii add dsm-iii-r dsm-iv adhd adhd adhd benzedrine methylphenidate adhd national institute health care keith conners times adhd adhd major league baseball adhd league adhd adhd ritalin adderall ushma s. neill adhd uk susan greenfield house lords adhd bbc panorama bbc trust panorama adhd adhd adhd adhd associated adhd adhd adhd adhd iq iq iq adhd iq adhd iq adhd children iq", " rimantadine inn flumadine food drug administration fda cdc usa william w. prichard du pont wilmington delaware u.s. patent u.s. patent prichard rimantadine parkinson tylenol cimetidine", " ecromeximab kyowa hakko kogyo ltd.", " atorvastatin lipitor hmg-coa august warner-lambert parke-davis pharmaceutical research ann arbor bruce roth lipitor atorvastatin high-dose fda co-administration oral auc ldl-c niacin ldl grapefruit co-administration auc hmg-coa hmg-coa hmg-coa ldl-cholesterol hdl-cholesterol atorvastatin hmg-coa atorvastatin administration auc evening auc l. atorvastatin hmg-coa atorvastatin atorvastatin noteworthy hmg-coa atorvastatin p-glycoprotein auc b-stage auc auc atorvastatin parke-davis bruce roth warner-lambert ci roth roger newton ronald cresswell warner-lambert merck mevacor mevacor merck zocor lancet warner-lambert pfizer lipitor pfizer warner-lambert lipitor lipitor lipitor pfizer inc. pfizer november atorvastatin pfizer lipitor pfizer caduet pfizer pfizer u.s. lipitor november watson pharmaceuticals ranbaxy laboratories stator atorvastatin teva litorva torid atoris atorlip mactor lipvas sortis torvast torvacard totalip tulip pfizer zarator pharmac november ranbaxy laboratories ltd. fda", " cns amazon basin u.s. food drug administration fda august august acetylcholine ache na ca ach gaba cns mesh world health organization atc use nsaids nsaids dantrolene cns cns fda diazepam cns gaba baclofen gaba gaba baclofen clonidine neurophysiologic cns dantrolene cyclobenzaprine cns", " intetumumab intetumumab centocor inc.", " pregabalin pregabalin gaba gabob drug enforcement administration dea schedule act csa usd pregabalin european federation neurological pregabalin hiv pregabalin world federation biological psychiatry pregabalin fda pregabalin pregabalin gaba gaba gaba gabaergic pregabalin gaba gaba gad gaba gaba gaba gaba baclofen gaba pregabalin pregabalin pregabalin administration pregabalin pregabalin pregabalin pregabalin pregabalin bruce silverman northwestern university european union pregabalin u.s. fda december u.s. june fda lyrica fda june generic european union u.s. food drug administration fda pregabalin european union pregabalin pfizer lyrica pfizer sec lyrica pfizer department justice lyrica lyrica pharmacia upjohn pfizer pfizer pfizer u.s. food drug administration fda northwestern university pfizer pfizer lyrica", " tc neutrospec palatin technologies tc neutrospec u.s. food drug administration fda june fda palatin neutrospec neutrospec neutrospec marketing december", " canakinumab inn ilaris canakinumab caps u.s. food drug administration fda june european medicines agency october caps canakinumab novartis october canakinumab schizophrenia", " efalizumab raptiva genentech merck serono efalizumab efalizumab pml pml pml european medicines agency fda european union april genentech inc. raptiva u.s.", " sufentanil sufenta sufentanil sufenta sufentil claris lifesciences ltd. sufentanil janssen pharmaceutica sufentanil transdur-sufentanil stage iii durect corp sufentanil sufentanil", " immunogen inc. nasdaq adc immunogen waltham massachusetts immunogen adc adcs immunogen immunogen amgen bayer healthcare biotest genentech roche eli lilly novartis sanofi takeda roche kadcyla immunogen adc genentech roche group october kadcyla gatsby immunogen adc", " lopinavir hiv kaletra aluvia fda september lopinavir csf csf csf-plasma csf ic hpv", " rna dna march", " aciclovir acv greater aciclovir dna world health organization list essential medicines usd usd aciclovir oral herpes aciclovir aciclovir hiv hiv art hiv category drug cdc hsv hsv iv aciclovir cdc aciclovir iv iv iv stevens\u2013johnson aciclovir ketoconazole probenecid interferon iv zidovudine hiv iv aciclovir aciclovir acv-tp acv-tp hsv-specified dna dna hiv mechanisms hsv dna aciclovir acyclovir aciclovir aciclovir herpes herpes zoster varicella caribbean cryptotethya howard schaffer robert vince s. bittner s. gurwara later schaffer burroughs wellcome gertrude b. elion u.s. schaffer vince hiv nobel prize medicine whitley university alabama birmingham usd usd aciclovir inn ban usan ban zovirax", " stavudine zerit hiv nrti world health organization list essential medicines monday november world health organization stavudine zidovudine azt hiv dna dna jerome horwitz rega institute medical research dr. william prusoff dr. tai-shun lin u.s. food drug administration fda june september june", " vzv multiple sclerosis ms ms mcdonald broca wernicke mt wisconsin card test broca area wernicke research humans diabetes-associated lesions bone lesions skin lesions gastrointestinal lesions endodermal lesions misc", " icrucumab icrucumab imclone systems inc.", " eldelumab crohn bristol-myers squibb", " keliximab macaca", " daclizumab zenapax daclizumab national institute health clinical nice ii ms daclizumab september iii daclizumab daclizumab pdl biopharma national institutes health nih december hoffmann-la roche april hoffmann-la roche eu january", " manganese botox macroscopic support bbb blood bbb csf importantly environmental protection agency epa usepa bbb ddt ion channel hodgkin-huxley curare tetrodotoxin tetradontidae ttx ttx ttx ttx ttx atropine tetraethylammonium tea tea tea tea tea tea tea parkinson chlorotoxin cltx ingestion cltx cltx cltx ca botulinum toxin btx btx-a,b,c,d,e,f,g,h btx btx ach ach btx btx btx btx tent nt btx tent btx pns tent cns tent cns btx tent neurotoxic bbb bbb cns alzheimer disease mercury bbb mercury mehg diethylmercury mehg glu fast death factor saskatchewan asia fast death factor vfdf vfdf bungarotoxin bungarotoxin ach caramboxin cbx averrhoa nmda ampa south american curare arsenic martinez-finley pns cns ammonia monophosphate kinase g-mediated pkg l-carnitine administration atpase bbb neurotoxicity pkc nmda ltp nmda ltp nmda ltp chu ros nmda dna cns cns support huntington", " cizdol subutex suboxone zubsolv bunavail hcl hcl temgesic buprenex norspan butrans buprenorphine rehabilitation alcoholics anonymous narcotics anonymous narcotics anonymous methadone anonymous suboxone ki ki ki butrans transdermal patch harvard medical school clinical iii buprenorphine fda ind reckitt colman reckitt benckiser reckitt uk subutex food drug administration october schedule iii schedule fda subutex suboxone suboxone reckitt benckiser congress addiction treatment act data secretary health human services schedule iii iv subutex suboxone european union subutex suboxone september list ii opium law buprenorphine mor kor dor buprenorphine buprenorphine buprenorphine mor dor kor p-glycoprotein p-glycoprotein mor dor kor mor dor kor buprenorphine buprenorphine cns buprenorphine buprenorphine cns butrans sufentanil sufenta fentanyl", " ppt condylox wartec hpv ppt podophyllum sinopodophyllum list essential medicines application cns ii dna dna dna ii mutant chinese aromatization chirality e. september nadph dir plr sdh american mayapple sinopodophyllum berberidaceae", " naptumomab chemically fab sea fab", " umifenovir russian chinese pharmstandard umifenovir umifenovir umifenovir rna dna umifenovir journal virolog p\u00e9cheur ebolavirus za\u00efre kikwit tacaribe hepatitis", " beta-receptor cbt healthcare cbt cbt prozac progressive relaxation emg biofeedback meditation regular meditation military medicine barbiturates cns ssris ssris gad ssris mirtazapine usa maois maoi maoi uk ssri snri ssri benzodiazepine beta alpha clonidine guanfacine mebicar latvia eastern gaba fabomotizole afobazole gabaergic ngf bdnf institute molecular genetics thr-lys-pro-arg-pro-gly-pro bromantane study currently buspar sediel hydroxyzine atarax fda pregabalin menthyl validol validol validol cannabidiol cbd cannabis cannabis thc cbd thc tetrahydrocannabinol certain gaba gaba gaba gaba chlorpheniramine chlor-trimeton benadryl fda melatonin gabaergic inositol british national formulary gabaa bowen", " claudiximab ganymed pharmaceuticals ag ii january", " chemical diet research mineral mineral mineral", " vedolizumab entyvio takeda pharmaceuticals crohn entyvio vedolizumab vedolizumab crohn massachusetts general hospital boston massachusetts dr. robert b. colvin department pathology dr. jim t. kurnick dr. andrew lazarovits crohn disease dr. lynn baird dr. atul bhan dr. lazarovits director transplantation university ontario madcam dr. lazarovits massachusetts general hospital boston leukosite massachusetts general hospital vedolizumab dr. a. a. ansari emory university aids virus-induced aids takeda marketing authorization application maa european union march application bla u.s. food drug administration june crohn disease september vedolizumab priority review december drugs advisory committee gidac drug safety risk management advisory committee dsarm vedolizumab uc cd entyvio gidac march committee medicinal products human use chmp european commission vedolizumab entyvio entyvio fda crohn entyvio crohn european union lichtenstein april health entyvio vedolizumab crohn disease gemini ii gemini iii gemini gemini crohn gemini lts br tsai matejko crohns", " orencia fc mhc bristol-myers squibb dmards tnf harvard massachusetts general hospital mgh fsgs iii diabetes abatacept ii multiple sclerosis bristol meyers vitiligo access phase ii national institute allergy diseases usfda apc apc mhc apc apc", " meprylcaine oracaine meprylcaine", " crohn uk children children children crohn fluticasone ritonavir hiv coadministration cushing syndrome ketoconazole", " vasodilation cardiac tpr tpr tpr tpr adp cold-induced civd civd flushing pah", " list essential medicines world health organization list essential medicines children april april", " iratumumab hodgkin medarex inc.", " greek anatomical therapeutic chemical classification mesh fen-phen food drug administration fda fda federal hoodia apocynaceae asclepiadoideae second world war", " clinical clinical clinical clinical people clinical open evar book daniel king avicenna canon medicine lady mary wortley montagu edward jenner james lind john woodall british east company lind john haygarth perkin sir william gull baronet frederick akbar mahomed guy collective investigation record british medical association sir ronald a. fisher rothamsted british medical research council council therapeutic trials committee mrc tuberculosis research unit sir geoffrey marshall sir austin bradford hill hill karl pearson doll royal society international u.s. national institutes health nih clinical currently multiple amgen astrazeneca pfizer details european union good clinical practice international conference harmonization human use regulatory journals clinical researchers declaration helsinki clinical drugs pharmaceutical research america phrma southern northern hemisphere clinical health study clinical clinical cro cro cro specialist cro irb cro irb irb cro janet yang interactional justice clinical clinical cros advanced edc iwrs statistical fda clinical institutional review board irb irb irb irb hipaa international conference harmonisation good clinical practice pharmaceutical research america congress ii iii national institutes health fda food drug administration researchers responsibility irbs dmc dmc fda ich irb irb institutional review board irb irb irbs irbs irb irb fda u.s. fda fda u.s. fda fda u.s. asia eastern central jacob sijtsma wemos european union international conference harmonisation human use currently clinical national national institutes health clinical new cro vis research institute volunteers fox trial finder parkinson volunteers clinicaltrials.gov u.s. national institutes health national library medicine z. janet yang katherine mccomas geri k. gay john p. leonard andrew j. dannenberg hildy dillon risp", " tc immunomedics fab tc arcitumomab fab f(ab fab tc arcitumomab cea spect technetium tc high sv", " nimotuzumab biomab egfr biocon theracim cimym biosciences theraloc oncoscience cimaher center molecular immunology havana eu egfr egfr nimotuzumab egfr egfr center cim havana cim cimab s.a. ym biosciences cimym biosciences cimab cimym biosciences oncoscience ag kuhnil pharmaceutical ltd. daiichi sankyo asia innogene kalbiotech pte ltd. biocon biopharmaceuticals ltd. bbpl biotech pharmaceutical ltd. delta laboratories european chemicals sac quality pharma peru eurofarma laboratorios ltda ferozsons labs laboratorio elea s.a.c.i.f.ya el kendi pharmaceutical algeria laboratorios pisa december cimym biosciences pte ltd. nimotuzumab scchn ivory coast gabon peru philippines usa nimotuzumab ii april daiichi sankyo iii egfr egfr nimotuzumab", " opioids l. e. hollister sir thomas browne ancient greek hallucinations mescaline lsd hollister ancient greek \u03c8\u03c5\u03c7\u03ae dmt psilocybin lsd glennon hollister dom nichols aldous huxley nbome dissociation simeon nmda mxe pcp dxm salvia cns dxm pcp pcp dxm ketamine dxm injury pcp high nan william e. white dxm faq white white john olney john olney nmda pcp nmda nmda nan lsd dob nan atropa brugmansia angel datura hyoscyamus mandragora myristica benadryl uni\u00e3o vegetal santo daime native american church native american church santo daime church uni\u00e3o vegetal supreme court uni\u00e3o vegetal rus ancient egyptian mycenaean ancient greek vedic inca aztec upper amazon urarina amazonia ayahuasca shamans aguaruna peru aguaruna kurt beringer der meskalinrausch mescaline intoxication louis lewin phantastica mexican robert j. weitlaner christmas evans schultes world war ii lsd world war ii lsd lsd hallucinogens cia west huxley r. gordon wasson life magic mushroom jerry garcia timothy leary allen ginsberg ken kesey lsd lsd lsd reese jones san francisco lsd lsd savage ocd lsd nichols intelligence maps heffter research institute center cognitive liberty ethics iii drugs acts october salvia mdma native american church santo daime mdma free parkinson alzheimer research lsd hppd lsd pcp lsd certain pcp louis lewin lewin lsd pcp pcp dmt humphrey osmond louis lewin hallucinogen ruck hallucinogens thc lewin phantastica mdma mdma dxm dxm lsd", " euphoria ancient greek \u03b5\u1f50\u03c6\u03bf\u03c1\u03af\u03b1 greek \u03b5\u1f50\u03c6\u03bf\u03c1\u03af\u03b1 certain euphoria euphoria dopaminergic mdma nicotine thc acute", " enoxaparin lovenox xaparin clexane dvt pe acs enoxaparin sanofi generic amphastar pharmaceuticals sandoz list essential medicines enoxaparin common frequency fda october nsaids fda enoxaparin iia ufh absorption bioavailability distribution metabolism enoxaparin", " maslimomab", " iogel small numby phoresor iomed iomed inc. iontocaine food drug administration december", " adc multiple ii nsclc taxotere ii seattle genetics ii nsclc fdg pet pet suv u.s. suv suv seattle genetics adc adc", " visilizumab nuvion pdl biopharma inc. crohn visilizumab crohn pdl biopharma inc. july visilizumab", " lexatumumab hgs cambridge technology", " pleconaril schering-plough pleconaril picornaviridae enterovirus rhinovirus pleconaril viropharma new drug application food drug administration fda viropharma schering-plough ii ii pleconaril rna pleconaril human hrvs proteins pleconaril pleconaril tyr val coxsackievirus pleconaril pleconaril pleconaril ii pcr hrv coxsackievirus nancy ile leu met ile->leu u.s. food drug administration pleconaril", " dna dna dna hyperthermia world war goodman gilman yale yale hodgkin goodman gilman bari gilman world war i. dna dna dna cyclophosphamide high dna dna dna dna busulfan methanesulfonate dna dna dna anatomical therapeutic chemical classification classical dna dna dna dna certain mgmt dna mgmt mgmt mgmt methylation mgmt", " ozoralizumab ozoralizumab pfizer ablynx nv ablynx eddingpharm", " tipranavir pi boehringer-ingelheim aptivus hiv tipranavir tipranavir food drug administration fda june june", " adefovir adefovir pmea preveon hepsera hiv adefovir institute organic chemistry biochemistry academy sciences czech republic anton\u00edn hol\u00fd gilead sciences hiv preveon november u.s. food drug administration fda fda hiv gilead sciences hiv december hbv fda september hepsera adefovir hbv european union march hbv alt nrti hbv adefovir", " rintatolimod ampligen rna hemispherx biopharma ampligen cfs european union fda new drug application nda u.s. food drug administration fda cfs december fda fda cfs august fda rintatolimod flu december journal clinical virology ampligen iv herxheimer hemispherx journal immunology hemispherx rintatolimod rna rna cfs rnase rintatolimod ifns ifns rnase l. rna rna rna accumulation rnase cfs rintatolimod merck rna i:c i:c william a. carter johns hopkins university rna ampligen amplified genetic i:c i:poly dr. carter johns hopkins carter hem research inc. hiv rintatolimod america dupont hemispherx aids fda usa hemispherx emergency drug release program cfs hiv biovail corporation international esteve hemispherx esteve portugal andorra bioclones pty uk southern hemisphere fda ahrq agency health research quality national academy sciences institute medicine chronic fatigue syndrome cfs october hemispherx biopharma new drug application nda fda cfs december hemispherx fda cfs fda response letter nda december william carter ampligen tamiflu relenza hemispherx biopharma fda cfs december fda advisory committee response letter january nk low natural killer nk chronic fatigue syndrome cfs disease spectrum cfs cfs clinical nk cfs hemispherx fda fda federal food drug cosmetic act manuel asensio hemispherx hemispherx hemispherx biopharma asensio asensio november mary schweitzer ampligen chronic fatigue syndrome co-ordinating committee u.s. department health human services fda ampligen fda ampligen digital street adam feuerstein hemispherx biopharma inc. june mr. feuerstein ampligen ampligen ampligen street ampligen u.s. mr. feuerstein hemispherx biopharma u.s. mr. feuerstein hemispherx biopharma street rintatolimod amp cfs open-label hemispherx nda october food drug administration fda nda december fda crl hemispherx cfs fda cfs january nk cfs rintatolimod ampligen hemispherx", " vinethene iupac semmler allium ursinum l. semmler knorr matthes merck merck chauncey leake mazurek ethyl ether mcintosch leake science news letter leake berkeley mazurek leake princeton randolph major w. t. ruigh princeton mei-yu chen mazurek samuel gelfan irving bell university alberta gelfan science news letter mary botsford university mazurek berkeley mazurek finer ether vinethene stumpf finer martin finer finer vinethene anesthetic mixture v.a.m. finer martin anderson martin stumpf v.a.m. grosskreutz davis october", " penciclovir denavir vectavir fenivir famciclovir penciclovir cellular dna dna dna", " catumaxomab removab epcam fresenius biotech trion pharma catumaxomab trion pharma helmholtz zentrum m\u00fcnchen dr. horst lindhofer fresenius biotech european medicines agency ema april ascites nsaids catumaxomab epcam fc-region fc epcam ret vandetanib vegfr egfr cabozantinib", " antihemorrhagic topical mch mch mch chitosan chitosan chitosan hemostatic chitosan zeolite quikclot", "", " clazakizumab chinese ii oct june nsclc iii june european league rheumatism eular mtx mtx mtx oct adalimumab mtx ii crohn", " topoisomerase ii dna dna topoisomerase quinolones dna topoisomerase egcg dna cns human dna dna dna dna dna dna cancer dna hycamtin u.s. fda dr. mark cushman purdue university dr. yves pommier national cancer institute ind food drug administration gmp purdue research foundation national cancer center linus oncology inc. linus oncology lymphomas dna nsc nsc national cancer institute http: dna iis n-terminal atpase ii ii", " racotumomab vaxira recombio center molecular immunology havana cim buenos aires university national university racotumomab n-glycolil ngc racotumomab nsclc ngc ngc cmp-n-acetyl racotumomab ngc racotumomab racotumomab racotumomab racotumomab racotumomab nci common toxicity criteria treatment racotumomab nsclc iii racotumomab nsclc philippines uruguay nsclc iiia iiib iv recombio elea laboratories cim europharma laboratories innogene kalbiotech", " parkinson parkinson parkinson antiparknison l-dopa parkinson parkinson l-dopa l-dopa l-dopa deprenyl mao-b parkinson deprenyl deprenyl l-dopa l-dopa l-dopa l-dopa tyrosine apomorphine parkinson anticholinergic phccc parkinson phccc phccc parkinson parkinson gad gaba gad parkinson preferred mao comt", " pegasys f.\u00a0hoffmann-la roche world health organization list essential medicines hiv alt eu u.s. peginterferon pegasys peg-intron nature nature cochrane review roferon-a roferon-a amd", " vantictumab oncomed pharmaceuticals inc.", " beta beta sir james w. black bisoprolol ace beta heart beta u.s. food drug administration lancet international conference symphony orchestra beta barry green game don greene olympic juilliard beta international olympic committee summer olympics kim jong-su raynaud mixed ace ii clinical great britain beta beta british national formulary beta ciacs ciacs ciacs american college cardiology heart association mi mi ciacs glucagon cardiac beta sotalol isa", " nevirapine nvp viramune nnrti aids hiv world health organization list essential medicines nevirapine hiv pis nevirapine pis nnrti hiv azt uganda world health organization fda however,supporters hivnet nevirapine mother-to-child hiv transmission breastfeeding march u.s. public health service task force stevens\u2013johnson nevirapine u.s. food drug administration u.s. dhss nevirapine nvp hsrs vl u.s. public health service task force nevirapine nevirapine nnrti rtis rna dna rtis nnrtis nnrtis nnrtis nnrtis nnrtis hiv hargrave boehringer ingelheim pharmaceuticals inc. boehringer ingelheim u.s. patent nnrti u.s. food drug administration fda june september u.s. president african aids", " zanamivir inn biota holdings glaxo b. zanamivir glaxosmithkline relenza zanamivir zanamivir zanamivir low prophylaxis food drug administration fda relenza relenza glaxosmithkline gsk fda zanamivir zanamivir zanamivir peter colman joseph varghese csiro college pharmacy monash university zanamivir biota biota dana nana dana biota glaxo glaxosmithkline gsk biota glaxo b. fda fda michael elashoff b. tamiflu glaxo tamiflu glaxo biota glaxo biota glaxo biota july biota glaxo august simon tucker biota april zanamivir june na tamiflu-resistance january gsk iii northern southern hemispheres dana grid molecular discovery dana dana dana glu zanamivir", " gaba alcoholic librium leo sternbach hoffmann\u2013la roche valium gaba gaba beers list gaba", " epratuzumab lymphocide sle ii early ii dlbcl august sle iii july phase iii sle epratuzumab elevated bcr sle epratuzumab bcr", " ace ii arbs ace nice uk eighth joint national committee prevention detection treatment high blood ace ii ace ii ace ace ii ace arbs aask ace ace ace ii allhat ace ace angiotensin ii bmj american heart association arbs mi mi value ii arbs angiotensin ii angiotensin ii june management hypertension care national institute health clinical hydralazine gaba-a gaba gaba-a gaba adenosine renin ace aliskiren novartis u.s. fda aldosterone bosentan blood american hypertension association ace ii antihypertensive lipid-lowering treatment heart attack trial allhat allhat ace-inhibitors hypokalemia hyperaldosteronism diabetes merck current uk ace-inhibitor triple uk", " bococizumab pfizer bococizumab ldl american college cardiology ldl-c spire high", " igg hyqvia immunoglobulin cvid hiv kawasaki trade flebogamma gamunex privigen gammagard hyqvia hizentra gamunex-c fda iga iga hizentra privigen hyperprolinemia immunoglobulin igg igg hiv kawasaki immunoglobulin hiv guillain\u2013barr\u00e9 council national health service hiv american academy allergy asthma immunology hiv hiv pandas pandas national advisory committee blood blood products nac canadian blood services hiv immunoglobulin imig ivig imig ivig vivaglobin cvid scig ivig fda igg fc ivig fc fcgriib igg ivig fc. fc igg", " ocrelizumab hoffmann\u2013la roche biogen idec iii ii ms march roche development october roche ms mri october iii disability ocrelizumab biogen rituxan fda rituxan ocrelizumab", " gavilimomab abx-cbl gavilimomab abgenix amgen", " fingolimod inn gilenya novartis ms fingolimod fingolimod ms ms fingolimod fingolimod european medicines agency ecg fingolimod fingolimod yoshitomi pharmaceuticals isp-i myriocin sar isp-i september food drug administration novartis march health april march european medicines agency european union patent trademark office uspto novartis iii fingolimod iii fingolimod mri fingolimod heart cardiac paks g-protein pak pak n-terminal fingolimod tni kach", " ontuxizumab morphotek inc.", " inclacumab inn", " zostavax merck vzv u.s. food drug administration fda fda october u.s. centers disease control prevention cdc advisory committee immunization practices acip march fda european medicines agency emea sanofi pasteur emea uk national health service september nhs pfu", " cantuzumab cantuzumab", " cixutumumab imclone systems inc. cixutumumab", " hcl industrial tce trike tricky trimar trilene imperial chemical industries britain tce tce tce ensolv leksol groundwater tce environmental protection agency final health assessment trichloroethylene tce epa uk ici trilene trilene tri-service uk tce ecco anti-static film cleaner conditioner tce tce protocol tce tce space shuttle main engine tce tce tce tce tce hfc dow chemical company tce tce tce tce respiratory research cancer national cancer institute national toxicology program national toxicology program report carcinogens nas august tce parkinson disease parkinson parkinson u.s. environmental protection agency epa national academy sciences tce epa tce tce scientific committee limit values scoel superfund twin cities army ammunition plant tce tce tce u.s. tce epa mcl tce mccook field neighborhood dayton ohio trichloroethylene superfund agency disease registry atsdr safe water act tce epa superfund north ibw scottsdale arizona tce epa tce fairchild semiconductor intel corporation raytheon company nasa ames moffett field mountain view view-master beaverton oregon tce lisle illinois tce u.s. environmental protection agency usepa illinois epa lockformer tce october november tce december illinois epa tce scottsdale arizona city phoenix city scottsdale city scottsdale scottsdale marine corps base camp lejeune north carolina tce epa rca corporation taoyuan city investigation environmental protection administration rca high tce pce rca stony hill road forest nc tce tce agency disease registry atsdr international agency research cancer group epa european union scientific committee limits scoel twa stel eu chemical agents directive carcinogens directive carcinogens directive emissions directive industrial emissions directive april october environmental protection agency epa epa department defense dod department energy nasa white house epa dod twin cities energy department lawrence livermore national laboratory san francisco bay nasa jet propulsion laboratory la ca\u00f1ada flintridge tce epa pentagon national academy sciences tce tce senator john kerry senator clinton tce reduction act. u.s. u.s. tce tce tce toluene tce xanthobacter tce", " sevelamer sevelamer geltex pharmaceuticals sevelamer sanofi renagel renvela sevelamer sevelamer sevelamer adrs sevelamer", " mavrilimumab mavrilimumab cambridge technology medimmune inc.", "", " pembrolizumab keytruda pembrolizumab gregory carven hans john dulos organon biosciences schering plough research institute merck mrc technology organon september food drug administration fda fda fast track development program braf braf merck october fda pembrolizumab pembrolizumab ii nsclc", " abciximab fab janssen biologics bv eli lilly reopro j.f. eur heart abciximab fab abciximab research abciximab abciximab thrombocytopenia platelet", " margetuximab inc.", " tremelimumab pfizer tremelimumab ctls tremelimumab ctls tremelimumab april pfizer iii october october medimmune llc tremelimumab pfizer iii pfizer response criteria recist april pfizer response criteria october medarex bristol-myers squibb", " hiv designing hiv aids researchers researchers hiv hiv hiv hiv hiv hiv hiv fuzeon\u2014has fda amantadine pleconaril rna dna rna dna rna dna dna rna hiv azt hiv hiv rnase dna rna august mit rna rna activated caspase oligomerizer draco draco dna rna dna dna rna aids rna dna rna dna hiv interference hiv hiv protease rifampicin relenza b. nature biotechnology relenza flu na", " dusigitumab medimmune llc", " etanercept enbrel tnf tnf u.s. f.d.a. tnf-alpha etanercept tnf-alpha etanercept dna tnf dna tnf dna fc dna tnf dna fc. dna tnf fc. tnf bruce beutler university southwestern medical center dallas immunex amgen tnf\u03b1 usa fda enbrel fda etanercept etanercept tnf tnf tnf tumor tnf tnf tnf tnf tnf tnf tnf tnf tnf etanercept tnf fc etanercept immunex tnf\u03b1 etanercept immunex corporation amgen pfizer enbrel wyeth enbrel takeda pharmaceuticals u.s. enbrel enbrel international federation health plans ifhp u.s. enbrel u.s. enbrel u.s. u.s. amgen enbrel u.s. pfizer inc. u.s. u.s. enbrel u.s. enbrel october european union april etanercept etacept april etanercept", " lintuzumab seattle genetics aml aml aml seattle genetics ii lintuzumab september u.s. food drug administration european medicines agency aml seattle genetics pdl biopharma aml lintuzumab americans aml iib february gemtuzumab mylotarg pfizer june clofarabine aml genzyme clolar fda october", " tigatuzumab october ii", " rafivirumab", " tovetumab medimmune llc", " erlizumab erlizumab genentech roche erlizumab genentech october june ii genentech genentech multiple icos protein design labs pdl centocor", " ibalizumab hiv hiv ii december research aaron diamond aids research center david ho ii hiv obr ibalizumab taimed biologics tanox genentech genentech tanox taimed biologics taiwanese government national development fund", " ccb t-type ccbs ccbs ccbs dihydropyridine dhp benzothiazepine bbb bbb gabapentinoids ziconotide research hill early vasopressin vgccs treistman vgcc vgccs recordings vgccs katsura vgcc malysz ca dsm vgccs mild ccb ccbs ccbs ccbs elevated ccbs ccbs ccbs ziconotide albrecht fleckenstein taxus canon medicine", " olmesartan ii sankyo benicar olmecip(cipla)olsar unichem laboratories olmesartan u.s. food drug administration fda benicar contraindications angiotensin-ii angiotensin-ii benicar vs ii tgf-\u03b2 arbs olmesartan ii ii ace ii olmesartan benicar olmesartan sevikar daiichi sankyo abbott healthcare pvt. ltd. winbp zydus cadila olmy ranbaxy laboratories ltd. olvance olsar unichem laboratories schering-plough hct glaxosmithkline olivus", " briakinumab abbott laboratories u.s. cambridge technology abbott november iii ii ii crohn briakinumab psoriasis area severity index pasi pasi january abbott fda abbott cambridge technology abbott humira abbott cat cat mrc cat mrc", " ublituximab", " fasinumab fasinumab regeneron pharmaceuticals", " hiv food drug administration february cytodyn inc. hiv rna hiv hiv", " budesonide copd astrazeneca symbicort symbicort european union budesonide ics symbicort gina march fda symbicort copd budesonide july", " regular cns mao", " evinacumab regeneron pharmaceuticals inc.", " fresolimumab ipf fresolimumab cambridge technology cat cat genzyme cat february sanofi-aventis genzyme june ipf august genzyme july sanofi-aventis ii", " volociximab pdl biopharma biogen idec early", " epoetin dna european medicines agency august amgen amgen epogen johnson johnson janseen biotech ortho biotech products lp u.s. darbepoetin amgen darbepoetin amgen aranesp fda epogen aransep u.s. medicare medicare erythropoietin dna ckd ferritin transferrin ckd march u.s. food drug administration fda esas amgen johnson johnson fda icu epo epo epo epoetin erythropoietin early retinopathy epo vs amgen january amgen u.s. food drug administration fda dahanca dahanca aranesp aranesp fda public health advisory march february esas march march fda esa black box warning fda esas esas kathleen sharp blood whistle deadliest prescription drugs johnson johnson mark duxbury dean mcclennan medicare duxbury gig harbor march tuesday october", " enfortumab nectin seattle genetics inc.", " ii ifns ifn-\u03b3 ifn-\u03b3 ifn-\u03b3 ifngr ifngr ifn-\u03b3 ifn-\u03b3 ifn-\u03b3 ifn-\u03b3 ifn-\u03b3", " narcobarbital riedel hean", " brentuximab inn adcetris adc hodgkin hl february seattle genetics biologics application bla u.s. food drug administration fda hodgkin fda august hl european medicines agency october hl brentuximab mmae mmae mmae hodgkin lymphoma tumor alcl american society hematology ii nhl iii abvd hodgkin avd hodgkin avd avd brentuximab chop iii chop chp december brentuximab ii january fda brentuximab adcetris seattle genetics pharmaceuticals oncology seattle genetics u.s. takeda group seattle genetics takeda group takeda group pbac pharmaceutical advisory committee march brentuximab vedotin pharmaceutical scheme section efficient funding chemotherapy ret vandetanib vegfr egfr cabozantinib", " cns neuroprotection cns cns common cns ca ca ca ca ca cns glutamate cns nmda ca cns parkinson alzheimer amyotrophic lateral sclerosis nmda", " toralizumab idec crohn cll ii malt waldenstrom hodgkin ii crohn idec pharmaceuticals corporation", " bupivacaine marcaine bupivacaine list essential medicines bupivacaine usd bupivacaine bupivacaine adrs cns cns cns cns toxicity bupivacaine bupivacaine bupivacaine bupivacaine usd durect corporation", " alzheimer parkinson creutzfeldt\u2013jakob diagnosis screening cholinesterase cognitive treatment usd social alzheimer depression psychosis mci mci mci mci mini-mental state mmse mmse alzheimer mmse alzheimer lyme lyme alzheimer alzheimer alzheimer insight alzheimer alzheimer alzheimer alzheimer multiple dlb parkinson dlb dlb dlb dlb ftd ftd ftd ftd ftd ftd tv-ftd ftd pnfa pnfa tv-ftd pnfa psp psp psp psp psp creutzfeldt-jakob alzheimer whipple hashimoto parkinson parkinson alzheimer beh\u00e7et sj\u00f6gren mild mmse mci mci mci mci alzheimer mci diagnosis mci peterson wernicke korsakoff causes alzheimer hypothyroidism alzheimer huntington cadasil melas binswanger alzheimer gaucher niemann-pick tay-sachs wilson wilson hiv lyme whipple diagnosis geriatric depression scale mci mmse amts modified mini-mental state cognitive abilities screening instrument casi moca cognitive assessment moca mmse questionnaire iqcode alzheimer disease caregiver questionnaire alzheimer general practitioner assessment cognition clinical tsh c-reactive mri mri spect pet spect alzheimer pet pittsburgh compound pib-pet alzheimer pib-pet alzheimer university pet pib dtbz cognitive psychiatric abc currently acetylcholinesterase alzheimer parkinson dlb aggressive n-methyl-d-aspartate nmda acheis alzheimer health family educational understand dementia tube cpr rates dementia dementia bc bc solon plato roman cicero cicero galen celsus constantinople roger bacon hamlet king lear alzheimer alzheimer wwii wwii public alzheimer disease robert katzmann alzheimer katzmann alzheimer alzheimer katzmann alzheimer alzheimer sdat alzheimer alzheimer alzheimer women alzheimer spect petscans alzheimer david cameron mental health act dvla driver vehicle licensing agency dvla", " piridocaine", " pemetrexed alimta eli lilly company edward c. taylor princeton university indianapolis eli lilly company paramount pemetrexed dhfr garft dna rna february food drug administration september fda nsclc iii nsclc pemetrexed pemetrexed alimta abbott healthcare pleumet cadila healthcare pemecad", " hiv dna dna polymerase dna dna dna dna nrtis", " inn copd boehringer-ingelheim pfizer spiriva cipla tiova copd fda copd handihaler", " mepolizumab nucala mepolizumab hes eoe egpa churg strauss copd iii mepolizumab u.s. food drug administration fda european commission european union december nucala", " iq gaba gaba gaba gaba gaba gaba gaba fda fda american academy neurology american epilepsy society cns nitrazepam gaba aan aes charles locock bromide tracy putnam h. houston merritt national institutes health j. kiffin penry uk uk european medicines agency european union", " inotuzumab pfizer ucb ii non-hodgkin nhl iii nhl iii nhl", " namilumab", " afelimomab mak administration", " ensituximab ensituximab neogenix oncology inc.", " priliximab crohn u.s. food drug administration centocor", " adaptive hiv aids hashimoto athens bc pierre-louis moreau maupertuis pasteur robert koch nobel prize walter reed paul ehrlich nobel prize elie metchnikoff chemical ph common leukocytes innate neutrophils basophils nk mhc nk nk mhc mhc kir nk mhc killer class ii mhc mhc killer killer tcr mhc class recognition mhc helper helper tcr class ii mhc lck helper mhc:antigen helper gamma tcr nk tcrs natural killer tcr tcr mhc ii mhc evolution vlrs igg iga immunodeficiencies chronic aids hypersensitivity i\u00a0\u2013 iv ige ii igg igm immune igg igm iii iv iv immune prokaryotes crispr rna ribonucleases rna pamps sar rna tumor nk mhc tumor tgf-\u03b2 d. d. complex rem tnf-alpha ifn-gamma apcs t-cells ctls overnutrition cancer elie metchnikoff robert koch emil von behring frank burnet niels jerne cst cst burnet polly matzinger da da taxol early immunoproteomics ii iii leishmania burkholderia staphylococcus peptostreptococcus hiv trypanosoma hiv", " adalimumab humira exemptia tnf adalimumab crohn tnf\u03b1 adalimumab tnf\u03b1 adalimumab fda basf bioresearch corporation worcester massachusetts basf cambridge technology basf bioresearch corporation basf knoll basf pharma abbott laboratories basf pharma abbott january abbott abbott abbvie humira abbvie humira tnf-alpha humira december cadila healthcare ltd. adalimumab exemptia humira u.s. adalimumab tnf adalimumab ra ra adalimumab adalimumab adalimumab crohn uk adalimumab fda adalimumab ps adalimumab adalimumab tnf u.s. food drug administration tnf anaphylaxis adalimumab basf bioresearch corporation worcester massachusetts basf cambridge technology tnf tnf cat tnf basf bioresearch corporation basf knoll abbott laboratories abbott basf knoll january abbott laboratories abbott abbvie abbvie humira u.s. food drug administration fda crohn fda crohn disease march cambridge technology cat humira abbott laboratories high court uk november december judge hon mr justice laddie cat justice laddie abbott cat cat justice laddie abbott cat abbott cat medical research council abbott mrc humira mrc johnson johnson centocor remicade tnf abbott laboratories humira humira court appeals federal circuit humira december cadila healthcare u.s. exemptia", " stovaine ernest fourneau pasteur institute", " butamben butamben butilaminobenzoato butoforme proprietary alvogil alvogyl cetacaine", " bivatuzumab", " la clinical low nsaids topical emla causes general csf cardiac ph fiber injection clinical amide las la peru brachial august bier august bier fidel pag\u00e9s metam\u00e9rica achile mario dogliotti", " pis hiv hoffman-la roche abbott aids hiv petri inhibitors bortezomib multiple myeloma crix crixivan", "", " moxetumomab moxetumomab astrazeneca medimmune iii november cambridge technology genencor genencor danisco cat genencor national cancer institute u.s. national institutes health genencor cooperative research development agreement crada nih cat nih cat nih cat new drug ind non-hodgkin nci hairy hcl cat cat nci cat astrazeneca medimmune medimmune moxetumumab pasudotox astrazeneca iii", " prostascint capromab psma dtpa spect early", "", " anatomical therapeutic chemical classification", " methoxyflurane inn penthrane abbott laboratories joseph f. artusio william t. miller manhattan methoxyflurane methoxyflurane dcaa methoxyflurane september food drug administration methoxyflurane medical developments international melbourne victoria penthrox pharmaceutical scheme penthrox cl chcl cf och international union pure applied chemistry iupac mac methoxyflurane ph boisvert hudon romagnoli korman robert wexler abbott laboratories analgizer analgizer analgizer analgizer analgizer apgar analgizer analgizer penthrox uk paddock crandell mazze mac mac mfaa dcaa methoxyflurane o-demethylation dcaa dcaa national institute occupational safety health thomas midgley jr. charles f. kettering teflon roy j. plunkett manhattan maud committee francis simon nicholas kurti graham uf uf uf uf william t. miller cornell university miller charles suckling halothane miller world war ii", " belimumab benlysta lymphostat-b baff blys sle belimumab sle iii sle iii sle u.s. f.d.a. belimumab belimumab uk national institute health care nice ii ii sj\u00f6gren syndrome belimumab human genome sciences hgs cambridge technology hgs iii black american iii selena-sledai selena-sledai belimumab selena-sledai benlysta ii belimumab ii sj\u00f6gren syndrome sle baff b-lymphocyte blys sle baff baff sle belimumab baff baff baff sle baff sj\u00f6gren baff baff baff-r bcma baff nf baff april april bcma taci baff-r belimumab baff national health national medical research center university colorado baff june july human genome sciences hgs blys blys october hgs cambridge technology cat blys cat hgs cat blys later lymphostat-b august hgs glaxosmithkline gsk hgs gsk february hgs gsk benlysta u.s. food drug administration fda sle march fda advisory selena-sleda sle iii ii african american belimumab u.s. uk national institute health care nice qaly uk national health service taci taci april blys ii blisibimod baff baff-r blys ocrelizumab", " libivirumab", " zalcitabine narti hivid food drug administration fda hiv rtis hiv zalcitabine jerome horwitz samuel broder hiroaki mitsuya robert yarchoan national cancer institute nci nci national institutes health nih hoffmann-la roche food drug administration fda hiv june azt nrtis fda nrtis pi december zalcitabine hiv hiv dna zalcitabine lamivudine", " lyme world health organization list essential medicines usd usd usd lyme brucella chlamydia mycoplasma mycoplasma leptospirosis yersinia lyme rocky mountain rocky mountain s. doxycycline wolbachia field representative chlamydia ureaplasma mycoplasma cautions fda doxycycline\u2013metal ph expired ph fanconi wwii american cyanamid pfizer pfizer lloyd conover charlie stephens pfizer fda pfizer international rectifier pfizer international rectifier rachelle laboratories january fda february teva mylan actavis hikma pharmaceuticals brand vibramycin monodox doryx vibrox adoxa doxyhexal atridox usd pentavalent", " injury guttate nsaids infections diagnosis crohn psoriatic generalized von zumbusch annular app app app guttate guttate oral fissured skin nail auspitz koebner mhc mhc wwc cdsn hiv hiv hiv malassezia candida tnf withdrawal skin gene dna puva dermatologic psoriasis area severity index pasi dlqi bsa dlqi dlqi dlqi pasi pasi topical greater coconut dead sea pasi side-effects dead sea phototherapy wavelengths dna nbuvb eye psoralen puva uva puva uva puva puva puva methotrexate biologics hiv tnf-\u03b1 mabs tnf-\u03b1 tnf-\u03b1 efalizumab efalizumab february june alefacept tnf-\u03b1 tnf-\u03b1 epa dha clinical children cardiovascular methotrexate mechanisms tnf\u03b1 crohn crohn african americans native americans scholars hebrew bible greek greeks willan robert willan thomas bateman cornelius celsus thomas willan thomas bateman fowler mercury sulfur coal greek \u03c8\u03c9\u03c1\u03af\u03b1\u03c3\u03b9\u03c2 international federation psoriasis associations ifpa psoriasis international network fondation ren\u00e9 touraine national psoriasis foundation psoriasis association psoriasis oral janus", " tenofovir hiv world health organization list essential medicines gilead sciences viread tdf cochrane hiv hiv u. s. centers disease control prevention cdc ministry public health mid-june hiv tenofovir tenofovir fanconi tenofovir tenofovir dna dna tenofovir dna dna dna nrti hiv tenofovir anton\u00edn hol\u00fd institute organic chemistry biochemistry academy sciences czech republic prague hol\u00fd hiv clercq holy pmpa hiv gilead sciences pmpa hiv gilead university san francisco tenofovir u.s. fda october hiv august tenofovir reviro dr. reddy laboratories tenofovir truvada atripla fda july hiv tenofovir", " siltuximab inn sylvant cnto siltuximab castleman castleman ii april siltuximab fda sylvant castleman mcd hiv castleman mcd castleman mcd hiv human kaposi castleman siltuximab siltuximab siltuximab common multicentric castleman siltuximab siltuximab co-administration siltuximab b-lymphocytes vegf", " refanezumab glaxosmithkline", " tositumomab tositumomab bexxar bexxar non-hodgkin corixa glaxosmithkline sale bexxar february ret vandetanib vegfr egfr cabozantinib", " cyclopropane cyclopropane cyclopropane cyclopropane august freund freund gustavson cyclopropane henderson lucas cyclopropane ralph waters cyclopropane cyclopropane gaba nmda ampa c-c c-c cyclic cc michael j. s. dewar cyclopropane wurtz cyclopropane c-c markovnikov cyclopropane", " edoxudine donald e. ruth jerry l. journal american chemical society pmid", " palivizumab synagis medimmune dna rsv palivizumab igg rsv iii palivizumab im rsv palivizumab rsv palivizumab june food drug administration american academy rsv rsv rsv rsv red book brady michael t. palivizumab", " hiv nrti epivir epivir-hbv world health organization list essential medicines hiv hiv raymond schinazi emory university glaxosmithkline hiv gsk hbv hbv hiv dna hiv dna dna dna hiv racemic dr. bernard belleau dr paul nguyen-ba iaf biochem international inc. dr. yung-chi cheng yale university azt lamivudine azt hiv lamivudine dna dr. cheng r.f. schinazi d.c. liotta hbv hbv subsequently emory university dr. dennis c. liotta dr. woo-baeg choi dr. raymond f. lamivudine emory hiv azt glaxo biochem pharma shire pharmaceuticals viiv healthcare food drug administration fda november azt nrti september dr. gorbee logan ebola lamivudine hiv", " ciclosporin csa beauveria hardangervidda hans peter frey sandoz list essential medicines ciclosporin fda kimura ciclosporin treatment adrs ciclosporin cyclosporin iarc group ciclosporin t-cells calcineurin nfatc ciclosporin nf-at ciclosporin ciclosporin cypd mptp mptp ca mptp ca calcineurin ca nfat dna dna ciclosporin ciclosporin csa individual ciclosporin n-methyltransferase ciclosporin d-alanine s-adenosyl d-ala l-ala d-ala sandoz novartis basel hartmann f. st\u00e4helin r.y. calne university cambridge thomas starzl university pittsburgh hospital march ciclosporin ciclosporin sandoz novartis sandimmune neoral generic cicloral sandoz gengraf abbott deximune dexcel pharma restasis health atopica atopica optimmune intervet merck ciclosporin inn ban usan ban ciclosporin ii iii neurovive pharma injury consortium neurovive neurostat ciclomulsion neurostat sandimmune neurostat ciclosporin ciclosporin ciclosporin hiroyuki uchino csa mpt ciclosporin mptp dna ca mptp csa csa mptp cypd mptp csa mptp ca ca csa", " fab fc fab fab f(ab f(ab ides fabricator igg ph f(ab fab fab", " famciclovir famciclovir famvir august food drug administration generic famciclovir tablets teva pharmaceuticals mylan pharmaceuticals famciclovir hiv famciclovir famciclovir famciclovir famvir vs valtrex herpes famvir", " alemtuzumab cll ctcl campath mabcampath lemtrada alemtuzumab cll food drug administration cll health cll lemtrada alemtuzumab b-cll adcc cambridge university iii september eu november fda december fda lemtrada ceo genzyme david meeker november alemtuzumab fda december lemtrada dr. christopher laganke fda alemtuzumab hiv alemtuzumab ards alemtuzumab dna-derived herman waldmann cam university greg winter campath genzyme bayer ag genzyme sanofi august campath lemtrada bayer lemtrada february sanofi-aventis sanofi genzyme contingent value rights cvr gcvrz august genzyme genzyme hsct ret vandetanib vegfr egfr cabozantinib", " incorporated hiv american society addiction medicine md addiction psychiatry american board psychiatry neurology american board addiction medicine american board addiction medicine american board medical specialties osteopathic association bureau osteopathic medicine osteopathic association aoa doctor osteopathic medicine neurology psychiatry internal medicine osteopathic association aoa aoa caq chapter addiction medicine royal college physicians addiction psychiatry royal australian college international society addiction medicine", " neoplasm ancient greek world health organization neoplastic tumor english latin current english tumor mri dna dna dna dna dna dna dna dna tobacco dna dna uv dna helicobacter dna dna katsurano dna dna dna dna dna dna dna dna dna dna dna mgmt mgmt mgmt mgmt mgmt dna epigenetics dna dna wrn fancb fancf mgmt xpf xpf facista dna dna dna dna dna hrr dna dna dna dna field dna dna field rubin vogelstein dna dna dna dna dna dna dna dna dna dna facista dna xpf dna dna dna dna dna latin french french commonwealth u.s. roman celsus medicina english", " felvizumab", " cetuximab inn egfr cetuximab erbitux u.s. bristol-myers squibb u.s. merck kgaa merck kgaa bristol-myers squibb eli lilly july fda erbitux kras kras egfr july fda pcr kras kras cetuximab kras committee medicinal products human use chmp cetuximab erbitux chmp october egfr fda egfr egfr egfr cetuximab egfr kras egfr erbitux kras opus crystal kras june erbitux erbitux congress european society medical oncology esmo milan iii coin hr ci cetuximab fda march scchn erbitux scchn bonner extreme iii erbitux european commission november extreme september dana-farber cancer institute cetuximab egfr mapk kras k-ras egfr kras kras egfr cetuximab egfr egfr egfr kras kras kras egfr kras kras kras kras kras kras egfr cetuximab egfr kras july food drug administration fda vectibix erbitux kras fda kras erbitux kras erbitux kras egfr kras kras egfr erbitux kras kras erbitux kras kras crystal egfr fda erbitux fda egfr fda erbitux fda kras michael sela egfr yeda research weizmann institute rhone-poulenc-rorer u.s. sanofi-aventis cetuximab merck kgaa erbitux bristol-myers squibb erbitux erbitux erbitux june u.s. biosimilars ret vandetanib vegfr egfr cabozantinib", " efavirenz efv sustiva nnrti haart hiv hiv department health human services panel truvada efavirenz hiv efavirenz hiv atripla haart efavirenz merck research laboratories list essential medicines efavirenz hiv hiv actg actg hiv efavirenz rtis rna dna rtis nnrtis efavirenz nnrtis nnrtis gaba gaba sert dat lsd lsd efavirenz clf efavirenz efavirenz fda september april merck cipla ltd. june thb aspen pharmacare sub-saharan generic abuse lsd", " uk iv combination nsaid european association palliative care oxycodone oxycodone iv im iv central powers world war oxycodone withdrawal oxycodone ca oxycontin oxycodone oxycontin n-oxide n-oxide n-oxide oxycontin oxycodone oxycodone unesco arabic freund speyer university frankfurt bayer merck scophedal twilight sleep ii fda oxycontin international narcotics control board international narcotics control board oxycodone august purdue pharma oxycontin intac oxycontin fda april pfizer oxecta aversion\u00ae technology fda june ontario ontario deaths atlantic ontario purdue pharma oxyneo oxycontin canadian centre abuse maclean alberta blood tribe january oxy blood reserve lethbridge alberta province-wide albertans abuse uk uk september fda department health human services america fda oxycontin oxycontin fda oxycontin oxycontin convention regulating distribution drugs league single convention drugs united nations schedule i. schedule schedule single convention drugs commonwealth drugs act schedule australian standard poisons poisons standard schedule drugs act cdsa february ontario nova scotia ontario february ontario oxyneo exceptional oxyneo purdue pharma oxyneo narcotics safety act ontario act purdue pharma oxyneo oxycontin canada-wide june minister health rona ambrose purdue pharma purdue claimants purdue purdue iii narcotics act bet\u00e4ubungsmittelgesetz btmg schedule drugs ordinance oxycodone misuse drugs act misuse drugs act schedule misuse misuse drugs act act president nixon schedule ii dea acscn percodan methyiodide", " march tegenero immuno therapeutics ii june b-cll march european medicines agency march tegenero immuno therapeutics parexel boehringer-ingelheim tegenero balb hybridomas tcr-independent igg cdrs tcr clinical immunology tcr-mediated ifn-\u03b3 pbmn fc tegenero fc\u03b3 hiv first-in-man parexel northwick park st. mark hospital march parexel good clinical practice gcp northwick park mohammed abdalla elephant man august july north west hospitals nhs trust june head university college trevor smart sunday times july medical professor powell powell ms northampton tegenero uk criticism medicines healthcare regulatory agency mhra mhra mhra dr. david glover march mhra new scientist bbc tegenero april medicines healthcare regulatory agency mhra tegenero parexel mhra boehringer ingelheim mhra uk secretary state health gordon duff professor molecular medicine sheffield university chair uk december expert group clinical trials german federal agency paul ehrlich institute database uk national institute biological standards control tnf\u03b1", " scripps research institute crucell", " anti-inflammatory nsaids cox cox nsaids nsaids nsaids u.s. tylenol nsaids cox nsaids gi nsaids nsaids nsaids nsaids llc imsaids cst-smg early cst-smg sgp-t sgp-t cst-smg sgp-t feg cellular effects imsaids feg phe-glu-gly d-isomer fcyriii plumbago zylanica alzheimer research harpagophytum zingiber arnica punica camellia uncaria uncaria indian boswellia roquefort cannabichromene honokiol magnolia black st. john anti-inflammatory extra-virgin", " atinumab", " cantuzumab canag", " orthoclone u.s. food drug administration fda european communities european medicines agency emea european union committee proprietary medicinal products cpmp chmp paul ehrlich institute frankfurt nuvion crohn iii crs crs neurological crs", " lorvotuzumab spp spp smcc lorvotuzumab merkel ii", " ribavirin rna copegus rebetol ribasphere vilona virazole rsv ribavirin rna rna multiple world health organization list essential medicines ribavirin hiv c. ribavirin crimean-congo hantavirus usamriid ebola marburg omsk kyasanur canine ribavirin ribavirin ribavirin rna rna-dependent rna rna dna rna dna ribavirin gtp rna dna ribavirin aicar j.t.witkowski rbcs iii viramidine", " evolocumab inn repatha amgen evolocumab ldl-c evolocumab ldl-c amgen biologics application bla fda august fda august european commission july evolocumab health september amgen health september", " valganciclovir hoffmann\u2013la roche cymeval valcyt valixa darilin rovalcyte patheon syntex world health organization list essential medicines orally hiv epstein-barr ebv multidimensional fatigue wednesday march new journal medicine cmv cmv national institute allergy diseases roche daiichi-ranbaxy district court new jersey usa roche november fda endo dr. reddy endo roche patent office roche", " filgrastim g-csf g-csf dna escherichia g-csf e. g-csf amgen neupogen list essential medicines filgrastim causes filgrastim filgrastim filgrastim g-csf dna g-csf g-csf g-csf neupogen filgrastim apricus biosciences nupen march sandoz zarxio fda amgen neupogen biologics price competition innovation act bpci act president obama march affordable care act zarxio fda bpci act fda zarxio zarxio neupogen zarxio neupogen", " viru-merz viru-merz serol", " vadastuximab adc seattle genetics aml acute aml american cancer society dna pbd ec-mab vadastuximab pbd ec-mab dec april annual american society hematology ash seattle genetics iii iii hmas ii aml mds vadastuximab u.s. food drug administration fda european commission aml fda", " esomeprazole nexium zollinger-ellison losec prilosec generic nexium h. crohn gastroesophageal gerd helicobacter h. proton drugs ph single oral vimovo vimovo vimovo gi fda viomovo mups astrazeneca daiichi sankyo nexium september nexium daiichi sankyo astrazeneca astrazeneca esomeprazole s-enantiomer r-omeprazole thomas a. scully centers medicare medicaid services astrazeneca nexium american medical association astra nexium generic nexium uk", " clinical ldl hdl hdl fda hdl-c hdl-c hdl-c fibrate cpk ppar ppar\u03b1 ppars ppars ppar\u03b3 fibrates c.", " odulimomab", " app pharmaceuticals emla eutectic mixture anesthetics separately fda promescent u.s. e. fougera prilocaine cream", " amantadine symmetrel endo pharmaceuticals u.s. food drug administration u.s. centers disease control prevention cochrane review parkinson cochrane parkinson centers disease control prevention cdc cdc cochrane amantadine ms amantadine cns cns parkinson livedo parkinson acidification influenza influenza nmda u.s. food drug administration october parkinson asia september u.s. food drug administration dingo chip", "", " elsilimomab", " dolutegravir dtg hiv dolutegravir tivicay glaxosmithkline gsk february food drug administration august fda november health january tivicay european commission european union dolutegravir hiv hiv tivicay c. gfr dolutegravir hiv tdf ftc abc hiv flamingo single hiv rna dolutegravir hiv rna", " rivaroxaban bay bayer janssen pharmaceutica rivaroxaban rivaroxaban september health vte september european commission july u.s. food drug administration fda dvt pe november u.s. fda july national institute clinical rivaroxaban factor xa factor factor xa factor xa rivaroxaban factor ii rivaroxaban clinical rivaroxaban factor xa ufh iii warfarin vka factor x. factor xa october portola pharmaceuticals ii factor xa iii u.s. food drug administration", " lampalizumab inn cfd", " fospropofol lusedra fospropofol fospropofol schedule iv act", " ii use l-methylfolate cns mood l-methylfolate u.s. national institutes health l-methylfolate bdnf gabaergic prayer", " bertilimumab cambridge technology cat january cat therapeutics inc. therapeutics inc. therapeutics inc. ii march ii lonza slough uk june immune pharmaceuticals nasdaq herzliya bertilimumab immune ii bertilimumab crohn bertilimumab nash", " neurology greek neurological m.d. foundation programme royal college physicians diploma psychological medicine aids institute neurology queen square cat mri eeg emg ncss alzheimer disease attention parkinson disease tourette treatment eeg emg ncss eeg emg ncss american board clinical neurophysiology american board electrodiagnostic medicine neurosurgery phd cerebral emg parkinson disease clinical usa eeg emg american journal psychiatry professor joseph b. martin dean harvard medical school neurological parkinson alzheimer huntington", " diridavumab janssen pharmaceutical companies johnson johnson", "", " fda", " nsaids nsaias nsaims nsaids paracetamol nsaids nsaids aspirin aspirin nsaids nsaids nsaids nsaids gi nsaids nsaids nsaids nsaids nsaid nsaids rofecoxib vioxx adrs vigor approve october nsaids nsaids mi nsaids nsaids nsaids nsaids july fda nsaid aspirin nsaids journal urology nsaids adrs gi gi gi clinical nsaid nsaid nsaid gi adrs nsaids adrs indomethacin adrs certain nsaids adrs adrs adrs gi misoprostol adrs nsaids crohn ibd nsaids adrs adrs nsaids gfr ii ii nsaids rpf ace ii nsaids nsaids nsaids nsaids benoxaprofen nsaids nsaids aspirin indomethacin nsaids nsaids nsaid nsaid nsaids dress stevens\u2013johnson nsaid nsaids nsaids nsaids adr rapid stevens\u2013johnson cns cox cns nsaids nsaid nsaids nsaids nsaids ace inhibitors nsaids ssri nsaids faah cox cox john vane nobel prize mechanism nsaids nsaids nsaids paracetamol nsaids nsaids nsaids antipyretics cox ibuprofen e. nsaids nsaids nsaids nsaid naproxen nsaids nsaids nsaids nsaids myrtle bce hippocrates bce bce celsus april edward stone royal society johann andreas buchner henri leroux hermann kolbe kolbe-schmitt felix hoffmann bayer heinrich dreser nsaids nsaids research nsaids nsaid european union eu", " telaprevir incivek incivo vertex pharmaceuticals johnson johnson telaprevir svr svr svr realize svr advance svr april fda antiviral drugs advisory committee c. advance illuminate realize hcv merck telaprevir svr ifn-\u03bb svr svr grade incivek food drug administration fda vertex pharmaceutical inc. december vertex incivek fda incivek august vertex pharmaceuticals incivek", " sirukumab inn usan interleukin sirukumab johnson johnson centocor ii december iii sirround-d ii", " copd fda boehringer ingelheim mdi combivent dey l.p. napa duoneb breva cipla combivent european union cfc", " clazakizumab chinese ii oct june nsclc iii june european league rheumatism eular mtx mtx mtx oct adalimumab mtx ii crohn", " fulranumab fulranumab johnson johnson", " flanvotumab flanvotumab imclone systems", " ruplizumab antova", " alzheimer nmda eli lilly company alzheimer alzheimer memantine u.s. fda european medicines agency alzheimer uk national institute health care alzheimer alzheimer ache alzheimer alzheimer adhd memantine nmda nmda nmda aids alzheimer memantine nmda nmda mg ca nmda nmda alzheimer nmda alzheimer memantine nmda alzheimer nmda alzheimer memantine nmda hcl abixa akatinol axura ebixa mimetix namenda namenda xr noojerone eli lilly company merck index merz neurobiological technologies inc. children hospital boston medical school forest u.s. lundbeck namenda memantine complex regional syndrome", " immunogen inc. nasdaq adc immunogen waltham massachusetts immunogen adc adcs immunogen immunogen amgen bayer healthcare biotest genentech roche eli lilly novartis sanofi takeda roche kadcyla immunogen adc genentech roche group october kadcyla gatsby immunogen adc", " girentuximab rencarex girentuximab wilex ag", " sofosbuvir sovaldi hcv sofosbuvir hcv sofosbuvir rna rna pharmasset gilead sciences fda rbv hcv rbv hcv u.s. u.s. uk september gilead world health organization list essential medicines sofosbuvir sofosbuvir hcv hiv electron hcv american association study liver diseases diseases society america c. hcv sofosbuvir category fda sofosbuvir fda ribavirin females pregnancy registry copegus sofosbuvir p-glycoprotein p-glycoprotein st. john hiv march gilead sciences sofosbuvir rna rna ntp ntp sobosbuvir rna-dependent rna sofosbuvir hcv rna hcv new drug application april fda breakthrough therapy designation december fda c. combinations hcv retroviruses march hcv gilead october fda harvoni sofosbuvir u.s. u.s. u.s. april u.s. house democrats henry waxman frank pallone jr. degette gilead sciences inc. gilead ceo john martin sofosbuvir c. congress february gilead technology assessment forum gilead gb\u00a3 september gilead jennifer cohn world medicines index manufacturing distribution gilead gilead september economic times february world european patent office world mcguigan cardiff university uk january patent office mumbai gilead february", " interleukin tnf-alpha cyclophosphamide baxter high methotrexate behcet disease azathioprine prometheus dna mercaptopurine alg atg gvhd march atgam thymoglobuline ptld urticaria tcr past tcr-antigen t. tac zenapax novartis sandimmune cni ciclosporin ciclosporin calcineurin nmsc cni tacrolimus prograf tacrolimus sirolimus rapamune sirolimus igm igg iga ifn-\u03b3 decrease tnf-\u03b1 enbrel humira crohn infliximab tnf tnf impdh fingolimod myriocin ciclosporin", " ganitumab ganitumab amgen iii august", " trastuzumab herclon herceptin egfs human epidermal growth factor receptor human epidermal growth factor cochrane review rr rr hr hr rr rr world health organization list essential medicines usd trastuzumab clinical roche trastuzumab trastuzumab fak trastuzumab akt mirk egf egf egfr egf map kinase kinase egf cdks akt. trastuzumab iv akt trastuzumab akt mirk trastuzumab trastuzumab ihc pcr ihc dako herceptest ventana pathway treatment ihc ihc fish cish cish fish cish june roche fda inform ish dna probe ventana medical systems ddish in-situ red ish dnp dig currently ihc fish ihc fish fda-cleared automated tissue herceptin herceptinr herceptinr herceptin antibodies herceptin ucla fda september dr. axel ullrich dr. h. michael shepard ucla jonsson comprehensive cancer center dr. dennis slamon dr. slamon living october pharmaceutical scheme roche roche herclon rs inr usd biocon november marketing authorization drugs controller general dcgi mylan canmab\u2122 biocon september october ret vandetanib vegfr egfr cabozantinib", " aducanumab usan alzheimer biogen idec neurimmune international conference alzheimer parkinsons diseases related neurological disorders march", " ganciclovir inn dhpg cmv ganciclovir cytovene cymevene roche ganciclovir vitrasert bausch lomb ganciclovir cmv subsequently cmv ganciclovir dna dna dna dna ganciclovir cmv hiv cmv ganciclovir human herpesvirus ganciclovir ganciclovir ph ganciclovir absorption hiv ganciclovir cmv hiv"]